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SUMMARY
A l p h a - l - f o e t o p r o t e i n  (AFP)  i s  a g l y c o p r o t e i n  p r e s e n t  a t  h i g h
c o n c e n t r a t i o n  i n  f o e t a l  se rum u n t i l  b i r t h ,  w i t h  r e s i d u a l  l o w  l e v e l s
p r e s e n t  t h r o u g h o u t  a d u l t  l i f e .  The m o s t  f r e q u e n t  ca use  o f  e l e v a t e d
AFP c o n c e n t r a t i o n  i n  a d u l t s  i s  p r e g n a n c y ,  d u r i n g  w h i c h  f o e t a l  AFP
p a s s e s  a c r o s s  t h e  p l a c e n t a  and t h e  a m n io n  i n t o  t h e  m a t e r n a l
c i r c u l a t i o n .  The c o n c e n t r a t i o n  o f  m a t e r n a l  serum AFP (MS-AFP) i s
r e l a t e d  t o  t h e  g e s t a t i o n a l  age ,  and t o  t h e  c l i n i c a l  s t a t u s  o f  t h e
f o e t u s  and p l a c e n t a .  E l e v a t e d  MS-AFP i s  a m a r k e r  o f  s e v e r a l  c l i n i c a l
e n t i t i e s ,  o f  w h i c h  t h e  mos t  i m p o r t a n t  and f r e q u e n t  a r e  n e u r a l  t u b e
d e f e c t s .  I n  v i e w  o f  t h i s ,  s i n c e  1 9 7 5 ,  t h e  e n t i r e  m i d - t r i m e s t e r
p r e g n a n t  p o p u l a t i o n  o f  t h e  West o f  S c o t l a n d  has been o f f e r e d  MS-AFP
s c r e e n i n g  and a t  t h e  s t a r t  o f  t h i s  p r o j e c t  t h e  West o f  S c o t l a n d
m a t e r n a l - s e r u m  s c r e e n i n g  p rogramme u s e d  a R a d io Im m unoA ssa y  ( R I A )  
1 2 5 -
t e c h n i q u e  w i t h  I o d i n e  l a b e l l e d  AFP and sheep  a n t i - h u m a n  AFP
a n t i s e r u m .  S e p a r a t i o n  was e f f e c t e d  by 1 6 - h o u r  i n c u b a t i o n  i n  
p o l y e t h y l e n e  g l y c o l  6 0 0 0 .  3 0 , 0 0 0  s a m p l e s  p e r  y e a r  were  b e i n g  a s s a y e d
and t h e  w o r k l o a d  was i n c r e a s i n g .  D i s a d v a n t a g e s  o f  t h e  RIA i n c l u d e d  
t h e  l o n g  i n c u b a t i o n  t i m e ,  l a c k  o f  r o b u s t n e s s  and r e l i a b i l i t y ,  and 
p o o r  s e n s i t i v i t y  and p r e c i s i o n .
The p o t e n t i a l  s u p e r i o r i t y  o f  a c o m m e r c i a l l y  a v a i l a b l e  
t w o - s i t e  I m m u n o R a d i o M e t r i c  Assay ( IRM A)  w i t h  r e s p e c t  t o  s e n s i t i v i t y ,  
p r e c i s i o n  and w o r k i n g  r a n g e  was c o n f i r m e d  d u r i n g  l o c a l  e v a l u a t i o n  b u t  
was i n v a l i d a t e d  f o r  r o u t i n e  use i n  t h e  s c r e e n i n g  p rogramme by i t s  
c o s t .  A c c o r d i n g l y ,  t h i s  p r o j e c t  was i n i t i a t e d  i n  o r d e r  t o
m a n u f a c t u r e  an i n - h o u s e  IRMA w h i c h  w o u l d  be a v a i l a b l e  t o  NHS 
l a b o r a t o r i e s .
P o l y c l o n a l  a n t i b o d i e s  w e re  g e n e r a t e d  by i m m u n i z i n g  m ic e  
i n t r a - p e r i t o n e a l l y  w i t h  10 m i c r o g r a m m e s  ( u g )  o f  AFP ( i n  a m n i o t i c  
f l u i d )  s u s p e n d e d  i n  F r e u n d ’ s a d j u v a n t .  Two b o o s t s  were  g i v e n  a t  two  
weeks  and f o u r  weeks ,  and a p r e - f u s i o n  i n t r a v e n o u s  b o o s t  o f  4 ug was 
a d m i n i s t e r e d  3 days  b e f o r e  p o s t - m o r t e m  r e m o v a l  o f  t h e  s p l e e n .  
M o n o c l o n a l  a n t i b o d y - s e c r e t i n g  c e l l  l i n e s  were  p r o d u c e d  by 
p o l y e t h y l e n e  g l y c o l  1500 f u s i o n  o f  mouse s p l e e n  c e l l s  1 :1  w i t h  mouse 
mye loma X63 A g 8 .6 5 3  c e l l s .  N o n - h y b r i d  mye loma c e l l s  were k i l l e d  by
i n c l u s i o n  o f  h y p o x a n t h i n e - a m i n o p t e r i n - t h y m i d i n e  (HAT) i n  t h e  medium 
and n o n - h y b r i d  s p l e e n  c e l l s  w e re  n o t  v i a b l e  i n  t h e  c u l t u r e
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c o n d i t i o n s .  P r e p a r a t o r y  w o rk  on t h e  f u s i o n  t e c h n i q u e  had shown t h a t
t h e  p r e s e n c e  o f  mouse p e r i t o n e a l  m a c r o p h a g e s  i n c r e a s e d  t h e  l i k e l i h o o d
o f  f i n d i n g  v i a b l e  h y b r i d  c o l o n i e s  f r o m  6 p e r  96 w e l l s  t o  >50 p e r  96
w e l l s ,  and r a p i d l y  r e d u c e d  t h e  q u a n t i t y  o f  d e b r i s  p r e s e n t .  Thus
c e l l s  f r o m  each f u s i o n  e x p e r i m e n t  were  p l a t e d  i n t o  480 w e l l s
p r e v i o u s l y  i n o c u l a t e d  w i t h  3 , 0 0 0  m a c r o p h a g e s  p e r  w e l l .
I n  o r d e r  t o  i n v e s t i g a t e  o n l y  h i g h  a v i d i t y / a f f i n i t y
a n t i b o d i e s ,  an RIA m et h o d  was used  t o  s c r e e n  s u p e r n a t a n t  f r o m  a l l
w e l l s  f o r  a n t i b o d y  s e c r e t i o n .  A l l  s u p e r n a t a n t s  d e m o n s t r a t i n g  h i g h
b i n d i n g  were  t h e n  a s s e s s e d  a t  an a p p r o p r i a t e  d i l u t i o n  f o r
d i s p l a c e m e n t .  F o r  t h i s  t h e  f l u i d  was i n c u b a t e d  i n  t h e  p r e s e n c e  and
a b s e n c e  o f  a n t i g e n .  S u p e r n a t a n t s  s h o w i n g  c o n s i d e r a b l e  d i s p l a c e m e n t
w e r e  s e l e c t e d  f o r  f u r t h e r  i n v e s t i g a t i o n ;  t h e  c e l l  l i n e s  w ere  c l o n e d
by l i m i t i n g  d i l u t i o n  and l a r g e  q u a n t i t i e s  o f  m o n o c l o n a l  a n t i b o d y
p r o d u c e d  by i n j e c t i n g  t h e  c l o n e  i n t o  mouse p e r i t o n e u m .
Of n i n e  m i c e  i m m u n i z e d ,  one was k i l l e d  b e f o r e  i t  was
r e a l i s e d  t h a t  t h e  mye loma c e l l s  were  n o n - v i a b l e  o w in g v  t o  h i g h
i n c u b a t o r  t e m p e r a t u r e .  Two m i c e  w e re  used  f o r  s i x  f u s i o n
e x p e r i m e n t s ,  and o v e r  90% o f  t h e  2880 w e l l s  p l a t e d  showed v i a b l e ,
h y b r i d  c o l o n i e s .  1136 w e l l s  ( 3 9 . 4 % )  c o n t a i n e d  a n t i - A F P  s e c r e t i n g
1 2 5 -
c o l o n i e s  ( a r b i t r a r i l y  d e f i n e d  as >10% b i n d i n g  o f  I o d i n a t e d - A F P ) ,
many o f  w h i c h  w i l l  ha ve  c o n t a i n e d  s e v e r a l  c l o n e s .  S u p e r n a t a n t  f r om
291 w e l l s  ( 1 0 . 1 % )  bound  g r e a t e r  t h a n  30% o f  added  l a b e l ,  and were
s u b j e c t e d  t o  d i s p l a c e m e n t  t e s t i n g .  67 w e l l s  w ere  s e l e c t e d  f o r
s t o r a g e  a f t e r  some g r o w t h ,  o f  w h i c h  16 w e l l s ,  e x h i b i t i n g  t h e  b e s t
g r o w t h - r a t e ,  a n t i b o d y  a v i d i t y  and s e c r e t i o n  c h a r a c t e r i s t i c s ,  were
c l o n e d  by l i m i t i n g  d i l u t i o n .  Two e p i s o d e s  o f  i n f e c t i o n ,  one by
Pseudomonas  ( f r o m  a b o u g h t - i n  r e a g e n t )  and one by an u n i d e n t i f i e d
b a c t e r i u m ,  p r e v e n t e d  more  t h a n  two  c l o n e s  b e i n g  used  t o  g e n e r a t e
l a r g e  q u a n t i t i e s  o f  m o n o c l o n a l  a n t i b o d y  i n  mouse a s c i t i c  f l u i d  f o r
125
s o l i d - p h a s e  c o u p l i n g  and - I o d i n a t i o n  s t u d i e s .
The two a n t i b o d i e s  were  o f  s i m i l a r  a v i d i t y  and had s i m i l a r
s p e c i f i c i t y ,  w h i c h  p r e v e n t e d  t h e  d e v e l o p m e n t  o f  a d o u b l e - m o n o c l o n a l
a s s a y .  C h a r a c t e r i z a t i o n  o f  t h e  a n t i b o d i e s  showed t h a t  t h e y  were  o f
10
t h e  I g G l  i s o t y p e  and had a v i d i t i e s  o f  a p p r o x i m a t e l y  10
IRMA a s s a y  c o n d i t i o n s  w ere  o p t i m i z e d ,  s t a r t i n g  f r o m  a
s t r a i g h t f o r w a r d ,  l o w - c o s t  b a s e .  A l a r g e - s c a l e  e v a l u a t i o n  o f  t h e
c o m p l e t e d  t e c h n i q u e  was p e r f o r m e d  u s i n g  b o t h  d e n s i t y  g r a d i e n t
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s e d i m e n t a t i o n ,  and s a l i n e  wash m e t h o d s  f o r  s e p a r a t i n g  t h e  bound  and 
f r e e  f r a c t i o n s .
D e v e l o p m e n t  o f  a p r a c t i c a b l e  IRMA p r o t o c o l  showed t h a t  
i n c u b a t i o n  t i m e  o f  2 . 5  h o u r s  gave  min imum d r i f t , a n d  t h a t  t h e  a d d i t i o n  
o f  s h eep  serum and d e t e r g e n t  t o  t h e  i n c u b a t e  was n e c e s s a r y  t o  
m i n i m i s e  n o n - s p e c i f i c  b i n d i n g  e f f e c t s  and m a x i m i s e  s e n s i t i v i t y .  
A f t e r  o p t i m i z a t i o n  o f  t h e  IRMA i t  was a p p a r e n t  t h a t  t h e  p a r a m e t e r s  o f  
t h e  a s s a y  ( b a s e d  on p r e c i s i o n  p r o f i l e  d a t a )  w e r e ;  s e n s i t i v i t y  < l k (J / L  
( c o m p a r e d  t o  RIA -  1 5 k U / L ) ,  i n t e r - a s s a y  CV 4% (c o m p a re d  t o  RIA 
10%) ,  and w o r k i n g  r a n g e  5 - > 5 0 0 k U / L  (c o m p a r e d  t o  RIA -  3 0 - 4 0 0 k U / L ) .  
No dose  d i f f e r e n c e  was o b s e r v e d  b e tw e e n  t h e  s e p a r a t i o n  m et hods  
i n v e s t i g a t e d ;  d e n s i t y  s e d i m e n t a t i o n  was used  f o r  t h e  West o f  S c o t l a n d  
m a t e r n a l  se rum s c r e e n i n g  p rogr amme b e c a u s e  o f  i t s  s u i t a b i l i t y  f o r  
l a r g e  a s s a y s  and t h e  a v a i l a b i l i t y  o f  s u i t a b l e  e q u i p m e n t .  L i n e a r  
r e g r e s s i o n  a n a l y s i s  o f  2291 s a m p l e s  a s s a y e d  i n  p a r a l l e l  by b o t h  RIA 
and IRMA d e m o n s t r a t e d  a g r a d i e n t  o f  1 . 2 9  ( f o r  l o c a l  r e a s o n s ,  1 . 2 5  was 
e x p e c t e d ) ,  i n t e r c e p t  + 3 . 1 k U / L  and c o r r e l a t i o n  c o e f f i c i e n t  0 . 9 5 6 .  The 
IRMA a s s a y  was c o n s e q u e n t l y  i n t r o d u c e d  i n t o  r o u t i n e  u s e .
E x p e r i e n c e  i n  r o u t i n e  use  d e m o n s t r a t e d  t h a t  p r e v i o u s l y  
u n d e t e c t a b l e  s h i f t s  o f  2% b e tw e e n  s t a n d a r d  p r e p a r a t i o n s  were  
d e t e c t a b l e .  T h i s  i m p r o v e m e n t  i n  p r e c i s i o n  has  e n a b l e d  a c l i n i c a l l y  
s i g n i f i c a n t  r e d u c t i o n  i n  t h e  i n t e r v e n t i o n  l e v e l  f r o m  t h e  9 7 t h  t o  t h e  
9 5 t h  c e n t i l e .  I m p r o v e d  s e n s i t i v i t y  has e n a b l e d  t h e  i n i t i a t i o n  o f  
l o w -M S - A F P  s c r e e n i n g  t o  g i v e  a r i s k  f a c t o r  f o r  D ow n ' s  syn dr om e i n  
each  p r e g n a n c y  wh e re  m a t e r n a l  age and w e i g h t  a r e  s u p p l i e d .  E i g h t  
o t h e r  l a b o r a t o r i e s  a re  u s i n g  t h e  l a b e l l e d  a n t i b o d y  ( A F 5 / A 2 )  r e a g e n t ,  
t h r e e  i n  S c o t l a n d ,  f o u r  i n  E n g l a n d  and one i n  W a l e s .  Each l a b o r a t o r y  
has  a d j u s t e d  t h e  p r o t o c o l  f o r  t h e i r  own c i r c u m s t a n c e s .
The a n t i b o d y  has been p u r c h a s e d  f o r  use  i n  a c o m m e r c i a l  
a l p h a - l - f o e t o p r o t e i n , i m m u n o f l u o r i m e t r i c a s s a y  m et hod  w h i c h  i s  w i d e l y  
m a r k e t e d  f o r  b o t h  m a t e r n a l  se rum  s c r e e n i n g  and t u m o u r  m a r k e r  s t u d i e s .
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CHAPTER 1 INTRODUCTION
1A CHEMISTRY OF ALPHA-1-FOETOPROTEIN
i )  D i s c o v e r y
The f i r s t  u n e q u i v o c a l  i d e n t i f i c a t i o n  o f  a l p h a - l - f o e t o p r o t e i n  
was made by B e r g s t r a n d  and Czar  ( 1 9 5 6 )  when t h e y  d e m o n s t r a t e d  a m a j o r  
p r o t e i n  c o m p o n e n t  o f  e a r l y  human f o e t a l  se rum  w h i c h  was n o t  p r e s e n t  
i n  a d u l t s  and w h i c h  m i g r a t e d  s l i g h t l y  more s l o w l y  t h a n  a l bum en  on 
e l e c t r o p h o r e s i s .  U l t r a c e n t r i f u g a t i o n  i n d i c a t e d  a m o l e c u l a r  w e i g h t  o f  
6 5 , 0 0 0  d a l t o n s .
i i )  S t r u c t u r e
N i s h i  ( 1 9 7 0 )  used  a n t i g e n - a n t i b o d y  p r e c i p i t a t i o n  t o  p u r i f y  AFP 
f r o m  two  s o u r c e  m a t e r i a l s ,  c a r d i a c  se rum f r o m  t e n  a b o r t e d  human
f o e t u s e s  a t  7 - 1 0  weeks g e s t a t i o n  and se ru m  f r o m  an h i s t o l o g i c a l l y
c o n f i r m e d  c a s e  o f  p r i m a r y  h e p a t o c e l l u l a r  c a r c i n o m a .  The two  AFPs
w ere  ' c h a r a c t e r i z e d  s e p a r a t e l y  and were  i n d i s t i n g u i s h a b l e  c h e m i c a l l y ;  
i n  n i t r o g e n ,  s u g a r ,  s u l p h u r  and a m i n o - a c i d  c o n s t i t u t i o n ,  and 
p h y s i c o c h e m i c a l l y  by d e t e r m i n a t i o n  o f  S v e d b e r g  and d i f f u s i o n
c o e f f i c i e n t s ,  d i s c  e l e c t r o p h o r e s i s  and d o u b l e  ( O u c h t e r l o n y ) 
i m m u n o d i f f u s i o n .
I n v e s t i g a t i o n  o f  t h e  amino a c i d  s e q u e n c e s ,  o f  a l bum en and AFP, 
o b t a i n e d  by c y a n o g e n  b r o m i d e  and p e p t i c  d i g e s t i o n  l e d  Brown ( 1 9 7 6 )  t o  
r e c o g n i z e  3 d o m a i n s ,  each  w i t h  3 s u b d o m a i n s ,  w h i c h  he p o s t u l a t e d  as 
d e r i v e d ,  by d u p l i c a t i o n  and s u b s e q u e n t  d i v e r g e n c e ,  some 700 m i l l i o n  
y e a r s  ago f r o m  a 190 amino  a c i d  a n c e s t r a l  p o l y p e p t i d e .
Sod ium d o d e c y l  s u l p h a t e  g e l  s t u d i e s  showed t h a t  AFP has a
s i n g l e  p o l y p e p t i d e  c h a i n ;  R u o s l a h t i  and H i r a i  ( 1 9 7 8 )  r e p o r t e d
e s t i m a t e s  o f  m o l e c u l a r  w e i g h t s  r a n g e d  f r o m  6 4 6 0 0 - 7 0 0 0 0 ,  and
c a r b o h y d r a t e  c o n t e n t ,  c o n s i s t i n g  o f  N - a c e t y l g l u c o s a m i n e , mannose,  
g a l a c t o s e  and s i a l i c  a c i d  r e s i d u e s ,  f r o m  3% t o  4 .5 % .  I n  a d d i t i o n ,  
a g g r e g a t i o n ,  e s p e c i a l l y  t o  a d i m e r i c  f o r m ,  was n o t e d  as was t h e  
s i m i l a r i t y  o f  t h e  amino  a c i d  c o m p o s i t i o n  t o  t h a t  o f  a l bumen
( R u o s l a h t i  & T e r r y  1 9 7 6 ) .  They c o n c l u d e d  t h a t  t h e r e  was some
h e t e r o g e n e i t y  b u t  t h e y  d i d  n o t  a c c e p t  t h a t  AFP had s u b s t a n t i a l  
v a r i a n t s .  Thus a l t h o u g h  two  N - t e r m i n a l  s e q u e n c e s  had been f o u n d ,  one 
l a c k i n g  a t r i p e p t i d e ,  b o t h  were p r e s e n t  i n  f o e t a l  and hepa toma serum
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and i n  e q u a l  p r o p o r t i o n s .
The c a r b o h y d a t e  c o n t e n t  o f  b o v i n e  AFP was i n v e s t i g a t e d  by 
K r u s i u s  & R u o s l a h t i  ( 1 9 8 2 )  u s i n g  p r o t e a s e  d i g e s t i o n  and 
h y d r a z i n o l y s i s . They f o u n d ;  N - a c e t y l  n e u r a m i n i c  a c i d ,
N - a c e t y l g l u c o s a m i n e , mannose ,  g a l a c t o s e  and a s m a l l  amount  o f  f u c o s e .  
T h e r e  were  t h r e e  v a r i a n t s  s e p a r a b l e  by f i l t r a t i o n  t h r o u g h  
c o n c a n a v a l i n - A  i m m o b i l i z e d  on s e p h a r o s e .  Human AFP has  been  r e p o r t e d  
t o  have o n l y  one g l y c a n  ( S m i t h  and K e l l e h e r  1 9 8 0 )  and M o r i n a g a  
e t  a l . ( 1 9 8 3 )  r e p o r t  a 12 r e s i d u e  g l y c a n  bound  t o .  a s p a r a g i n e  23 2 ,
w h i c h  t h e y  f o u n d  t o  be t h e  o n l y  a v a i l a b l e  a t t a c h m e n t  p o i n t  on t h e  
p o l y p e p t i d e  c h a i n .  N o n e t h e l e s s ,  T o f t a g e r - L a r s e n  e t  a l . ( 1 9 8 3 )  showed 
t h e  e x i s t e n c e  o f  s e v e r a l  v a r i a n t s  i n  t h e  c a r b o h y d r a t e  m o i e t y  by 
b a n d i n g  p a t t e r n s  w i t h  p l a n t  l e c t i n s .
i i i )  Gene
E l e c t r o n  m i c r o s c o p y  ( K i o u s s i s  e t  a l . 1 9 8 1 )  o f  AFP and a lbu men  
mRNAs h y b r i d i z e d  t o  g e n o m i c  DNA d i s p l a y e d  15 e x o n s  and 14 i n t r o n s  i n  
b o t h  p r o t e i n s .  E i f e r m a n  and c o l l e a g u e s  ( 1 9 8 1 )  i n v e s t i g a t e d  t h e  exon  
j u n c t i o n s  o f  m u r i n e  AFP w i t h  c l o n e d  g e n o m i c  DNA and showed t h a t  t h e  
p r o t e i n  s e q u e n c e ,  and n u c l e o t i d e  s e q u e n c e s  o f  e x o n s  3 t o  14 
c o r r e s p o n d e d  t o  a t h r e e f o l d  r e p e a t  o f  f o u r  e x o n s  p e r  d o m a i n .  They 
s u g g e s t e d  an e v o l u t i o n a r y  mec han i sm  o f  t r i p l i c a t i o n  and d i v e r g e n c e  
a f t e r  d u p l i c a t i o n  o f  t h e  a n c e s t r a l  gene 3 0 0 - 5 0 0  m i l l i o n  y e a r s  ago t o  
f o r m  AFP and a l b u m e n .
B e a t t i e  and D u g a i c z y k  ( 1 9 8 2 )  i d e n t i f i e d  human AFP mRNA 
e x t r a c t e d  f r o m  f o e t a l  l i v e r  ( 1 7 - 2 0  weeks g e s t a t i o n )  u s i n g  a mouse 
cDNA p r o b e .  The p r o t e i n  se q u e n ce  d e duce d  ( a m i n o  a c i d s  4 0 5 - 5 3 2 )  
showed good  a g r e e m e n t  w i t h  c y a n o g e n  b r o m i d e  d e g r a d a t i o n  and 
d e m o n s t r a t e d  44% h o m o l o g y  w i t h  t h e  3 r d  d o m a i n  o f  a lb u m e n .  They 
showed t h a t  t h e  r a t e  o f  e v o l u t i o n  f o r  AFP was g r e a t e r  t h a n  t h a t  f o r  
a l b u m e n .
H a r p e r  and D u g a i c z y k  ( 1 9 8 3 )  used  two cDNA c l o n e s  p r e p a r e d  f r o m  
mRNA and a b o u t  1600 and 384 b a s e s  l o n g  f o r  i n  s i t u  h y b r i d i z a t i o n  
s t u d i e s  and showed t h a t  a l bum en and AFP a r e  l i n k e d .  They l o c a l i z e d  
b o t h  genes  t o  bands  q l l - 2 2  on chromosome 4 .
M o r i n a g a  e t  a l . ( 1 9 8 3 )  s e q u e n c e d  t h r e e  cDNA c l o n e s  and a
g e n o m i c  c l o n e  t o  p r o d u c e  t h e  c o m p l e t e  a l p h a - f o e t o p r o t e i n  mRNA 
s t r u c t u r e .  The de duce d  amino a c i d  s e q u e n c e  c o n t a i n s  590 r e s i d u e s
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(mouse  AFP has  5 8 6 )  and i s  shown i n  F i g u r e  1. The c a l c u l a t e d  
m o l e c u l a r  w e i g h t  i s  6 6 , 3 0 0  o r ,  w i t h  4% c a r b o h y d r a t e ,  6 9 , 0 3 0  d a l t o n s .  
The p r o t e i n  showed 39% o v e r a l l  h o m o l o g y  w i t h  human a lb um en  and t h e  
m a j o r  s t r u c t u r a l  d i f f e r e n c e  was f o u n d  t o  be l a c k  o f  two d i s u l p h i d e  
b r i d g e s  w i t h ,  c o n s e q u e n t l y ,  t h e  f o r m a t i o n  o f  a " h i n g e "  be tw e e n  
d o m a i n s  2 and 3 i n  AFP.
A g e n o m i c  c l o n e  f rom f i b r o b l a s t s  w h i c h  were  n o t  p r o d u c i n g
e i t h e r  AFP o r  a l bu m en  i s o l a t e d  by U ra no  e t  a l  ( 1 9 8 4 )  and i n s e r t e d  i n
b a c t e r i o p h a g e  la m b d a  (C ha ro n  4A) showed t h a t  t h e  genes were  i n  tandem
1 4 . 5  k i l o b a s e s  a p a r t  and i n  t h e  same o r i e n t a t i o n  w i t h  a l bum en  
u p s t r e a m .  They  a l s o  c o n c l u d e d  t h a t  no g r o s s  r e a r r a n g e m e n t  o f  t h e  
g e n e s  was n e c e s s a r y  f o r  e x p r e s s i o n  o f  t h e  p r o t e i n s .
O l s s o n  e t  a l . ( 1 9 7 7 )  r e p o r t e d  t h e  d i s c o v e r y  o f  p e r s i s t e n t  h i g h  
AFP i n  t h e  mouse s t r a i n  B A L B / c / J  and  t h a t  i t  i s  c o n t r o l l e d  by one 
r e c e s s i v e  M e n d e l i a n  g e ne .  The h e r e d i t a r y  p e r s i s t e n c e  o f  human 
h y p e r a l p h a - f o e t o p r o t e i n a e m i a  (HP-AFP 1 0 4 1 4 ;  M c K u s i c k  1988 )  i n  a l a r g e  
k i n d r e d  was r e p o r t e d  by F e r g u s o n - S m i t h  e t  a l . ( 1 9 8 3 ) .  T h i s  was shown
t o  be an a u t o s o m a l  d o m i n a n t  t r a i t ,  and c o s e g r e g a t i o n  o f  HP-AFP,
a l b u m e n ,  AFP and GC ( v i t a m i n  D b i n d i n g  a l p h a g l o b u l i n ) was o b s e r v e d  
w i t h  r e s t r i c t i o n  f r a g m e n t  l e n g t h  p o l y m o r p h i s m s  d e t e c t e d  u s i n g  a cDNA 
a l b u m e n  p r o b e  ( F e r g u s o n - S m i t h  e t  a l . 1 9 8 5 ) .
DOMAIN 1





FIGURE 1 The 590 amino-acid sequence of A l p h a - 1- foetoprotein.
The 4-amlno-ac1d group absent from mouse AFP Is underlined and the 
carbohydrate slde-chaln attachment point (at  asparaglne-232)  Is 
indicated.
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IB  PHYSIOLOGY OF ALPH A-1-FOETOPROTEIN
i )  F u n c t i o n
No c o n v i n c i n g  e v i d e n c e  has  been  g i v e n  f o r  t h e  e x i s t e n c e  o f  
s p e c i f i c  f u n c t i o n s  f o r  AFP b u t  s i n c e  i t  i s  l i n k e d ,  and c l o s e l y  
r e l a t e d ,  t o  a l b u m e n ,  and a p p e a r s  i n  i t s  s t e a d  i n  t h e  f o e t u s ,  e f f o r t s  
h ave  been made t o  show t h a t  i t  a c t s  as a t r a n s p o r t  p r o t e i n .  S o l o f f  
e t  a l  ♦ ( 1 9 7 1 )  f o u n d  t h a t  r a t  AFP b i n d s  o e s t r i o l ,  b u t  t h i s  has n o t
been  c o n f i r m e d  i n  man. B e l a n g e r  e t  a l . ( 1 9 8 1 )  r e p o r t e d  d e x a m e t h a s o n e  
s u p p r e s s i o n  o f  AFP s y n t h e s i s  i n  n e w b o r n  r a t  l i v e r ,  and S a k a i  e t  a l . 
( 1 9 8 5 )  fo u n d  a 9 b a s e - p a i r  se q u e n ce  i n  t h e  5 - p r i m e  f l a n k i n g  r e g i o n  o f  
t h e  human gene w h i c h  i s  s i m i l a r  t o  t h e  g l u c o c o r t i c o i d  r e s p o n s e
s e q u e n c e  (S c h m i d  1 9 8 2 ) .
I m m u n o s u p p r e s s i v e  a c t i v i t y  has  been  r e p o r t e d  by M u r g i t a  and 
To m as i  ( 1 9 7 5 )  and w o u l d  be c o n s i s t e n t  w i t h  t h e  p r e s e n c e  o f  AFP d u r i n g  
p r e g n a n c y .
i i )  S i t e  o f  S y n t h e s i s
The y o l k  sac  i s  a l m o s t  c e r t a i n l y  t h e  s o u r c e  o f  e a r l y  AFP, b u t  
p r o d u c t i o n  l a t e r  s h i f t s  t o  t h e  l i v e r .  T h e r e  i s  some e v i d e n c e  o f  AFP
s y n t h e s i s  i n  t h e  g a s t r o i n t e s t i n a l  t r a c t  ( G i t l i n  1 9 7 5 ) .  T h i s
p r o d u c t i o n  p a t t e r n  i s  r e f l e c t e d  i n  t h e  p a t h o l o g y .
S t u d i e s  on t h e  b i n d i n g  o f  AFP t o  j a c k  bean  ( C a n a v a l i a  
e n s i f o r m i s )  l e c t i n  c o n c a n a v a l i n - A  ( t e r m i n a l  m a n n o s y l  and g l u c o s y l  
r e s i d u e  b i n d i n g  p r o t e i n )  r e v e a l e d  t h e  e x i s t e n c e  o f  b i n d i n g  and 
n o n - b i n d i n g  f r a c t i o n s  ( K r u s i u s  & R u o s l a h t i  1 9 8 2 ) .  L e n t i l  (Lens  
c u l i n a r i s )  l e c t i n  was shown t o  p o s s e s s  n o t  o n l y  n o n - r e a c t i v e  and
r e a c t i v e  v a r i a n t s ,  b u t  a l s o  a w e a k l y  r e a c t i v e  f r a c t i o n
( T o f t a g e r - L a r s e n  e t  a l . 1 9 8 3 ) .  I n  e a r l y  p r e g n a n c y  a s u b s t a n t i a l  
p r o p o r t i o n  o f  f o e t a l  AFP i s  c o n c a n a v a l i n - A  n o n - r e a c t i v e , w h e re a s  th e  
p r o p o r t i o n  o f  c o n c a n a v a l i n - A  r e a c t i v e  AFP i n c r e a s e s  w i t h  g e s t a t i o n  
w h i c h  s u g g e s t s  t h e  l i v e r  i s  t h e  s o u r c e  o f  t h i s  v a r i a n t .  As t h e r e  i s  
o n l y  one AFP g e n e ,  t h e  l e c t i n  b i n d i n g  p a t t e r n s  show e i t h e r  
p o s t - t r a n s l a t i o n a l  p r o c e s s i n g  d i f f e r e n c e s  o r  mRNA p r o c e s s i n g  a t  t h e  
v a r i o u s  p r o d u c t i o n  s i t e s .
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i i i )  P r o d u c t i o n  p a t t e r n
P r o d u c t i o n  o f  AFP i n  t h e  f o e t u s  b e g i n s  w i t h  t h e  d e v e l o p m e n t  o f  
t h e  y o l k  sac a t  a r o u n d  4 - 6  weeks and t h e  f o e t a l  se rum c o n c e n t r a t i o n  
p e a k s  a t  a b o u t  13 weeks  g e s t a t i o n ,  when i t  may c o n s t i t u t e  up t o  1 / 3  
o f  t o t a l  serum p r o t e i n ,  a l t h o u g h  p r o d u c t i o n  may peak a t  2 0 - 3 0  weeks 
( G i t l i n  1 9 7 5 ) .
I n  n o r m a l  a d u l t s  t h e  n o r m a l  r a n g e  o f  AFP has been r e p o r t e d  t o  
be 2 - 2 0 n g / m L  ( T a l e r m a n n  e t  a l . 1 9 7 8 ) .  T h i s  i s  e q u i v a l e n t  t o  a b o u t  
1 . 6 - 1 6 k U / L  o f  AFP u s i n g  t h e  B r i t i s h  S t a n d a r d  c o r d  se rum p r e p a r a t i o n  
BS 7 2 / 2 2 7  ( S i z a r e t  e t  a l . 1 9 7 5 ) .
i v )  D i s t r i b u t i o n  i n  n o r m a l  p r e g n a n c y
G i t l i n  and Boesman ( 1 9 6 6 )  d e s c r i b e  t h e  b i o l o g y  o f  AFP and i t s  
p r o d u c t i o n  d u r i n g  p r e g n a n c y  w h i c h  t h e y  f o u n d  l o w  a t  6 . 5  weeks 
g e s t a t i o n  r e a c h i n g  a p l a t e a u  f r o m  22 t o  32 weeks f o l l o w e d  by s t e a d y  
f a l l .  They r e p o r t e d  t h e  h i g h e s t  c o n c e n t r a t i o n  o f  AFP i n  f o e t a l  se rum 
t o  be 3 g / L  a t  13 weeks and t h e  p o s t - n a t a l  h a l f - l i f e  t o  be f i v e  d a y s .  
They  s u g g e s t e d  t h e  p l a c e n t a  as t h e  s i t e  o f  s y n t h e s i s .  P r o d u c t i o n  o f
a l b u m e n  was a l s o  lo w  a t  6 . 5  weeks ( c o n c e n t r a t i o n  o f  0 . 1 5 g / L ) ,  r i s i n g  
i n  p a r a l l e l  w i t h  AFP c o n c e n t r a t i o n  b u t  d e l a y e d  by 4 - 6 w e e k s ,  t o  a 
p l a t e a u  o f  30 g / L  ( a p p r o x i m a t e l y  n o r m a l  a d u l t  l e v e l )  a t  26 w eeks .  
They  re m a rk e d  on t h e  h i g h e r  c o n c e n t r a t i o n  o f  a l bu m en  f o u n d  i n  
a m n i o t i c  f l u i d  com pa re d  t o  f o e t a l  u r i n e  and c o n c l u d e d  t h a t  i t  must  
have  a d i f f e r e n t  s o u r c e .  I n  19 70 ,  G i t l i n  and P e r r i c e l l i  d e t e c t e d  
u p t a k e  o f  r a d i o l a b e l l e d  amino  a c i d s  by c u l t u r e s  o f  m in ce d  human y o l k  
sac  a t  5 . 5  weeks g e s t a t i o n ,  b u t  n o t  i n  t h e  s o l i d ,  n o n - v a s c u l a r  1 1 .5
week m a t e r i a l ,  and s u b s e q u e n t l y  i d e n t i f i e d  r a d i o a c t i v e  AFP as w e l l  as
p r e a l b u m e n ,  a l p h a - l - a n t i t r y p s i n  and t r a n s f e r r i n .  They  d e t e r m i n e d  
t h a t  t h e  p r o d u c t i o n  r a t e  o f  t h e s e  m a t e r i a l s  i n  t h e  y o l k  sa c  a t  5 . 5  
weeks  was a t  l e a s t  a m a tc h  f o r  t h e  l i v e r  s y n t h e s i s  a t  t h i s  p e r i o d .
F o e t a l  se rum AFP may r e a c h  3 m i l l i o n  k U / L  ( 3 g / L )  a t  13 wee ks ,  
a f t e r w a r d s  d i m i n i s h i n g  t o  a l e v e l  o f  3 0 , 0 0 0  t o  1 0 0 , 0 0 0 k U / L  a t  40 
weeks  (May e t  a l . 1 9 8 8 ) .  N e o n a t a l l y ,  AFP a p p e a r s  t o  have  a h a l f  l i f e  
o f  a b o u t  5 d a y s ,  w h i c h  i s  c o n s i s t e n t  w i t h  p r o d u c t i o n  h a v i n g  c e a s e d .  
A m n i o t i c  f l u i d  AFP c o n c e n t r a t i o n  i s  a b o u t  1% o f  t h e  f o e t a l  serum 
l e v e l ,  t h e  b u l k  n o r m a l l y  b e i n g  d e r i v e d  f r o m  f o e t a l  u r i n e .  I t  i s  
assumed t h a t  i n g e s t i o n  and d i g e s t i o n  o f  AFP by t h e  f o e t u s  i s  t h e  main 
r o u t e  f o r  c o n s u m p t i o n  ( B r o c k  1 9 8 3 ) .
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M a t e r n a l  se rum  AFP r i s e s  f r o m  n o r m a l  a d u l t  l e v e l s  a t  4 - 6  weeks 
g e s t a t i o n  t o  a pe ak  o f  2 0 0 - 4 0 0  k U /L  a t  a b o u t  25 w e e k s ,  as t h e  s i z e  o f  
t h e  p l a c e n t a  i n c r e a s e s ,  a f t e r  t h i s  t h e  d e c r e a s i n g  f o e t a l  se rum AFP 
o u t w e i g h s  t h e  s i z e  i n c r e a s e  o f  t h e  p l a c e n t a  and MS-AFP a t  b i r t h  may 
be 5 0 - 2 0 0 k U / L  ( C l a y t o n - H o p k i n s  e t  a l . 1 9 8 2 ) .
A f t e r  a l l o w i n g  f o r  t h e  e f f e c t s  o f  i n c r e a s i n g  g e s t a t i o n ,  Los 
e t  a l . ( 1 9 8 5 )  showed a weak c o r r e l a t i o n  b e tw e e n  a m n i o t i c  f l u i d  
a l b u m e n  and m a t e r n a l  serum AFP i n  81 p a i r e d  s a m p l e s .  They showed 
m a t h e m a t i c a l l y  t h a t  t h e  t r a n s p l a c e n t a l  r o u t e  m u s t  be t h e  m a j o r  s o u r c e  
o f  MS-AFP i n  n o r m a l  p r e g n a n c i e s ,  and o n l y  i n  a b n o r m a l  p r e g n a n c i e s  can 
t h e  g r e a t l y  r a i s e d  a m n i o t i c  f l u i d  AFP c o n t r i b u t e  s u b s t a n t i a l l y  t o  th e  
MS-AFP. T h i s  w o u l d  e x p l a i n  t h e  l a c k  o f  c o r r e l a t i o n  w h i c h  t h e y  f o u n d  
b e t w e e n  a m n i o t i c  f l u i d  AFP and m a t e r n a l  se rum  AFP.
1C PATHOLOGICAL IMPLICATIONS 
i )  Tumours
The p r e n a t a l  p r o d u c t i o n  p a t t e r n  i s  r e f l e c t e d  i n  t h e  t y p e s  o f
n e o p l a s m s  a s s o c i a t e d  w i t h  e l e v a t e d  AFP c o n c e n t r a t i o n ,  t h e s e  a re
g e n e r a l l y  p r i m a r y  h e p a t o c e l l u l a r  o r  e n d o d e r m a l  s i n u s  t u m o u r s ,
i n c l u d i n g  germ c e l l  and t e r a t o m a  t y p e s .  R a r e l y ,  o t h e r  AFP s e c r e t i n g  
t u m o u r s  a r e  f o u n d ,  f o r  e x a m p l e ,  i n  t h e  g a s t r o i n t e s t i n a l  t r a c t .
N i s h i  ( 1 9 7 0 )  used  an i n s e n s i t i v e ,  r a d i a l  i m m u n o d i f f u s i o n  
t e c h n i q u e  t o  a s s a y  s e r a  f r o m  500 p a t i e n t s  and showed one a b n o r m a l  
r e s u l t :  a ca se  o f  c a r c i n o m a  w i t h  l i v e r  m e t a s t a s e s .  By c o n t r a s t ,  23
o f  31 p a t i e n t s  w i t h  p r i m a r y  h e p a t o c e l l u l a r  c a r c i n o m a  had h i g h
c o n c e n t r a t i o n s  o f  AFP.
P r o s p e c t i v e  s t u d i e s  u s i n g  s p e c i a l l y  s e n s i t i z e d
r a d i o i m m u n o a s s a y s  ( R I A )  showed t h a t  AFP s e c r e t i o n  can be d e t e c t e d  as 
much as two  y e a r s  b e f o r e  c l i n i c a l  m a n i f e s t a t i o n .  The b i o l o g i c a l  h a l f  
l i f e  o f  5 d a ys  ( Mi 1 f o r d - W a r d  & B a t e s  1 9 7 9 )  has been w i d e l y  used as an 
i n d i c a t o r  o f  c o m p l e t e n e s s  o f  r e s e c t i o n  o f  t u m o u r  m a t e r i a l  and s e r i a l  
s a m p l i n g  i s  a v a l u a b l e  p r o g n o s t i c  t o o l  i n  t h e  p o s t - o p e r a t i v e  p e r i o d .
i i )  N e u r a l  Tube D e f e c t  D i a g n o s i s  and S c r e e n i n g
I t  was p o s t u l a t e d  t h a t  t h e  f a i l u r e  d u r i n g  e m b r y o g e n e s i s  o f  t h e  
n e u r a l  t u b e  t o  c l o s e  w o u ld  a l l o w  l a r g e  a m oun ts  o f  AFP i n t o  t h e
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a m n i o t i c  f l u i d .  A c c o r d i n g l y  B r o c k  and S u t c l i f f e  ( 1 9 7 2 )  s u b j e c t e d
o
a m n i o t i c  f l u i d s ,  w h i c h  had been s t o r e d  a t  - 2 5  C f o r  up t o  3 y e a r s ,  
f r o m  37 a b n o r m a l  p r e g n a n c i e s  t o  q u a n t i t a t i v e  " r o c k e t "  
i m m u n o e l e c t r o p h o r e s i s  f o r  AFP. A l l  31 a n e n c e p h a l i c  p r e g n a n c i e s  
c o l l e c t e d  b e t w e e n  25 and 35 weeks and one o u t  o f  t h r e e  open s p i n a
b i f i d a  p r e g n a n c i e s  showed a b n o r m a l  c o n c e n t r a t i o n s ,  b u t  t h e  3
h y d r o c e p h a l i c s  w e re  w i t h i n  n o r m a l  l i m i t s .  They c o n c l u d e d  t h a t  t h e  
a s s a y  was u n r e l i a b l e  f o r  d e t e c t i o n  o f  f o e t a l  a b n o r m a l i t y  above  35 
w e e k s .  L i t t l e  o v e r l a p  be t w e e n  n o r m a l  and a b n o r m a l  r a n g e s  was n o t e d ,  
see f i g u r e  2 .  They a l s o  p r e d i c t e d  t h a t  t h e  e l e v a t e d  a m n i o t i c  f l u i d  
a l p h a - l - f o e t o p r o t e i n  (A F -A FP )  w o u ld  c a u s e  i n c r e a s e d  AFP p as sa ge
t h r o u g h  t h e  a m n i o n  i n t o  t h e  m a t e r n a l  c i r c u l a t i o n  and t h u s  r a i s e  
MS-AFP.  A m n i o t i c  f l u i d s  f r o m  p r e g n a n c i e s  a f f e c t e d  by v a r i o u s  f o e t a l  
and m a t e r n a l  a b n o r m a l i t i e s ,  p a r t i c u l a r l y  t h e  e f f e c t s  o f  Rhesus 
i s o i m m u n i z a t i o n ,  w ere  s t u d i e d  by B r o c k  & S u t c l i f f e  ( 1 9 7 3 ) ,  who
c o n f i r m e d  t h a t  a n e n c e p h a l u s  was t h e  main  c a u s e  o f  r a i s e d  AF-AFP.
The RIA t e c h n i q u e s  ( p i o n e e r e d  by Y a lo w  & B e r s o n  19 6 0 )  i n  use 
f o r  t u m o u r  m a r k e r  s t u d i e s  were s e n s i t i v e  b u t  s l o w ,  t a k i n g  up t o  4 
d a ys  ( C h a y v i a l l e  4 G a n g u l i  1 9 7 3 ) .  Use o f  a s p e c i a l l y  d e v e l o p e d  RIA ,  
d e s i g n e d  t o  a l l o w  r a p i d  t u r n r o u n d  o f  l a r g e  nu mb er s  o f  MS-AFP sa m p l e s  
( V i n c e  e t  a l . 1 9 7 5 ) ,  i n  a p r o s p e c t i v e  p i l o t  s t u d y  f o r  e v a l u a t i o n  o f  
t h i s  t h e o r y  l e d  t o  f u l l  s c a l e  m a t e r n a l  se rum  s c r e e n i n g  p rogramme i n  
t h e  West  o f  S c o t l a n d .
The n o r m a l  r a n g e  f o r  MS-AFP o v e r l a p s  t h e  r a n g e  f o r  a n e n c e p h a l u s  
and s u b s t a n t i a l l y  o v e r l a p s  t h e  r a n g e  f o u n d  i n  open  s p i n a  b i f i d a ,  as 
shown i n  f i g u r e  2 .  Serum assay  c a n n o t  t h e r e f o r e  be used  as a 
d i a g n o s t i c  t e s t .  The o v e r l a p  has i m p o r t a n t  i m p l i c a t i o n s  f o r  t h e  
p r e c i s i o n  and r o b u s t n e s s  o f  ass ay  m e t h o d s  used  i n  t h e  s c r e e n i n g  
p r o g r a m m e .
M a t e r n a l  se ru m AFP s c r e e n i n g  p ro gr am me s ha ve  been r e s t r i c t e d  t o  
1 6 - 2 0  weeks i n c l u s i v e  s i n c e  t h e  R e p o r t  o f  t h e  UK C o l l a b o r a t i v e  S tu d y  
( 1 9 7 7 )  b e c a u s e  b e f o r e  t h i s  t h e  MS-AFP i s  n o t  r e l i a b l y  r a i s e d ,  and 
a f t e r w a r d s  i t  i s  i m p r a c t i c a l l y  l a t e  i n  g e s t a t i o n .
C r a n d a l l  and c o l l e a g u e s  ( 1 9 8 3 )  showed t h a t  b l a c k  women had 
h i g h e r  ( a b o u t  10%) MS-AFP l e v e l s  t h a n  C a u c a s i a n ,  h i s p a n i c  o r  o r i e n t a l  
women i f  a l l  v a l u e s  were  c o r r e c t e d  f o r  t h e  e f f e c t s  o f  m a t e r n a l  
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Overlap is shown between unaffected, open spina bifida and anence- 
phalic pregnancies for MSa-FP levels (top) andama-FP levels (bottom). 
The choice of intervention point between 2 and 3 MoMs (multiples of 
the median) determines the proportion of false-positive and false- 
negative results. (The unit of Iog10 a-FP used is 0.2163).
From UK Collaborative Study. Fourth Report (1982)
FIGURE 2 Frequency  dis tr ibut ion of A l p h a - 1 - foetoprote ln  
concentrations at 16 to 18 weeks gestat ion for maternal  serum and  
amniotic fluid.
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i i i )  O t h e r  C o n d i t i o n s  i n  P r e g n a n c y
B r o c k  ( 1 9 7 6 )  s u g g e s t e d  m e c h a n i s m s  f o r  t h e  m a t e r n a l  se rum and 
a m n i o t i c  f l u i d  AFP c o n c e n t r a t i o n s  f o u n d  i n  v a r i o u s  c o n d i t i o n s  by 
a s s u m i n g  t h a t  f o e t a l  u r i n e  i s  t h e  s o u r c e  o f  a m n i o t i c  f l u i d  and o f  
AF-AFP,  and t h a t  i n g e s t i o n  o f  t h e  a m n i o t i c  f l u i d  and d i g e s t i o n  o f  
c o n s t i t u e n t  p r o t e i n s  i s  t h e  m a i n  r o u t e  o f  AFP c a t a b o l i s m .  Thus h i g h  
AF-AFP i s  e x p e c t e d  where  f o e t a l  b l o o d  o r  se rum e n t e r s  t h e  a m n i o t i c  
f l u i d .  I f  t h e  AF-AFP i s  h i g h  e n o u g h ,  MS-AFP w i l l  be r a i s e d  b e c a u s e  
o f  i n c r e a s e d  AFP p ass ag e  a c r o s s  t h e  a m n i o n .
T h i s  w o u l d  a c c o u n t  f o r  t h e  p a t t e r n  seen i n  NTD and i n  some 
c a s e s  o f  a n t e r i o r  a b d o m i n a l  w a l l  d e f e c t s  (AAWD) wh e re  t h e  c o v e r i n g  
membrane i s  t h i n .  A s i m i l a r  p a t t e r n  w i l l  be e v i d e n t  i n  c a s e s  w i t h  
a b n o r m a l  o r  i m p a i r e d  k i d n e y  f u n c t i o n ;  t h u s  i n  c o n g e n i t a l  ( F i n n i s h )  
n e p h r o s i s  ( 2 5 6 3 0 ;  M c K u s i c k  1 988)  AF-AFP i s  g r o s s l y  e l e v a t e d  ( R y y a n e n  
e t  a l . 1 9 8 3 ) .  I n  t h i s  2 - y e a r  s t u d y  o f  1 0 , 7 2 4  women i n  K u o p i o  and 
N o r t h  K a r e l i a  ( F i n l a n d ) ,  96% o f  p r e g n a n c i e s  i n  t h e  a r e a  were  s t u d i e d  
and t h e  ou tc om e  d e t e r m i n e d  f o r  1 0 , 5 8 4 .  509 r a i s e d  AFP s a m p l e s  w ere
r e d u c e d  t o  267 by e x c l u s i o n  o f  m u l t i p l e  p r e g n a n c y ,  wrong  d a t e s  and 
n o r m a l  sec o n d  s a m p l e .  225 p r o c e e d e d  t o  a m n i o c e n t e s i s  and o f  t h e  16 
f o e t u s e s  w h i c h  gave r i s e  t o  AF-AFP c o n c e n t r a t i o n s  >10 s t a n d a r d  
d e v i a t i o n s  above  t h e  me d i an  (SDAM),  6 s u f f e r e d  f r o m  c o n g e n i t a l  
n e p h r o s i s ,  6 had s e r i o u s  a b n o r m a l i t i e s  ( i n c l u d i n g  45X0,  47XXV, 47XYY, 
n e u r a l  t u b e  d e f e c t  and e x o m p h a l o s )  and 4 were  n o r m a l .  No m i s s e d  
c a s e s  were d i s c o v e r e d  and t h e  i n c i d e n c e  o f  F i n n i s h  c o n g e n i t a l  
n e p h r o s i s  was a s s e s s e d  as 1 : 2 6 0 0 .  I n  t h i s  c o n d i t i o n ,  l a r g e  
q u a n t i t i e s  o f  p r o t e i n  pass  t h r o u g h  t h e  k i d n e y  as a r e s u l t  o f  
m i c r o s c o p i c  g l o m e r u l a r  a b n o r m a l i t y .  I t  i s  n o t a b l e  t h a t  t h e  p l a c e n t a  
i s  g r e a t l y  e n l a r g e d  i n  t h i s  c o n d i t i o n .  I n f a n t s  i n v a r i a b l y  d i e  b e f o r e  
1 y e a r .
The e l e v a t e d  c o n c e n t r a t i o n s  o f  AFP f o u n d  i n  m u s c l e  and s k i n  
( B r o c k  19 8 3 )  may be t h e  r e a s o n  f o r  e l e v a t e d  AF-AFP fo u n d  i n  f o e t u s  
p a p y r a c e o u s  (L ange  e t  a l . 1 9 7 9 ) .
Lac k  o f  f o e t a l  u r i n e  w i l l  c a u s e  o l i g o h y d r a m n i o s  w i t h  ( p o s s i b l y )  
l o w  AF-AFP and r a i s e d  MS-AFP b e c a u s e  o f  i n c r e a s e d  t r a n s p l a c e n t a l  AFP 
mo vem en t .  T h i s  i s  t h e  case  i n  P o t t e r s  Syndrome ( F r e l i n g  e t  a l . 19 8 3 )  
and has been  seen i n  a t r e s i a  o f  t h e  u r e t h r a  i n  a t r i s o m y  18 f o e t u s  
( H e l l e r  e t  a l . 1 9 8 0 ) .  I n  a s i m i l a r  f o e t u s  b u t  s h o w in g  m ar ked  
t h i n n i n g  o f  t h e  a b d o m i n a l  w a l l ,  a b s e n c e  o f  t h e  u r e t h r a  a s s o c i a t e d
Page 20
w i t h  t r i s o m y  ( N e v i n  e t  a l . 19 8 3 )  t h e  AF-AFP was r a i s e d  and t h e
a c e t y l c h o l i n e s t e r a s e  (AChE) p a t t e r n  was s i m i l a r  t o  a NTD. 
F i f t y - e i g h t  t r i s o m y  18 f o e t u s e s  were  com pared  by L i n d e n b a u m  e t  a 1 . 
( 1 9 8 7 )  and t h e y  c o n f i r m e d  t h e  t e n d e n c y  t o  l o w  MS-AFP and r a i s e d  
AF-AFP c o n c e n t r a t i o n s .
Q u a n t i t a t i o n  o f  f o e t o m a t e r n a l  t r a n s f u s i o n ,  w h i c h  c a u s e s  r a i s e d  
MS-AFP, d u r i n g  m e d i c a l  p r o c e d u r e s  has p r o v e d  u s e f u l ,  e s p e c i a l l y  i n  
a m n i o c e n t e s i s  and c h o r i o n i c  v i l l u s  s a m p l i n g  ( M a r i o n a  e t  a l . 1 9 8 6 ) .
C l a y t o n - H o p k i n s  e t  a l  ♦ ( 1 9 8 2 )  i n v e s t i g a t e d  t h e  use o f  MS-AFP i n  
l a t e  ( 3 3 - 4 0  w e e k s )  p r e g n a n c y  as an i n d i c a t o r  o f  o n s e t  o f  f o e t a l  
d i s t r e s s ,  m a t e r n a l  h y p e r t e n s i o n  and p r e - e c l a m p s i a .  They  showed t h a t  
m a t e r n a l  h y p e r t e n s i o n  was a s s o c i a t e d  w i t h  r a i s e d  AFP c o n c e n t r a t i o n  
and t h a t  s e r i a l  s a m p l i n g  may i n d i c a t e  t h e  s e v e r i t y  o f  f o e t a l  
d i s t r e s s .
Non-NTD c a u s e s  o f  r a i s e d  MS-AFP i n c l u d e  u n d e r e s t i m a t e d  
g e s t a t i o n ,  m u l t i p l e  p r e g n a n c y  (Ghosh e t  a l . 1 9 8 2 ;  Thom e t  a l . 1 9 8 4 ) ,  
a n t e r i o r - a b d o m i n a l - w a l l  d e f e c t  (Mann e t  a l . 1 9 8 4 ) ,  i n t r a - u t e r i n e
d e a t h )  t h r e a t e n e d ,  m i s s e d  o r  i n c o m p l e t e  a b o r t i o n ,  h y d r o c e p h a l u s ,  
f o e t a l  n e o p l a s m ,  p l a c e n t a l  haemangioma (Mann e t  a l . 1 9 8 3 ) ,  a m n i o t i c
band  syn dro me  ( A i t k e n  e t  a l . 1 9 8 4 a ) ,  f o e t a l  s k i n  d e f e c t s  and HP-AFP. 
S t u d i e s  have shown r a i s e d  MS-AFP c o n c e n t r a t i o n  t o  be a s s o c i a t e d  w i t h ;  
p l a c e n t a l  d y s f u n c t i o n  a n d / o r  i n f a r c t i o n  and i n c r e a s e d  s i z e  (Boyd & 
K e e l i n g  1 9 8 6 ) ,  and lo w  b i r t h - w e i g h t  ( B r o c k  e t  a 1 . 1 9 7 7 ,  B r o c k  e t  a l . 
197 9 ,  B r o c k ,  B a r r o n  and Raab 1 9 8 0 ) .  P u r d i e  e t  a l . ( 1 9 8 3 )  s c r e e n e d  
7223 p r e g n a n c i e s  and r e p o r t e d  t h a t  37 o u t  o f  141 h i g h  MS-AFP ( o v e r
2 . 5  MoM a t  1 6 - 2 0  w e e k s )  s a m p l e s  l e d  t o  a b i r t h w e i g h t  l e s s  t h a n  t h e  
1 0 t h  c e n t i l e  and t h a t  t h e r e  was a h i g h l y  s i g n i f i c a n t  a s s o c i a t i o n  
b e tw e e n  r a i s e d  AFP and a b r u p t i o n ,  p r e s u m a b l y  b e c a u s e  o f  f o e t o m a t e r n a l  
t r a n f u s i o n .  Some f a c t o r s  may be e x c l u d e d  by c a r e f u l  d a t i n g  u s i n g  
u l t r a s o u n d  as used  by P u r d i e ,  and o t h e r s  by d e t a i l e d  ( d i a g n o s t i c )  
u l t r a s o n o g r a p h y .  A sec o n d  sam p le  i s  us e d ,  i n  t h e  West  o f  S c o t l a n d ,  
t o  p r e v e n t  p o s s i b l e  e r r o r s  o f  i d e n t i f i c a t i o n  and t o  d e t e c t  f a l l i n g  
AFP w h i c h  may s u g g e s t  t h r e a t e n e d  a b o r t i o n  o r  t r a n s i e n t  f o e t a l  
d i s t r e s s  as t h e  ca u se  o f  t h e  e l e v a t e d  AFP c o n c e n t r a t i o n .  P e r h a p s  t h e  
use  o f  g e n e a l o g y  t o  e x c l u d e  HP-AFP i s  a p p r o p r i a t e .
The e f f e c t  o f  f o e t a l  v i r a e m i a  on m a t e r n a l  se ru m AFP has  been 
i n v e s t i g a t e d  i n  p a r v o v i r u s  i n f e c t i o n  as a mea su re  o f  a p l a s t i c  c r i s i s
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( C a r r i n g t o n  e t  a l . 1 9 8 7 )  f o l l o w i n g  a s u g g e s t i o n  by Anand e t  a l . 
( 1 9 8 7 ) .
The a s s o c i a t i o n  o f  l o w  c o n c e n t r a t i o n s  o f  MS-AFP l i n k e d  t o  
f o e t a l  t r i s o m y ,  w h i c h  was r e p o r t e d  by M e r k a t z  e t  a l . ( 1 9 8 4 ) ,
s t i m u l a t e d  w i d e s p r e a d  i n t e r e s t  i n  t h e  e s t i m a t i o n  o f  MS-AFP and 
i n c r e a s e d  t h e  need f o r  i m p r o v e d  s e n s i t i v i t y  and w o r k i n g  r a n g e .
i v )  O t h e r  C o n d i t i o n s  o u t w i t h  P r e g n a n c y
A t a x i a  t e l a n g i e c t a s i a  ( 2 0 8 9 0 ;  M c K u s i c k  1 9 8 8 )  has been 
a s s o c i a t e d  w i t h  r a i s e d  serum AFP (Waldmann & M c l n t i r e  1 9 7 2 )  and used 
f o r  d i a g n o s i s .  I n  t h i s  c o n d i t i o n  t h e  l i v e r  i s  i m m a t u r e .  The 
p o s i t i o n  i n  s e v e r a l  i m m u n o d e f i c i e n c y  s ynd ro m es  was s t a t e d  by Amman 
e t  a l . ( 1 9 8 6 )  who n o t i c e d  r a i s e d  serum AFP i n  t h e  a b s e n c e  o f  l i v e r  
d i s e a s e  i n  s e v e r e  c o m b i n e d  i m m u n o d e f i c i e n c y  ( w i t h  and  w i t h o u t  
a d e n o s i n e  d e a m i n a s e  d e f i c i e n c y ) ,  i n  c o m b i n e d  T - c e l l  and B - c e l l  
d e f i c i e n c y  and i n  g a s t r o i n t e s t i n a l  d i s e a s e .
A n t e n a t a l  l i v e r  d i s e a s e  i s  i m p l i c a t e d  i n  t h e  e l e v a t e d  c o r d  
s e ru m  AFP r e p o r t e d  i n  Type I  T y r o s i n a e m i a  ( 2 7 6 7 0 ;  M c K u s i c k  1988)  
r e p o r t e d  by H o s t e t t e r  e t  a l . ( 1 9 8 3 ) .
ID  CLINICAL APPLICATIONS
i )  D i a g n o s t i c  Assay
The l o c a l  r i s k  o f  h a v i n g  a se co n d  NTD p r e g n a n c y  was a s s e s s e d  as 
1 / 2 0 ,  c o n s i d e r a b l y  h i g h e r  t h a n  t h e  p o p u l a t i o n  r i s k  o f  5 . 7 / 1 0 0 0  ( l o c a l  
f i g u r e s  f o r  1 9 7 4 ) .  F o r  p a t i e n t s  a t  r i s k ,  a m n i o c e n t e s i s  and 
d i a g n o s t i c  AFP ( i n  a m n i o t i c  f l u i d  u s i n g  i m m u n o e l e c t r o p h o r e s i s ) a ss ay  
have  been a v a i l a b l e  i n  t h e  West o f  S c o t l a n d  s i n c e  1973 and t h e  f i r s t  
r e p o r t  o f  s u c c e s s f u l  p r e n a t a l  d i a g n o s i s  u s i n g  AF-AFP was g i v e n  by 
A l l a n  e t  a l . i n  t h e  same y e a r .
F o l l o w i n g  S m i t h  CJ e t  a l . ( 1 9 7 9 )  and B r o c k  ( 1 9 7 9 ) ,  t h e  use o f  
c o n c a n a v a l i n - A  b i n d i n g  p a t t e r n  was s u g g e s t e d  as a means o f  
e l i m i n a t i n g  u n c e r t a i n t i e s  i n  t h e  d i a g n o s i s  o f  NTD. U n f o r t u n a t e l y ,  
t h e  a ssa y  i s  r e l a t i v e l y  d i f f i c u l t  t o  p e r f o r m  and has c o n s e q u e n t l y  n o t  
been  w i d e l y  u s e d .
S m i t h  AD e t  a l . ( 1 9 7 9 )  s u g g e s t e d  t h e  use o f  a m n i o t i c  f l u i d  
a c e t y l c h o l i n e s t e r a s e  as an a d j u n c t  t o  t h e  AFP d i a g n o s t i c  a s s a y .  In
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o r d e r  t o  d i a g n o s e  f o e t a l  NTD, t h e  use  o f  a c u t - o f f  a t  5 s t a n d a r d  
d e v i a t i o n s  above  t h e  n o rm a l  m e d i a n  l e v e l  o f  AF-AFP had been 
s u c c e s s f u l ,  b u t  t h e  a d v e n t  o f  s p e c i f i c - i n h i b i t a b l e
a c e t y l c h o l i n e s t e r a s e  (AChE) e l e c t r o p h o r e s i s  b a n d i n g  p a t t e r n  p r o m i s e d  
r e d u c e d  f a l s e  p o s i t i v e  and f a l s e  n e g a t i v e  r e s u l t s .  The s t a t u s  o f  
a m n i o t i c  f l u i d  t e s t s  a t  t h i s  t i m e  was r e v i e w e d  by B r o c k  ( 1 9 8 3 ) .  
A i t k e n  e t  a l . ( 1 9 8 4 b )  r e p o r t e d  t h e i r  e x p e r i e n c e  i n  e s t i m a t i n g  AFP and 
AChE i n  3785 a m n i o t i c  f l u i d s .  Of  t h e s e ,  541 were  t a k e n  f r o m  f r o z e n  
s t o r a g e  and q u a n t i t a t i v e  AChE a s s a y  was . u n s u c c e s s f u l  i n  
d i s c r i m i n a t i n g  be tw e e n  n o r m a l s  and open n e u r a l  t u b e  d e f e c t .
Q u a l i t a t i v e  p o l y a c r y l a m i d e  g e l  e l e c t r o p h o r e s i s  i d e n t i f i e d  251 o u t  o f  
255  NTDs and 29 o u t  o f  31 f a l s e  p o s i t i v e  AFP r e s u l t s .  These r e s u l t s  
l e d  t o  t h e  p r o s p e c t i v e  a n a l y s i s  o f  3244  f l u i d s  and t h e  i d e n t i f i c a t i o n  
o f  a l l  170 open NTDs and 20 o t h e r  f o e t a l  a b n o r m a l i t i e s .  The f a l s e  
p o s i t i v e  r a t e  o f  0 .4% i s  b e t t e r  t h a n  t h e  1.8% o f  t h e  AF-AFP t e s t .  
The a p p e a r a n c e  o f  a t y p i c a l  l o w  i n t e n s i t y  se c o n d  bands and s e c o n d  
ban ds  i n  f l u i d s  c o n t a m i n a t e d  by m a t e r n a l  b l o o d  c o n s t i t u t e d  11 o f  t h e  
13 f a l s e  p o s i t i v e  AChEs. They c o n c l u d e d  t h a t  t h e  use o f  AChE w o u ld  
i m p r o v e  t h e  s e n s i t i v i t y  and s p e c i f i c i t y  comp a re d  t o  t h e  use o f  AF-AFP 
a l o n e .  I n  a r e c e n t  p a p e r ,  B r o c k  & B a r r o n  ( 1 9 8 8 )  s u g g e s t  t h e  use o f  a 
m o n o c l o n a l  a n t i b o d y ,  s p e c i f i c  f o r  t h e  f a s t - m o v i n g  AChE ba nd ,  as t h e  
b a s i s  f o r  a q u a n t i t a t i v e  a s s a y  t o  r e p l a c e  t h e  q u a l i t a t i v e  g e l  
e l e c t r o p h o r e s i s  t e c h n i q u e  and t h e r e b y  r e d u c e  o p e r a t o r  d e p e n d e n c e .  
B o t h  m e t h o d s  a r e  a f f e c t e d  by c o n t a m i n a t i o n  w i t h  o l d  b l o o d .
i i )  P r e n a t a l  s c r e e n i n g  f o r  n e u r a l  t u b e  d e f e c t
P r e n a t a l  s c r e e n i n g  f o r  n e u r a l  t u b e  d e f e c t s  was f i r s t  c a r r i e d  
o u t  i n  a r e a s  o f  h i g h  i n c i d e n c e  ( e . g .  West  o f  S c o t l a n d ;  F e r g u s o n - S m i t h
e t  a l . 1 9 78 ,  N o r t h  E a s t  o f  S c o t l a n d ;  Thom e t  a l . 19 84 )  and has s i n c e
been  s u c c e s s f u l l y  a p p l i e d  t o  lo w  i n c i d e n c e  a r e a s  (Ghosh e t  a l ♦ 19 8 6 )  
by u s i n g  d i f f e r e n t  i n t e r v e n t i o n  c r i t e r i a .  The i n t e n t i o n  o f  s c r e e n i n g  
i s  t o  i d e n t i f y  a g r o u p  o f  m o t h e r s  a t  i n c r e a s e d  r i s k  o f  c a r r y i n g  a 
f o e t u s  a f f e c t e d  by one o f  s e v e r a l  a b n o r m a l i t i e s .  The p r o p o r t i o n  o f  
p r e g n a n c i e s  f o l l o w e d  up i s  based  on d a t a  c o l l e c t e d  by each s c r e e n i n g  
c e n t r e  u s i n g  a c o m b i n a t i o n  o f  p r a c t i c a b i l i t y ,  a s s a y  p r e c i s i o n ,  and 
i n c i d e n c e .  The i n t e r v e n t i o n  l e v e l  i s  u s u a l l y  b e tw een 2 and 3 
m u l t i p l e s  o f  t h e  med ia n  AFP l e v e l  (MoM) and 1 t o  5 p e r c e n t  o f
p r e g n a n c i e s  w i l l  r e q u i r e  f u r t h e r  a c t i o n .  MS-AFP s c r e e n i n g  i s  a t
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p r e s e n t  p e r f o r m e d  a t  1 6 - 2 0  ( i n c l u s i v e )  c o m p l e t e d  weeks o f  g e s t a t i o n ,
a f t e r  e x p e r i e n c e  o f  m i s s e d  a n e n c e p h a l i c  p r e g n a n c i e s  a t  15 w eeks .
S u f f i c i e n t  t i m e  mus t  be a l l o w e d  f o r  r e p e a t  se rum a s s a y  and d i a g n o s t i c  
a m n i o t i c  f l u i d  as say  i n  o r d e r  t o  g i v e  t h e  o p t i o n  o f  t e r m i n a t i o n  w e l l  
b e f o r e  24 w ee k s .
F i g u r e  2 shows t h e  d i s t r i b u t i o n  o f  t h e  serum AFP
c o n c e n t r a t i o n s ,  i n  m u l t i p l e s  o f  t h e  m e d i a n  (MoM),  f o r  m a t e r n a l  se rum 
f r o m  " n o r m a l "  p r e g n a n c i e s  ( i n c l u d i n g  c l o s e d  l e s i o n s )  and t h o s e  
a f f e c t e d  by open s p i n a  b i f i d a  and a n e n c e p h a l y  (UK C o l l a b o r a t i v e  S t u d y  
1 9 8 2 ) .
IE  D IF F I C U L T IE S  WITH CURRENT RIA
The n o r m a l  ( h i g h e s t  w o u ld  be 6 0 , 0 0 0  k U / L  a t  16 w eeks )  and
a b n o r m a l  l e v e l s  o f  a m n i o t i c  f l u i d  AFP and t h e  e x t r e m e  e l e v a t i o n  o f
s e ru m  AFP ( o v e r  1 , 0 0 0  k U /L  and o f t e n  o v e r  1 0 0 , 0 0 0 k U / L )  seen  i n
n e o n a t e s  and c e r t a i n  n e o p la s m s  were  d e t e c t a b l e  by q u a n t i t a t i v e  r o c k e t  
i m m u n o e l e c t r o p h o r e s i s . T h i s  t e c h n i q u e  i s  s t i l l  w i d e l y  used f o r  t h e  
d i a g n o s t i c  a m n i o t i c  f l u i d  assay  w he re  t h e  l o w e s t  d e t e c t a b l e  l e v e l  o f  
2 , 0 0 0 k U / L  and minimum r e p o r t a b l e  l e v e l  o f  5 , 0 0 0 k U / L  i s  n o t  a 
d i s a d v a n t a g e .
The n o r m a l  a d u l t  c o n c e n t r a t i o n  o f  se rum AFP was n o t  amenab le  t o  
a s s e s s m e n t  u n t i l  t h e  d e v e l o p m e n t  o f  s e n s i t i v e  r a d i o i m m u n o a s s a y s  
( R u o s l a h t i  and S e p p a l a  1971 ,  C h a y v i a l l e  and G a n g u l i  1 9 7 3 ) .  The a s s a y  
t e c h n i q u e s  used f o r  tu m o u r  m a r k e r  s t u d i e s  were  u n s u i t e d  t o  m a t e r n a l  
se rum s c r e e n i n g  beca use  t h e y  w e re  s l o w ,  t e c h n i c a l l y  dema nd in g  and 
u n n e c e s s a r i l y  s e n s i t i v e .  V i n c e  e t  a l . ( 1 9 7 5 )  d e v e l o p e d  a
s i n g l e - s t a g e  RIA ,  u s i n g  p o l y e t h y l e n e  g l y c o l  s e p a r a t i o n  (a r e v i e w  o f
s e p a r a t i o n  m et hods  i s  g i v e n  i n  R a t c l i f f e  1 9 8 3 ) ,  t o  a l l o w  a
h i g h - t h r o u g h p u t  a s s a y .  T h i s  was o p t i m i z e d  t o  g i v e  b e s t  p r e c i s i o n  a t  
6 0 - 1 0 0  k U / L  w i t h  a minimum d e t e c t a b l e  c o n c e n t r a t i o n  o f  25 k U / L .  T h i s  
i s  an u n s a t i s f a c t o r y  s e n s i t i v i t y  f o r  t u m o u r  m a r k e r  as s a y  and as a 
r e s u l t  a s e p a r a t e ,  s p e c i a l l y  s e n s i t i z e d  a s s a y  was m a i n t a i n e d  f o r  t h i s  
p u r p o s e .  The i n s e n s i t i v i t y  and p o o r  p r e c i s i o n  p r e c l u d e d  t h e
i n v e s t i g a t i o n  o f  t h e  s i g n i f i c a n c e  o f  s m a l l  ch a n g e s  o f  AFP 
c o n c e n t r a t i o n .
The RIA b e i n g  used  a t  t h e  s t a r t  o f  t h i s  p r o j e c t  showed t y p i c a l  
a s s a y  p a r a m e t e r s ,  based on p r e c i s i o n  p r o f i l e  d a t a ,  t o  b e ;  s e n s i t i v i t y
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1 5 k U / L ,  i n t e r - a s s a y  CV 10%, and w o r k i n g  r a n g e  3 0 - 4 0 0 k U / L .  A l t h o u g h  
many i m p r o v e m e n t s  had been a p p l i e d ,  t h e  l i m i t a t i o n s  o f  t h e  b a s i c  
t e c h n o l o g y  were  a p p a r e n t  i n  i n t e r n a l  q u a l i t y  c o n t r o l  d a t a  and t h e s e
w er e  s u p p o r t e d  by p e r f o r m a n c e  i n  t h e  UK E x t e r n a l  Q u a l i t y  A s s e s s m e n t
Scheme (EQAS: S e th  e t  a l . 1 9 8 8 ) .
E v i d e n t  w e r e :  r e s t r i c t e d  w o r k i n g  r a n g e ,  p o o r  p r e c i s i o n ,  l a c k  o f  
r o b u s t n e s s  (s e e n  i n  o p e r a t o r  d e p e n d e n c y ) ,  number o f  r e p e a t  
e s t i m a t i o n s  n e c e s s a r y  and p e r i o d i c  e p i s o d e s  o f  h i g h  o r  l o w  i n t e r n a l
q u a l i t y  c o n t r o l  ( w h i c h  were  u s u a l l y  c o n f i r m e d  by EQAS),  and v e r y
v a r i a b l e  w e e k l y  f o l l o w - u p  r a t e .  T h i s  was n o m i n a l l y  3%, b u t  i n t e r n a l  
q u a l i t y  c o n t r o l  d a t a  showed e x t r e m e  r e s u l t s  f o r  a week o f  0 .6% and 
6 .6% d e s p i t e  t h e  l a r g e  sa m p le  number  ( a p p r o x i m a t e l y  6 0 0 ) .  The 
a p p a r e n t  AFP v a l u e  was m a r k e d l y ,  and v a r i a b l y ,  r a i s e d  when a s s a y i n g  
p l a s m a  s a m p l e s .  I n c u b a t i o n  t i m e  o f  16 h o u r s  was n e c e s s a r y ,  l i m i t i n g  
t h e  t u r n r o u n d  and t h r o u g h - p u t  o f  s a m p l e s  and t h i s  was mo s t  i m p o r t a n t  
i n  p r e v e n t i n g  r e p l a c e m e n t  o f  t h e  i m m u n o e l e c t r o p h o r e s i s  f o r  AF-AFP .  
P e r f o r m a n c e  d a t a ;  a d o s e - r e s p o n s e  c u r v e  and a p r e c i s i o n  p r o f i l e  
( E k i n s  19 8 3 )  f o r  t h e  RIA method  as a p p l i e d  t o  AFP a s s a y  a r e  shown i n  
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FIGURE 3 Dose-response curve and precision prof i le  for the  
RadlolmmunoAssay used in the West of Scotland MS-AFP Screening 














IF  AIMS OF THE PRESENT STUDY
I n  v i e w  o f  t h e  l i m i t a t i o n s  o f  t h e  RIA o u t l i n e d  ab o v e ,  t h e  
p u r p o s e  o f  t h i s  p r o j e c t  was t h r e e - f o l d :
A) t o  p r o d u c e  a t w o - s i t e  IRMA m et hod  f o r  t h e  e s t i m a t i o n  
o f  AFP i n  b i o l o g i c a l  f l u i d s ,  u s i n g  m o n o c l o n a l  a n t i b o d y  t e c h n o l o g y ,  
and w h i c h  w o u l d  be a v a i l a b l e  t o  a l l  N a t i o n a l  H e a l t h  S e r v i c e  
l a b o r a t o r i e s ,
B) t o  v a l i d a t e  t h e  new t e c h n i q u e  s c i e n t i f i c a l l y  and i n  
c l i n i c a l  p r a c t i c e ,  and
C) t o  i n t r o d u c e  i t  i n t o  t h e  West  o f  S c o t l a n d  m a t e r n a l  
se rum a l p h a - l - f o e t o p r o t e i n  s c r e e n i n g  p r o g r a m m e .
Page 26
CHAPTER 2 MATERIALS AND METHODS
2A PREPARATION OF MONOCLONAL ANTIBODIES
The i n s u l i n  r a d i o i m m u n o a s s a y  d e s c r i b e d  by Ya low  & B e r s o n  ( 1 9 6 0 )  
was t h e  f i r s t  i n  v i t r o  use o f  t h e  e x t r e m e  s e n s i t i v i t y  a v a i l a b l e  i n  
b i o l o g i c a l  s y s t e m s  t o  q u a n t i t a t e  a n a l y t e s  w h i c h  a r e  p r e s e n t  a t  v e r y  
l o w  c o n c e n t r a t i o n  i n  t h e  b l o o d .  D e s p i t e  t h e  s e n s i t i v i t y  o b t a i n e d  i t  
was c l e a r  t h a t  t h e  p r o d u c t i o n  o f  a n t i b o d i e s  i n  w h o le  a n i m a l s  l e d  t o  
t h e  g e n e r a t i o n  o f  a n t i s e r a  c o n t a i n i n g  c o m p o n e n t s  w i t h  a w i d e  r a n g e  o f  
s p e c i f i c i t i e s  and a v i d i t i e s .  These  r e a g e n t s  were  v e r y  p o o r l y  
c h a r a c t e r i z e d  and were  d e p e n d e n t  on t h e  b a t c h  o f  a n t i g e n ,  i t s  p u r i t y  
and t h e  immune c a p a c i t y  o f  th e  a n i m a l s  u s e d .
K o h l e r  & M i l s t e i n  ( 1 9 7 5 )  r e p o r t e d  t h e  c o n s e q u e n c e s  o f  f u s i o n  o f
p l u r i p o t e n t  myeloma c e l l s  o b t a i n e d  f r o m  m ic e  w i t h  f u l l y  
d i f f e r e n t i a t e d  c e l l s  o b t a i n e d  f r o m  mouse s p l e e n .  They g e n e r a t e d  
i m m o r t a l i z e d  c e l l  l i n e s  d e r i v e d  f r o m  a s i n g l e  c e l l  w h i c h  c o n t i n u e d  t o  
s e c r e t e  a s i n g l e  a n t i b o d y  s p e c i e s  o f  t h e  d e s i r e d  s p e c i f i c i t y  and i n  
l a r g e  ' q u a n t i t i e s .  T h i s  a l l o w e d  t h e  s u g g e s t i o n s  o f  M i l e s  & H a le s  
( 1 9 6 8 )  t o  be r e a l i z e d  i n  t h e  d e v e l o p m e n t  o f  t w o - s i t e  im m u n o a s s a y s .  
U n t i l  t h e  a d v e n t  o f  m o n o c l o n a l  a n t i b o d i e s  c a r e f u l  p u r i f i c a t i o n  o f  t h e  
p o l y c l o n a l  a n t i b o d i e s  was r e q u i r e d  f o r  t h e s e  t e c h n i q u e s  and t h e  
q u a n t i t i e s  o f  a n t i b o d y  r e q u i r e d  made w i d e s p r e a d  use i m p r a c t i c a b l e .
i )  I m m u n i z a t i o n  o f  m ice
A sa m p le  (250  u L )  o f  a m n i o t i c  f l u i d  f r o m  a p r e g n a n c y  a f f e c t e d
by an a n e n c e p h a l i c  f o e t u s  and w h i c h  c o n t a i n e d  a h i g h  c o n c e n t r a t i o n
( 2 0 0 m g / L )  o f  AFP was d i l u t e d  1+3 i n  F r e u n d ' s  C o m p le t e  A d j u v a n t
( D i f c o ,  E a s t  M o l e s e y ,  UK) .  The m i x t u r e  was e m u l s i f i e d  by u l t r a s o u n d  
o
a t  k C. The e m u l s i o n  was t a k e n  up i n t o  a lmL s y r i n g e  and
1
a p p r o x i m a t e l y  o n e - t h i r d  ( l O u g )  i n j e c t e d  (2 6  g a u g e ,  /  i n c h  n e e d l e )
2
w h i l e  s t i l l  c o l d  i n t o  t h e  p e r i t o n e u m  o f  each  o f  t h r e e  a n a e s t h e t i s e d ,  
m a t u r e ,  f e m a l e  BALB/c  m ice  ( U n i v e r s i t y  o f  G la sg o w  s t o c k ) .
T h r e e  s e c o n d a r y  i m m u n i z a t i o n  i n j e c t i o n s ,  i n t o  each  a n i m a l ,  were 
p e r f o r m e d  i n  each  a n i m a l  a t  two week i n t e r v a l s  by t h e  same method  b u t  
u s i n g  F r e u n d ' s  I n c o m p l e t e  A d j u v a n t  ( i b i d )  w h i c h  l a c k s  k i l l e d
m y c o b a c t e r i a .  A t  each o f  t h e s e  s t a g e s  t h e  t a i l  v e i n -  was p u n c t u r e d  
and a d r o p  o f  b l o o d  a b s o r b e d  i n t o  f i l t e r  p a p e r  f o r  a s s e s s m e n t  o f  
a n t i - A F P  t i t r e  (s ee  s e c t i o n  2A v ) ) .  The a b s o r b e d  b l o o d  was t e s t e d
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f o r  t h e  p r e s e n c e  o f  a n t i - h u m a n  c h o r i o n i c  g o n a d o t r o p h i n  and 
a n t i - p r o l a c t i n  a c t i v i t y .  On c o n f i r m i n g  h i g h  t i t r e s  o f  a n t i - A F P
a c t i v i t y  i n  t h e  i m m un iz ed  m i c e ,  a n o t h e r  s i x  were  t r e a t e d  s i m i l a r l y  
b u t  u s i n g  a d i f f e r e n t ,  h i g h - A F P  c o n c e n t r a t i o n ,  a m n i o t i c  f l u i d .
i i )  P r e p a r a t i o n  o f  myeloma c e l l s
Myeloma c e l l  c u l t u r e  medium was p r e p a r e d  f r o m  R PM I-1640  
( c o n t a i n i n g  20mM HEPES) t o  w h i c h  was added  10% f o e t a l  b o v i n e  s e ru m ,  
2mM L - g l u t a m i n e , 1 0 0 , 0 0 0 U / L  p e n i c i l l i n ,  lOOmg/L - s t r e p t o m y c i n  and
2 . 5 m g / L  A m p h o t e r i c i n - B  ( a l l  p u r c h a s e d  f r o m  F lo w  L a b s ,  I r v i n e ,  U . K . ) .
A l l  s t a g e s  o f  i n  v i t r o  c e l l  c u l t u r e  used m a c ro phag es  o b t a i n e d  
by w a s h i n g  o u t  t h e  p e r i t o n e a  o f  f r e s h l y  k i l l e d  BALB/C m ic e  w i t h
R PM I- 1 6 4 0  and d i l u t i n g  t h e  p r o d u c t  t o  3 0 , 0 0 0  c e l l s  p e r  mL i n  myeloma 
medium w i t h  added 20% f o e t a l  b o v i n e  s e ru m .
L i v i n g  c e l l s  f r om mouse myeloma c e l l  l i n e  X63 A g 8 . 6 5 3  w ere
p u r c h a s e d  f r o m  F low  L a b s .  These  w ere  m u l t i p l i e d  u n t i l  s u f f i c i e n t  
s t o c k s  w ere  a v a i l a b l e  f o r  f r e e z i n g  down a t  5 m i l l i o n  c e l l s  p e r  0 .5mL 
a l i q u o t .  The method used f o r  s t o r i n g  c e l l s  i n  l i q u i d  n i t r o g e n  
( v a p o u r  p h a s e )  was t o  t r a n s f e r  5 m i l l i o n  c e l l s  t o  a s t e r i l e  u n i v e r s a l  
c o n t a i n e r  and t h e n  t o  c e n t r i f u g e  t h e  t u b e  a t  1500g f o r  7 m i n u t e s ,  
f o l l o w e d  by r e s u s p e n s i o n  o f  t h e  c e l l s  i n  0 .5mL o f  i c e - c o l d  f r e e z i n g  
m i x t u r e .  T h i s  was p r e p a r e d  by d r o p w i s e  a d d i t i o n  o f  lOmL warm DMSO 
( d i m e t h y l  s u l p h o x i d e ;  S igm a,  P o o l e ,  UK) t o  lOOmL i c e - c o l d ,  f o e t a l ,  
b o v i n e  s e ru m .
To e s t a b l i s h  a c o l o n y  o f  h e a l t h y ,  m u l t i p l y i n g  c e l l s  s u i t a b l e
o
f o r  h y b r i d i z a t i o n ,  one p e l l e t  was t h a w e d  a t  37 C and t r a n s f e r r e d
a s e p t i c a l l y  t o  a s t e r i l e  p l a s t i c  c o n t a i n e r .  The c e l l s  were  washed  by
o
t w i c e  r e s u s p e n d i n g  i n  5mL myeloma medium a t  37 C, added s l o w l y  w i t h
g e n t l e  a g i t a t i o n ,  f o l l o w e d  by c e n t r i f u g a t i o n  a t  1500g f o r  7 m in  and
a s p i r a t i o n  o f  t h e  s u p e r n a t a n t .  A f t e r  f u r t h e r  r e s u s p e n s i o n  t h e
c o n c e n t r a t i o n  o f  c e l l s  was a s s e s s e d  i n  a h a e m o c y t o m e t e r  and a d j u s t e d
t o  2 0 0 , 0 0 0  p e r  mL by a d d i t i o n  o f  f u r t h e r  medium. The s u s p e n s i o n  was
2
t r a n s f e r r e d  t o  a 25cm c e l l  c u l t u r e  f l a s k  ( J .  B i b b y ,  S t o n e ,  S t a f f s . ,
UK) i n  w h i c h  t h e  c o n c e n t r a t i o n  o f  c e l l s  and t h e i r  c o n d i t i o n ,  a s s e s s e d
by v i a b i l i t y  c o u n t i n g  u s i n g  T r y p a n  B l u e ,  was m o n i t o r e d .  The p l a t e s
o
w er e  s e a l e d  and i n c u b a t e d  a t  37 C w i t h o u t  c a r b o n  d i o x i d e .  Medium was
2
a d d e d ,  and t h e  i n c u b a t e  ex pan ded  i n t o . 7 5 c m  f l a s k s  when n e c e s s a r y  i n  
o r d e r  t o  m a i n t a i n  c e l l  d e n s i t y  b e tw e e n  1 0 0 , 0 0 0  and 8 0 0 , 0 0 0  p e r  mL.
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i i i )  H y b r i d  g e n e r a t i o n
Th r e e  days  p r i o r  t o  f u s i o n ,  20uL ( c o n t a i n i n g  4ug o f  AFP) o f
a m n i o t i c  f l u i d  d i l u t e d  w i t h  80uL  o f  s t e r i l e  s a l i n e  was i n j e c t e d  i n t o
t h e  t a i l  v e i n  o f  t h e  s e l e c t e d  mouse ( F a z e k a s  de S t  G r o t h  &
S c h e i d e g g e r  1 9 8 0 ) .
On t h e  f u s i o n  d a y ,  a f t e r  s a c r i f i c e ,  a l l  a v a i l a b l e  b l o o d  was
rem o ve d  by c a r d i a c  s t a b  and t h e  s p l e e n  was d i s s e c t e d  and t r a n s f e r r e d
t o  5mL R P M I- 1 6 4 0 .  Serum was s t o r e d  f o r  c o n t r o l  p u r p o s e s .  The s p l e e n
was t e a s e d  o u t  t h o r o u g h l y  b e f o r e  t r a n s f e r  ( d i s c a r d i n g  d e t r i t u s )  i n t o
a c e n t r i f u g e  t u b e .  C e l l s  were  c e n t r i f u g e d  a t  1500g f o r  7 m i n ,  t h e
s u p e r n a t a n t  was removed  and 20mL R PM I-1 640  was add e d .  The c e l l s  were
r e s u s p e n d e d  and c o u n t e d  i n  d i l u t e  s o l u t i o n  ( t o  l y s e  e r y t h r o c y t e s )
b e f o r e  f u r t h e r  w a s h in g  and r e s u s p e n s i o n  i n  15 mL o f  R P M I - 1 6 4 0 .  T h i s
was d i v i d e d  e q u a l l y  i n t o  t h r e e  u n i v e r s a l  c o n t a i n e r s .
A r a t i o  o f  1 : 1  f o r  myeloma t o  s p l e e n  c e l l s  was s o u g h t .
S u f f i c i e n t  myeloma c e l l s  ( t y p i c a l l y  50 m i l l i o n  p e r  f u s i o n )  w h i c h  had
been  m a i n t a i n e d  i n  l o g - p h a s e  g r o w t h  f o r  a t  l e a s t  se ve n  d a y s ,  were
c o n c e n t r a t e d  and d i v i d e d  i n t o  t h r e e  u n i v e r s a l  c o n t a i n e r s .  One
a l i q u o t  o f  myeloma c e l l s  was m i x e d  t h o r o u g h l y  w i t h  one a l i q u o t  o f
s p l e e n  c e l l s ,  c e n t r i f u g e d  (150Q g,  7 m i n )  and t h e  s u p e r n a t a n t  rem oved
o
c o m p l e t e l y .  W i t h  c o n t i n u a l  s w i r l i n g  i n  a 37 C w a t e r  b a t h ,  0 .8m L 50%
( l O g  p l u s  1 0 m l ,  pa ssed  t h r o u g h  0 .22um f i l t e r  t o  e n s u r e  s t e r i l i t y )  
p o l y e t h y l e n e  g l y c o l  1500 ( m o l e c u l a r  w e i g h t  r a n g e  1 4 3 0 - 1 5 7 0 )  i n  
R PM I - 1 6 4 0  was added (more s l o w l y  a t  f i r s t )  d r o p w i s e  o v e r  60 s e c .  
A f t e r  90 sec r e a c t i o n  t i m e ,  t h e  m i x  was r e h y d r a t e d  w i t h  10 mL 
R PM I-1 6 4 0  w h i c h  was add e d ,  more s l o w l y  a t  f i r s t ,  o v e r  5 m i n .  S w i r l i n g  
was t h e n  s t o p p e d  and t h e  f u s i o n  p r o d u c t s  washed and d i l u t e d  t o  50mL.
A lOOuL a l i q u o t  was i n t r o d u c e d  i n t o  each  w e l l  o f  f i v e  9 6 - w e l l  t i s s u e  
c u l t u r e  p l a t e s  ( F l o w  L a b s . ,  I r v i n e ,  UK) w h i c h  had been  a l r e a d y  
p r e p a r e d  by t h e  a d d i t i o n  o f  lOOuL o f  m ac ro phag e  p r e p a r a t i o n  ( 3 , 0 0 0  
c e l l s ) .
i v )  C h e m i c a l  s e l e c t i o n  o f  h y b r i d s
Mouse s p l e e n  l y m p h o c y t e s  do n o t  m u l t i p l y  i n  t h e  c u l t u r e  
c o n d i t i o n s  u s e d .  The mye loma c e l l  l i n e  g ro w s  r a p i d l y  and 
i n d e f i n i t e l y  i n  t h e s e  c o n d i t i o n s  b u t  i t  l a c k s  t h e  enzyme h y p o x a n t h i n e  
g u a n i n e  r i b o s y l  t r a n s f e r a s e  (HGPRT).  The scheme d e v i s e d  by 
L i t t l e f i e l d  ( 1 9 6 4 )  r e l i e s  on t h e  i n a b i l i t y  o f  c e l l s  w h i c h  l a c k  t h i s
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enzyme t o  s y n t h e s i z e  p u r i n e  n u c l e o t i d e s  when t h e  ma in  m e t a b o l i c
p a t h w a y s  a r e  b l o c k e d  by t h e  p r e s e n c e  o f  a m i n o p t e r i n  ( f o l i c  a c i d
+
a n t a g o n i s t ) .  HGPRT c e l l s  w o u ld  be a b l e  t o  use h y p o x a n t h i n e  o r
g u a n i n e  v i a  t h e  " s a l v a g e "  p a th w a y  f o r  t h e i r  n u c l e o t i d e  s y n t h e s i s .  
The a d d i t i o n  o f  h y p o x a n t h i n e  ( f i n a l  c o n c e n t r a t i o n  o f  1 3 . 6 1 1  mg/mL) ,  
a m i n o p t e r i n  ( 0 . 1 7 6  m g / m L ) ,  and t h y m i d i n e  ( 3 . 876 m g /m L) ,  s u p p l i e d
c o m b i n e d  as HAT medium x50 c o n c e n t r a t e  ( F l o w  L a b o r a t o r i e s ,  I r v i n e ,  
U K) ,  t o  t h e  mye loma medium k i l l s  u n f u s e d  mye loma c e l l s ,  b u t  h y b r i d s  
c o n t a i n i n g  t h e  p a r t  o f  t h e  s p l e e n  genome (X ch rom osom e)  w h ic h
i n c l u d e s  t h e  gene f o r  HGPRT w i l l  s u r v i v e .  A l t h o u g h  HAT may be
o m i t t e d  f r o m  t h e  medium used  t o  f e e d  t h e  h y b r i d s  a f t e r  7 d a y s ,  i n  
t h i s  s t u d y  i t  was i n c l u d e d  t h r o u g h o u t ,  i n  o r d e r  t o  e r a d i c a t e  u n s t a b l e  
h y b r i d s  and r e v e r t a n t s .
v )  RIA f o r  d e t e c t i o n  o f  a n t i - A F P  a c t i v i t y
A n t i b o d y  s e c r e t i n g  h y b r i d o m a s  w ere  d e t e c t e d  by i n c u b a t i n g
125
0 .0 5 m L  a l i q u o t s  o f  t h e  w e l l  s u p e r n a t a n t  w i t h  0 .2mL - I o d i n e  
l a b e l l e d  AFP ( D e p a r t m e n t  o f  O b s t e t r i c s  and G y n a e c o l o g y ,  Dundee)  f o r  
16 h o u r s  p r i o r  t o  a d d i t i o n  o f  0 .2mL sheep  a n t i - m o u s e  g a m m a - g l o b u l i n  
( S c o t t i s h  A n t i b o d y  P r o d u c t i o n  U n i t ,  Law H o s p i t a l ,  UK) l i n k e d  (see
s e c t i o n s  28 i )  t o  v i ) )  t o  Se p h a ro s e  CL-4B ( P h a r m a c i a ,  M i l t o n  Key nes ,
UK) and a g i t a t i n g  f o r  60 m i n .  S e p a r a t i o n  o f  r e a c t e d  ( b o u n d )  and
u n r e a c t e d  ( f r e e )  l a b e l  was e f f e c t e d  by t h r e e  c y c l e s  o f  wash (3mL o f  
0 .9%  s a l i n e ,  0 .2% Tween 20 (S i g m a ,  P o o l e ,  UK) i n  d i s t i l l e d  w a t e r ) ,  
c e n t r i f u g a t i o n  and a s p i r a t i o n .
Mouse a n t i - A F P  a c t i v i t y  was d e t e c t e d  s i m i l a r l y  u s i n g  mouse 
se rum  o r  6mm c i r c l e s  o f  f i l t e r  p a p e r  ( s e e  s e c t i o n  2A i ) ) .  The serum 
and f i l t e r  p a p e r  c i r c l e s  were s i m i l a r l y  use d  t o  a s s a y  a n t i - h C G  and 
a n t i - p r o l a c t i n .
I n  o r d e r  t o  s e l e c t  f o r  c l o n i n g  o n l y  h i g h - a v i d i t y  a n t i b o d y
s e c r e t i n g  c e l l  l i n e s  a l l  s u p e r n a t a n t s  w i t h  h i g h  b i n d i n g  were
r e a s s a y e d ,  a t  s e v e r a l  d i l u t i o n s ,  i n  t h e  p r e s e n c e  o f  25 uL lOOkU/L  AFP 
s t a n d a r d .
v i )  C l o n i n g  and c h o i c e  o f  a n t i b o d y
The g r o w t h  o f  c e l l s  on t h e  p l a t e s  was m o n i t o r e d  so t h a t  th e
w e l l s  c o u l d  be t e s t e d  f o r  t h e  p r e s e n c e  o f  c r o s s  r e a c t i v i t y ,  a n t i - A F P
a c t i v i t y  and d i s p l a c e m e n t  w i t h  AFP, b e f o r e  a t t a i n i n g  c o n f l u e n c e .  I t
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i s  i m p o r t a n t  t h a t  c l o n i n g  i s  o n l y  p e r f o r m e d  on c e l l s  i n  
l o g a r i t h m i c - p h a s e  g r o w t h .
The c e l l s  f r o m  each s u p e r n a t a n t  c o n t a i n i n g  h i g h  a v i d i t y  
a n t i b o d y  ( h i g h  b i n d i n g  p l u s  good d i s p l a c e m e n t  -  s e c t i o n  2A v ) )  were 
t r a n s f e r r e d  w i t h  f r e s h  m a c r o p h ag e s  t o  2 4 - w e l l  p l a t e s ,  and a l l o w e d  t o  
become c o n f l u e n t .  A t  t h i s  p o i n t  t h e y  w e re  c l o n e d  by l i m i t i n g  
d i l u t i o n .  C e l l  c o n c e n t r a t i o n  was a s s e s s e d  and a d j u s t e d  t o  800 c e l l s  
p e r  mL w i t h  medium (Row A ) .  S even ,  d o u b l i n g ,  s e r i a l  d i l u t i o n s  o f  
t h i s  were  made, so t h a t  t h e  l a s t  d i l u t i o n  (Row H) c o n t a i n e d ,  on 
a v e r a g e ,  l e s s  t h a n  1 c e l l  p e r  lOOuL. T w e l v e  a l i q u o t s  were  t a k e n  f r o m  
each  d i l u t i o n  and p l a c e d  i n  w e l l s  1 t o  12 o f  t h e  a p p r o p r i a t e  row i n  a 
9 6 - w e l l  m i c r o t i t r e  p l a t e  p r e p a r e d  w i t h  3000 m a c r o p h a g e s / w e l l .
v i i )  M u l t i p l i c a t i o n  o f  c l o n e
A f t e r  two  c l o n i n g  s t a g e s ,  t h e  c o n t i n u e d  p r o d u c t i o n  o f  a n t i - A F P
was c o n f i r m e d  and t h e  a s s u m p t i o n  made t h a t  a l l  c e l l s  p r e s e n t  were  o f
m o n o c l o n a l  o r i g i n .  The c l o n e  was g rown u p ,  u s i n g  m a cr opha ges  as
2
f e e d e r  c e l l s ,  v i a  2 4 - w e l l  p l a t e s  and 25 & 75cm f l a s k s  u n t i l  t h e y  
w ere  i n  s u f f i c i e n t  q u a n t i t y  ( i n  l o g - p h a s e  g r o w t h )  t o  i n j e c t  m i c e .
v i i i )  P r e p a r a t i o n  o f  a s c i t i c  f l u i d
Each o f  f i v e  m ic e  was i n j e c t e d  i n t r a p e r i t o n e a l l y  w i t h  p r i s t a n e
( 2 , 6 , 1 0 , 1 4  t e t r a m e t h y l p e n t a d e c a n e , S igma,  P o o l e ,  U K . ) ,  t o  i m p r o v e
a c c e p t a n c e  o f  t h e  t u m o u r  c e l l s ,  a t  l e a s t  14 and p r e f e r a b l y  21 days
6
b e f o r e  t h e y  w ere  g i v e n  a s i m i l a r  i n j e c t i o n  o f  5 x 1 0  h y b r i d o m a  c e l l s .  
The m ic e  w er e  i n s p e c t e d  d a i l y  and t h e  p e r i t o n e a  w ere  d r a i n e d  o f  
a s c i t i c  f l u i d  as n e c e s s a r y .
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2B DEVELOPMENT AND OPTIMIZATION OF AN IMMUNORADIOMETRIC ASSAY
i )  P r e p a r a t i o n  o f  i m m u n o g l o b u l i n  f r a c t i o n  f r o m  p o l y c l o n a l  a n t i b o d y
F o l l o w i n g  t h e  method  o f  S t e i n b u c h  and A udr an  ( 1 9 6 9 ) ,  20 mL o f
s hee p  s e ru m  ( h i g h  a n t i - A F P  t i t r e )  were  a d j u s t e d  t o  pH 5 . 0  by a d d i t i o n
o f  0 .1 M  a c e t i c  a c i d  (0 . 5 7 2 m L  g l a c i a l  a c e t i c  a c i d  i n  lOOmL w a t e r ) .
1 .7 6m L  o f  n - o c t a n o i c  a c i d  was d r i p p e d  i n  s l o w l y  w h i l e  s t i r r i n g .
A f t e r  m i x i n g  by r o t a t i o n  f o r  3 0 m i n .  t h e  t u b e  was c e n t r i f u g e d  f o r  20
m i n .  a t  1 5 0 0 g .  The s u p e r n a t a n t  was re m oved  and t h e  p e l l e t  washed
w i t h  20mL 0 .01M sod iu m b i c a r b o n a t e ,  pH 8 .C  ( 4 . 2 g  o f  s o d i u m
b i c a r b o n a t e  i n  5L w a t e r )  and r e c e n t r i f u g e d .  Wash ings  and s u p e r n a t a n t
w e re  p o o l e d  and d i a l y s e d  f o r  24 h o u r s  a g a i n s t  0 .1 M s o d i u m
o
b i c a r b o n a t e .  The IgG was s t o r e d  a t  - 2 0  C a f t e r  c o n c e n t r a t i o n  by
u l t r a f i l t r a t i o n  t o  a b o u t  50mg/mL.
i i )  P r e p a r a t i o n  o f  i m m u n o g l o b u l i n  f r a c t i o n  f r o m  m o n o c l o n a l  a n t i b o d y  
The above  method  was used b u t  u s i n g  a p p r o p r i a t e  v o l u m e s  o f
a s c i t i c  f l u i d ,  2mL f o r  t e s t i n g ,  20mL f o r  l a r g e r - s c a l e  p r e p a r a t i o n .
i i i )  P r o t e i n  a ss a y
To a s s e s s  t h e  e f f i c i e n c y  o f  s o l i d - p h a s e  c o u p l i n g ,  and t o
q u a n t i t a t e  t h e  p r o d u c t i o n  o f  m o n o c l o n a l  a n t i b o d y  i n  t h e  a s c i t i c  
f l u i d s ,  t h e  p r o t e i n  c o n c e n t r a t i o n  was m ea su r e d  by t h e  m o d i f i e d  Low ry  
m e th o d  o f  S c h a c t e r l e  and P o l l a c k  ( 1 9 7 3 ) .
Aque ous  s t a n d a r d s  were p r e p a r e d  by d o u b l i n g ,  s e r i a l  d i l u t i o n  o f  
a s o l u t i o n  c o n t a i n i n g  50mg b o v i n e  serum a l bum en i n  50mL o f  w a t e r .  
The w o r k i n g  r a n g e  o f  t h e  a ssa y  was 0 . 0 6 3  t o  l m g /m L ;  t h e  p r o t e i n  
s o l u t i o n  t o  be a n a l y s e d  was p r e d i l u t e d  b e tw e e n  1 : 5 0  and 1 : 2 0 0  f o r  IgG 
f r a c t i o n s  and s o l i d  p h a s e s ,  and b e tw e e n  1 : 1 0  and 1 : 2 5  f o r  a s c i t i c  
f l u i d .
0 .2m L o f  s o l u t i o n  was s a m p l e d  and 0 .2mL o f  a l k a l i n e  c o p p e r
r e a g e n t  (10% sod iu m c a r b o n a t e  w i t h  2% s o d i u m  h y d r o x i d e ,  0.1% so d iu m
p o t a s s i u m  t a r t r a t e  and 0 .05% c o p p e r  s u l p h a t e )  ad d e d ,  t h e  t u b e  m i x e d
and a l l o w e d  t o  s t a n d  f o r  10 m i n .  a t  room t e m p e r a t u r e .  lmL o f  w o r k i n g
F o l i n - C i o c a l t e a u  r e a g e n t ,  s t o c k  s o l u t i o n  d i l u t e d  1+25 w i t h  d i s t i l l e d
o
w a t e r ,  was added  and t h e  t u b e s  v o r t e x e d  b e f o r e  i n c u b a t i o n  a t  55 C f o r  
5 m i n . .  A f t e r  r a p i d  c o o l i n g  t h e  a b s o r b a n c e  was measured  a t  650 urn
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and unk now ns  c a l c u l a t e d  by i n t e r p o l a t i o n  f r o m  a p l o t  o f  t h e  s t a n d a r d  
p o i n t s  and m u l t i p l i c a t i o n  by t h e  p r e d i l u t i o n  f a c t o r .
i v )  S o l i d  ph ase  a c t i v a t i o n
F o l l o w i n g  t h e  method  o f  Chapman 4 R a t c l i f f e  ( 1 9 8 2 ) ,  500mL o f
S e p h a r o s e  CL-4B ( P h a r m a c i a ,  M i l t o n  K e y n e s ,  UK) was a l l o w e d  t o  s t a n d  
o v e r n i g h t  and was made up t o  t w i c e  t h e  s e t t l e d  g e l  v o l u m e  w i t h  
i s o t o n i c  s a l i n e  (9g  Sodium c h l o r i d e  i n  1 l i t r e  o f  w a t e r ) .  The 
s o l u t i o n  was w e l l  m ix e d  and 200mL t r a n s f e r r e d  t o  a p o r o s i t y  3 
s i n t e r e d  g l a s s  f u n n e l  (>500mL c a p a c i t y )  f o r  d e h y d r a t i o n  w i t h  500mL o f  
s u c c e s s i v e l y ;  d i s t i l l e d  w a t e r ,  30%, 50%, 70% and 100% a c e t o n e .  Care 
was t a k e n  t o  p r e v e n t  t h e  S e p h a ro s e  d r y i n g  o u t ,  and i t  was s t i r r e d  
g e n t l y  t o  r e s u s p e n d  i t  b e f o r e  each wa sh .  The s o l i d - p h a s e  s l u r r y  was 
t r a n s f e r r e d  t o  a c o n i c a l  f l a s k  ( c a l i b r a t e d  t o  200mL) u s i n g  a s m a l l  
am o u n t  o f  a c e t o n e  t o  p r e v e n t  l o s s .  F u r t h e r  a c e t o n e  was added  t o  
b r i n g  t h e  v o l u m e  up t o  200mL. 4 . 8 7 g  o f  f r e s h  c a r b o n y l d i i m i d a z o l e  was
ad ded  and t h e  f l a s k  s e a l e d  w i t h  a g r o u n d  g l a s s  s t o p p e r .  I t  was 
s t i r r e d  f o r  a t  l e a s t  1 h o u r  and t h e n  t r a n s f e r r e d  ba c k  t o  t h e  s i n t e r  
f u n n e l  and r e h y d r a t e d  w i t h ,  s u c c e s s i v e l y ,  500mL o f  each o f  100%, 70%, 
30% a c e t o n e  and d i s t i l l e d  w a t e r .
v )  C o u p l i n g
The a c t i v a t e d ,  r e h y d r a t e d  S e p h a r o s e  was i m m e d i a t e l y  washed
t h r o u g h  w i t h  500mL o f  c o u p l i n g  b u f f e r  ( 0 . 1 M  EPPS [ N - 2 - h y d r o x y e t h y 1
- p i p e r a z i n e - N 1 - 3 - p r o p a n e - s u l p h o n i c  a c i d ] ,  2 5 . 2 3  g i n  w a t e r )  and
was hed  i n t o  a 500mL c a l i b r a t e d  c o n i c a l  f l a s k .  lOOmg o f  p r e p a r e d
i m m u n o g l o b u l i n  f r a c t i o n  o f  t h e  a n t i s e r u m  was added and t h e  vo lu m e
made up t o  200mL.  T h i s  was s t i r r e d  o v e r n i g h t  and washed s l o w l y  w i t h
500mL o f  0 .5M Sodium b i c a r b o n a t e  ( 4 . 2 g i n  1 l i t r e ) ,  0 .1M a c e t i c  a c i d
( 5 . 7 2 m L  i n  1 l i t r e  w a t e r ) ,  w a t e r  and 0.9% Sodium c h l o r i d e .  The
o
r e a g e n t  was s t o r e d  a t  50% s e t t l e d  g e l  i n  s a l i n e  a t  4 C.
v i )  P r o d u c t i o n  b a t c h e s  o f  s o l i d - p h a s e
U s i n g  a p u r p o s e - b u i l t  2 l i t r e  s i n t e r  w i t h  an o v e r h e a d  s t i r r e r ,  
t h e  a b o v e  v o l u m e s  ( s e c t i o n s  2B i v )  and v ) )  were  t r i p l e d  and t h e  
d e h y d r a t i o n  s i m p l i f i e d  t o  w a s h i n g  t h r o u g h  1 l i t r e  each  o f ;  w a t e r ,  50% 
and 100% a c e t o n e .  The 100% a c e t o n e  was r e t a i n e d  f o r  t h e  r e h y d r a t i o n
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p r o c e d u r e .  A c t i v a t i o n  and c o u p l i n g  were e f f e c t e d  i n  t h e  s i n t e r  
v e s s e l .
v i i )  T e s t  b a t c h e s  o f  S o l i d - p h a s e  m o n o c l o n a l  a n t i b o d y .
The same p r o t o c o l  was f o l l o w e d  as i n  i i i )  and i v )  b u t  t h e  
v o l u m e s  r e d u c e d  t o  one t e n t h  o f  t h e  a b o v e .
v i i i )  I o d i n a t i o n  o f  i m m u n o g l o b u l i n  f r a c t i o n  f r o m  m o n o c l o n a l  a n t i b o d y
The q u a n t i t i e s  and c o n s t i t u t i o n  o f  t h e  r e a g e n t s  f o r  i o d i n a t i o n
( K a r o n e n  e t  a l . 1 9 7 5 ) w e r e  as f o l l o w s .  10 uL o f  0 . 5M  p h o s p h a t e  b u f f e r
125
pH 7 . 4 ,  5uL c a r r i e r - f r e e  - I o d i n e  (Ame rs ham,  UK) ,  lOuL
l a c t o p e r o x i d a s e  l i n k e d  t o  m i c r o c r y s t a l l i n e  c e l l u l o s e ,  and 10 uL 
h y d r o g e n  p e r o x i d e  ( l O u L  o f  lO O v o l  h y d r o g e n  p e r o x i d e  s o l u t i o n  i n  250mL 
d i s t i l l e d  w a t e r ) ,  each  s e p a r a t e d  by lOuL  o f  a i r ,  w ere  d rawn up i n t o  a 
n a r r o w  p o l y t e t r a f l u o r o e t h y l e n e  (PTFE) t u b e  u s i n g  a lOOuL g l a s s  
s y r i n g e .  The c o n t e n t s  were c a r e f u l l y  e x p e l l e d  i n t o  20uL o f  0 .05M 
p h o s p h a t e  b u f f e r ,  pH 7 . 4 ,  c o n t a i n i n g  a p p r o x i m a t e l y  20ug  o f  IgG .  The 
r e a c t i o n  m i x  was v o r t e x e d  b r i e f l y  and i n c u b a t e d  a t  room t e m p e r a t u r e  
f o r  t h i r t y  m i n u t e s ,  m i x i n g  e v e r y  10 m i n u t e s .  The r e a c t i o n  was 
s t o p p e d  u s i n g  200uL  co lu mn  b u f f e r  (0 . 0 5 M  EPPS, pH 8 . 0 ) .  The p r o d u c t s  
w ere  p a s s e d  t h r o u g h  a Se p h a ro s e  6B co l um n  t o  rem ove  u n r e a c t e d  i o d i n e  
and t o  s e p a r a t e  i m m u n o r e a c t i v e  and n o n - i m m u n o r e a c t i v e  f r a c t i o n s .
A s i m i l a r  method  was used f o r  c o m p a r i s o n ,  b u t  s u b s t i t u t i n g  l u g  
o f  c h l o r a m i n e  T i n  10 uL p h o s p h a t e  b u f f e r  (pH 7 . 4 )  f o r  t h e  
l a c t o p e r o x i d a s e ,  o m i t t i n g  t h e  h y d r o g e n  p e r o x i d e  and i n c u b a t i n g  f o r  
t h i r t y  s e c o n d s .  T h i s  method was a l s o  u se d  f o r  i o d i n a t i o n  o f  IgG 
s t o r e d  i n  s o d i u m  a z i d e  s o l u t i o n .
i x )  Assay  o p t i m i z a t i o n
The c h o i c e  o f  b u f f e r ,  and c o n c e n t r a t i o n s  o f  l a b e l ,  s o l i d  p h a s e ,  
shee p  s e r u m ,  Twe en- 20  and sample  were i n v e s t i g a t e d ,  and t h e  t i m e  
c o u r s e  o f  t h e  r e a c t i o n  d e t e r m i n e d ,  and t h e  c e n t r i f u g a t i o n  and d e n s i t y  
s e d i m e n t a t i o n  ( W r i g h t  & H u n t e r  1983)  s e p a r a t i o n  m e t h o d s  c o m p a r e d .
x )  S t a n d a r d s  and q u a l i t y  c o n t r o l s
One a m pou le  o f  human c o r d  se rum B S 7 2 / 2 2 7  ( S i z a r e t  e t  a l . 19 7 5 )  
was r e c o n s t i t u t e d  i n  w a t e r  and s t o c k  s t a n d a r d  p r e p a r e d  by d i l u t i n g  t o  
lOOmL i n  EPPS b u f f e r  pH 8 . 0  (see  IRMA p r o t o c o l  s e c t i o n  f o l l o w i n g ) .
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lmL a l i q u o t s  were  s t o r e d  a t  - 7 0  C.
S e v e r a l  p o s s i b l e  m a t r i c e s  f o r  t h e  p r e p a r a t i o n  o f  s t a n d a r d s  were 
e v a l u a t e d  by a d d i t i o n  o f  known am ount s  o f  s t a n d a r d  m a t e r i a l .
R e c o v e r y  was s i m i l a r l y  a s s e s s e d  i n  6 human s e r a .
x i )  IRMA p r o t o c o l  f o r  s m a l l  b a t c h e s
B u f f e r  ( 0 . 1 M  EPPS, 0.2% T w e e n - 2 0 ,  0.1% s o d i u m  a z i d e )  was
p r e p a r e d  by d i s s o l u t i o n  o f  2 5 . 2 3 g  o f  EPPS, 2mL Tween-20  and l g  so d iu m
a z i d e  i n  750mL o f  d i s t i l l e d  w a t e r ,  a d j u s t i n g  t h e  pH t o  8 . 0  w i t h  s o l i d
s o d i u m  h y d r o x i d e  and m a k i n g  up t o  lOOOmL. " M i x e d  s o l i d  p h a s e / l a b e l "
r e a g e n t  was one p a r t  o f  w e l l - m i x e d  p o l y c l o n a l  s h e e p - a n t i - h u m a n  AFP
c o v a l e n t l y  l i n k e d  t o  S e p h a ro s e  CL-4B ( s t o r e d  as 50% s e t t l e d  g e l  i n
i s o t o n i c  s a l i n e )  p l u s  t h r e e  p a r t s  b u f f e r ;  w i t h  4uL (2% f i n a l
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c o n c e n t r a t i o n )  sheep  serum and 5ng - I o d i n a t e d  m o n o c l o n a l  a n t i b o d y
( AF5 /A2  ) p e r  2 0 0 u L .
The o p t i m i s e d  p r o t o c o l  f o r  s m a l l  b a t c h e s  (100  t u b e s )  was as
f o l l o w s .  U s i n g  a s e m i - a u t o m a t i c  p i p e t t e  ( o r  m a n u a l l y ) ,  a 25 uL
sa m p le  was d i l u t e d  w i t h  200uL  b u f f e r .  400uL  " m i x e d  s o l i d
p h a s e / l a b e l "  r e a g e n t  was added by H a m i l t o n  PB600 -1 0  o r  B o e h r i n g e r
8000  r e p e a t i n g  p i p e t t e  and t h e  t u b e s  i n c u b a t e d  f o r  2 . 5 h o u r s  a t  room
t e m p e r a t u r e  w h i l e  b e i n g  shak en  a t  2 5 0 rp m .  S e p a r a t i o n  was e f f e c t e d  by
t h r e e  p a s s e s  o f  3mL o f  0.9% s a l i n e ,  b r i e f  c e n t r i f u g a t i o n  t o  1500g  and
a s p i r a t i o n  by m u l t i - p r o b e  vacuum pump. The bound f r a c t i o n  was
c o u n t e d  on a NE1600 g a m m a - c o u n t e r  ( N u c l e a r  E n t e r p r i s e s ,  E d i n b u r g h ,
UK) and t h e  d a t a  g e n e r a t e d  p r o c e s s e d  u s i n g  t h e  s i n g l e - b i n d i n g - s i t e
o p t i o n  i n  t h e  W o r l d  H e a l t h  O r g a n i z a t i o n  " l a w  o f  mass a c t i o n "
m o d e l - b a s e d  d a t a  r e d u c t i o n  programme (E d w a rd s  & E k i n s  19 8 3 )  o r  by
ma nua l  i n t e r p r e t a t i o n  o f  a g r a p h  o f  p e r c e n t  bound  ( l o g  ) v e r s u s  AFP
10
c o n c e n t r a t i o n  ( l o g  ) .
10
x i i )  IRMA p r o t o c o l  f o r  l a r g e  b a t c h e s
L a r g e  b a t c h e s  o f  up t o  400 t u b e s  were  p e r f o r m e d  as f o l l o w s .  The
M i c r o m e d i c  APS-2 was used t o  t a k e  up 200uL  b u f f e r  p l u s  25uL s a m p l e .
On c o m p l e t i o n  o f  a l l  sa m p le  d i l u t i o n ,  2 0 0 u l  o f  " m i x e d
s o l i d - p h a s e / l a b e l "  r e a g e n t  was added r a p i d l y  t o  each t u b e  u s i n g  a
H a m i l t o n  PB6 00 -1 0  o r  B o e h r i n g e r  8000 r e p e a t i n g  p i p e t t e .  I n c u b a t i o n
o
was f o r  2 . 5  h o u r s  a t  room t e m p e r a t u r e  ( 1 0 - 3 0  C) on an o r b i t a l  s h a k e r  
(2 50  r p m ) .  A f t e r  s e p a r a t i o n  o f  bound  and f r e e  r a d i o a c t i v i t y  u s i n g
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two p a s s e s  o f ;  a d d i t i o n  o f  lmL 0.9% s a l i n e  and 1.0% Twee n- 20  (2mL 
C o r n w a l l  s y r i n g e )  f o l l o w e d  by a d d i t i o n  t o  t h e  b o t t o m  o f  t h e  t u b e  o f  
3mL 10% s u c r o s e  and 1% Tween-20  ( 4 0 - t u b e  p e r i s t a l t i c  pump) and 
a s p i r a t i o n  o f  t h e  s u p e r n a t a n t  ( 4 0 - t u b e  vacuum pum p ) ,  t h e  bound  
f r a c t i o n  was c o u n t e d  on a Rackgamma 1270 ( L K B - P h a r m a c i a , M i l t o n  
Keyne s ,  UK) and t h e  d a t a  g e n e r a t e d  r e d u c e d  u s i n g  a 5 p a r a m e t e r  
l o g - l o g i t  t r a n s f o r m a t i o n  i n  t h e  E d i n b u r g h  RIAPAC Programme ( M c K e n z i e  
& Thompson 1 9 8 3 :  Raab 1 9 8 3 ) .
x i i i )  S t a t i s t i c a l  m e th ods
R e s u l t s  f r o m  t h e  tw o  a s s a y  m e th ods  w e re  co mp a re d  u s i n g  l i n e a r  
r e g r e s s i o n  a n a l y s i s  and S t u d e n t ' s  ' t ' - s t a t i s t i c . Q u a l i t y  c o n t r o l  
v a l u e s  w ere  a s s e s s e d  u s i n g  s t a n d a r d  d e v i a t i o n  and c o e f f i c i e n t  o f  
v a r i a t i o n  e s t i m a t e s .
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CHAPTER 3 RESULTS
The r e s u l t s  a r e  d i v i d e d  i n t o  t h r e e  S e c t i o n s ;  A) P r e p a r a t i o n  o f  
M o n o c l o n a l  A n t i b o d i e s ,  B) D e v e l o p m e n t  and O p t i m i z a t i o n  o f  an 
I m m u n o r a d i o m e t r i c  Assay  ( I R M A ) ,  and C) R o u t i n e  Use and E x p e r i e n c e .
3A PREPARATION OF MONOCLONAL ANTIBODIES
i )  I m m u n i z a t i o n  and f u s i o n
F o l l o w i n g  i m m u n i z a t i o n  o f  t h e  m i c e  as i n  s e c t i o n  2A i ) ,  b i n d i n q
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o f  - I  AFP by b l o o d  s a m p l e s  f r o m  t h r e e  m i c e  a t  0 weeks was 4% 
( e q u i v a l e n t  t o  z e r o ) ;  a t  4 weeks two  mi ce  showed 47% and one 20% and 
a t  6 weeks a l l  had r e a c h e d  63%. A l l  s u b s e q u e n t  m ic e  r e a c h e d  h i g h ,  
s t a b l e  a n t i - A F P  t i t r e s  i n  4 - 6  w eeks .
Two m i c e  were  used  f o r  s i x  f u s i o n  e x p e r i m e n t s .  I n  f u s i o n s  
AA-AC 207 m i l l i o n  s p l e e n  t o  130 m i l l i o n  mye loma c e l l s  (89% v i a b l e ,  
r a t i o  1 . 5 9 : 1 )  were  used and i n  f u s i o n s  AD-AF 105 m i l l i o n  s p l e e n  t o  
153 m i l l i o n  myeloma (92% v i a b l e ,  0 . 6 8 6 : 1 ) .
Over  90% o f  t h e  2880 w e l l s  p l a t e d  f r o m  a l l  s i x  f u s i o n s  showed
v i s i b l e  c o l o n i e s  a t  4 d a y s .  A t h i r d  s e t  o f  t h r e e  f u s i o n s  was
a ban d o n e d  b e c a u s e  t h e  myeloma c e l l s  were  45% v i a b l e ,  an a r b i t r a r y
min imum a c c e p t a b l e  v i a b i l i t y  o f  85% was a p p l i e d .
i i )  T e s t i n g
As shown i n  s e c t i o n  2A v ) ,  t h e  t e s t i n g  scheme u s e d ,  a )
d i l u t i o n s  o f  se rum f r o m  one o f  t h e  h i g h - a n t i - A F P - t i t r e  m i c e ,  and b)  a
c o m m e r c i a l  m o n o c l o n a l  a n t i b o d y  as p o s i t i v e  c o n t r o l s .  A t  1 i n  1000
d i l u t i o n  t h e  m o n o c l o n a l  bound 22 .0% o f  added  l a b e l ,  and 8.0% w i t h
5 0 0 n g / m l  AFP s t a n d a r d  added ( d i s p l a c e m e n t  o f  64%) .  Co mp ara b le
f i q u r e s  f o r  t h e  mouse serum were  1 i n  1 6 , 0 0 0 ,  21 .4% and 3.2%
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( d i s p l a c e m e n t  o f  85%) .  The mouse serum d i d  n o t  b i n d  - I o d i n e
l a b e l l e d  p r o l a c t i n  o r  human c h o r i o n i c  g o n a d o t r o p h i n .
A p o s i t i v e  w e l l  was a r b i t r a r i l y  d e f i n e d  as >10% b i n d i n g  o f  
125
added  J-AFP l a b e l .  T h e r e  were  384 p o s i t i v e  w e l l s  i n  f u s i o n s  AA-AC 
( T a b l e  4 ) ,  and 752 p o s i t i v e  w e l l s  i n  f u s i o n s  AD-AF ( T a b l e  5 ) ,  a t o t a l  
o f  1 1 3 6 .  Thus 39.4% o f  w e l l s  c o n t a i n e d  a n t i - A F P  s e c r e t i n g  c o l o n i e s ,  
many o f  w h i c h  w o u ld  have c o n t a i n e d  s e v e r a l  s e c r e t i n g  a n d / o r  
n o n - s e c r e t i n g  c l o n e s .  256 w e l l s  (8 . 9% o f  w e l l s ,  22 .5% o f  p o s i t i v e s )
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w ere  s u b j e c t e d  t o  d i s p l a c e m e n t  t e s t i n g .  Those  w i t h  b i n d i n g  g r e a t e r  
t h a n  40% f r o m  f u s i o n s  AA-AC were  a s s a y e d  a t  d i l u t i o n s  o f  1 : 3  (> 40% ) ,  
1 : 9  (>50%) and 1 : 2 7  (> 6 0 % ) .  Those  w i t h  b i n d i n g  g r e a t e r  t h a n  30% f r o m  
f u s i o n s  AD-AF w e re  a s s a y e d  a t  d i l u t i o n s  o f  1 : 3  (> 30% ) ,  1 : 9  (> 40% ) ,  
1 : 2 7  (>50%) and 1 : 8 1  (> 60% ) .  The r e s u l t s  a r e  d i s p l a y e d  i n  T a b l e s  6 
and 7.
The 19 " h i g h  b i n d e r s "  f r o m  f u s i o n s  AA-AC were  n o t  d i l u t e d  
s u f f i c i e n t l y  and t h e  c e l l  l i n e s  were  l o s t  due t o  c e l l  o v e r g r o w t h  
b e f o r e  t h e y  c o u l d  be r e t e s t e d  a t  a h i g h e r  d i l u t i o n .  ,
From f u s i o n s  AA-AC, c o l o n i e s  f r o m  t h e  38 w e l l s  w i t h  g r e a t e s t  
d i s p l a c e m e n t  w e re  t a k e n  on b u t  se ve n  w e re  l o s t  b e f o r e  s t o r a g e .  
C o n c u r r e n t l y  t h e  b e s t  8 were c l o n e d .  C o l o n i e s  f r o m  t h e  48 w e l l s  w i t h  
g r e a t e s t  d i s p l a c e m e n t  f r o m  f u s i o n s  AD-AF w e re  t a k e n  on i n t o  2mL w e l l s  
b u t  10 d i d  n o t  s u r v i v e  t o  be f r o z e n  down.
PERCENT BOUND <10 
PLATE
1 0 - 2 0  2 0 - 3 0  3 0 - 4 0
F u s i o n  A















































































TOTAL 1056 165 76 35 32 58 18
AA-AC PERCENT 7 3 . 3  
% OF +ves
1 1 . 5
4 3 . 0
5 . 2 8
1 9 . 8
2 . 4 3
9 . 1 1
2 . 2 2
8 . 3 3
4 . 0 3
1 5 . 1 0
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1 . 2 5
4 . 6 9
T a b l e  4 B i n d i n g  o f  - I o d i n a t e d  AFP by S u p e r n a t a n t  f r o m  9 6 - w e l l  
p l a t e s  a t  11 days  p o s t - f u s i o n
PERCENT BOUND <10 10 -2 0 2 0 - 3 0 3 0 - 4 0 4 0 - 5 0 5 0 - 6 0 >60
PLATE F u s i o n  D
ADI 51 25 5 5 6 2 2
AD2 56 18 15 2 3 1 1
AD3 65 19 6 1 1 3 1
AD4 62 20 7 3 0 4 0
AD5 59 29 4 2 2 0 0
F u s i o n  E
AE1 26 38 20 7 2 1 2
AE2 24 35 18 10 7 2 0
AE3 36 36 15 7 0 2 0
AE4 42 32 10 7 1 2 2
AE5 ' 42 34 12 4 3 1 0
F u s i o n  F
AF1 42 32 9 7 5 1 0
AF2 43 33 10 5 2 3 0
AF3 42 41 5 5 1 2 0
AF4 48 36 7 2 2 1 0
AF5 50 29 4 5 5 2 1
TOTAL 688 457 147 72 40 27 9
AD-AF PERCENT 4 7 . 8 3 1 . 7 1 0 . 2 5.  00 2 . 7 8 1 . 8 7 0 . 6 2
% OF +ves 6 0 . 8 1 9 . 6 9 . 5 7 5 . 3 2 3 . 5 9 1 . 2 0
GRAND TOTAL 1744 622 223 107 72 85 27
AA-AF PERCENT 6 0 . 6 2 1 . 6 7 . 7 4 3 . 7 2 2 .  50 2 . 9 5 0 . 9 4
% OF +v es 5 4 . 8 1 9 . 6 9 . 4 2 6 . 3 4 7 . 4 8 2 . 3 8
T a b l e 5 B i n d i n g
125
o f I o d i n a t e d AFP by S u p e r n a t a n t f r o m  96
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TOTAL 43 16 14 19
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T a b l e  6 D i s p l a c e m e n t  o f  - I o d i n a t e d  AFP by S u p e r n a t a n t  f r o m  
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TOTAL 10 17 65 54
-  Assay e r r o r s
125
T a b l e  7 D i s p l a c e m e n t  o f  - I o d i n a t e d  AFP by S u p e r n a t a n t  f r o m  
9 6 - w e l l  p l a t e s  a t  8 da ys  p o s t - f u s i o n .
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i i i )  C l o n i n g
From f u s i o n s  AA-AC, 8 c e l l  l i n e s  were  c l o n e d  f r o m  t h e  9 6 - w e l l
p l a t e s ,  o f  w h i c h  5 were no l o n g e r  p r o d u c i n g  a n t i b o d y  when t e s t e d  f o r
d i s p l a c e m e n t .  The o t h e r  t h r e e  " c l o n e s "  were p o s i t i v e  and w e l l s
2
s h o w in g  good g r o w t h  were  t a k e n  on i n t o  2mL w e l l s  and 25 cm f l a s k s ,
f r o m  w h i c h  t h e y  were  f r o z e n  down.  A s e v e r e  c o n t a m i n a t i o n  e v e n t
p r e v e n t e d  seco nd  c l o n i n g .  From f u s i o n s  AD-AF,  6 c e l l  l i n e s  were
c l o n e d  a f t e r  g r o w i n g  up i n  2 mL w e l l s  o f  w h i c h  2 were n o t  p r o d u c i n g
a n t i b o d y  when t e s t e d  f o r  d i s p l a c e m e n t .  C e l l  l i n e ?  f r o m  t h e  f o u r
p r o d u c i n g  " c l o n e s "  w h i c h  were s h o w i n g  good g r o w t h ,  were t a k e n  on i n t o
2
2mL w e l l s  and t h e n  25 cm f l a s k s ,  f r o m  w h i c h  t h e y  were f r o z e n  down.  
Two m a i n t a i n e d  t h e i r  g r o w t h - r a t e ,  d i s p l a c e m e n t  and s e c r e t i o n  
p a r a m e t e r s  and were  c l o n e d  a se c o n d  t i m e ,  by l i m i t i n g  d i l u t i o n .  B o th  
s u r v i v e d  t h e  p r o c e d u r e  and m a i n t a i n e d  t h e i r  c h a r a c t e r i s t i c s .
i v )  A n t i b o d y  S e l e c t i o n
The two  s e c o n d - c l o n e  c e l l  l i n e s  ( A F 5 / A 2 / G 1 1 / H 1 0  and
A F 4 / B i l / C l / B 2  known h e n c e f o r t h  as AF5 /A2  and A F 4 / B 1 1 )  were  used  t o
g e n e r a t e  a s c i t i c  f l u i d  (up  t o  9 t a p s  w e re  t a k e n  f r o m  each mouse
w i t h o u t  d i s t r e s s )  and s u b s e q u e n t l y  f o r  s o l i d - p h a s e  c o u p l i n g  and 
125
- I o d i n a t i o n  s t u d i e s .
P r o t e i n  c o n c e n t r a t i o n  and v o l u m e s  o f  a s c i t i c  f l u i d  o b t a i n e d
f r o m  t h e  10 mice  a r e  shown i n  T a b l e  8 .  The p r o t e i n  c o n c e n t r a t i o n s  o f
i m m u n o g l o b u l i n  f r a c t i o n s  o f  i n d i v i d u a l  t a p s  a r e  shown i n  T a b l e  9.
The two  c e l l  l i n e s  had shown s i m i l a r  g r o w t h  c h a r a c t e r i s t i c s  and 
125
by p r e p a r i n g  - I o d i n a t e d  ( s e c t i o n s  2B i i  & v i i i ) )  and s o l i d - p h a s e
l i n k e d  ( s e c t i o n s  2B i i )  i v )  v )  & v i i ) )  v e r s i o n s  o f  each  a n t i b o d y  f r om  
t h e  i m m u n o g l o b u l i n  f r a c t i o n s  o f  t h e  a s c i t i c  f l u i d s ,  t h e i r  s p e c i f i c i t y  
was i n v e s t i g a t e d .  T a b l e  10 shows t h e  i n h i b i t i o n  o f  b i n d i n g  o f  
l a b e l l e d  AF5/A2  by s o l i d - p h a s e  AF4/B11  and v i c e  v e r s a  and w i t h  
s o l i d - p h a s e  SAPU p o l y c l o n a l .  T h i s  s i m i l a r  s p e c i f i c i t y  p r e v e n t e d  t h e  
d e v e l o p m e n t  o f  a d o u b l e - m o n o c l o n a l  a s s a y .  F i g u r e  11 shows t h e  h i g h e r  
p o t e n c y  o f  a s c i t i c  f l u i d s  t a k e n  f r o m  AF5/A2  mi ce  and t h a t  t h e  p o t e n c y  
o f  t h e  t a p s  i n c r e a s e s  w i t h  t h e  t a p  n um ber .
C e l l  L i n e
AF5/A2  AF4/B11
Tap P r o t e i n  IgG Volum e T o t a l P r o t e i n  IgG Volume T o t a l
Number mg/mL mg/mL mL P r o t e i n mg/mL mg/mL mL P r o t e i n
1 55 7 . 1 11 605 35 3 . 5 6 210
2 48 8 . 0 9 432 42 4 . 6 9 378
3 63 7 . 1 5 315 30 4 . 8 3 90
4 43 8 . 4 4 172 35 5 . 9 5 175
5 ' 89 1 2 . 3 7 623 39 6 . 5 3 117
6 64 2 5 . 3 7 448 49 7 . 8 9 441
7 89 2 6 . 0 7 623 40 9 . 6 3 120
8 56 1 0 . 4 4 224
9 63 1 2 . 0 3 189
T a b l e  8 P r o t e i n  c o n c e n t r a t i o n and v o l u m e s o f  a s c i t e s f l u i d o b t a i n e d
f r o m  t h e 12 m i c e .
A n t i b o d y Mouse Tap IgG
mg/mL
AF5/A2 B l a c k 3 7





AF4/B11 B lu e 4 11
Red 3 7
T a b l e  9 The p r o t e i n  c o n c e n t r a t i o n s  o f  i m m u n o g l o b u l i n  f r a c t i o n s  o f  
s e l e c t e d  i n d i v i d u a l  t a p s .  ^      7   "
S o l i d - p h a s e  
AF4/B11  AF5 /A2  p o l y c l o n a l
a n t i b o d y
l a b e l  AF4 /B11  1.6% 1 . 5 % 5 2 . 3 %
l a b e l  AF5 /A2  1.256 0 .99% 63.0%
T a b l e  10 The b i n d i n g  o f  m o n o c l o n a l  and p o l y c l o n a l  a n t i b o d i e s  i  







































FIGURE 11 Binding of 125 Iodinated alphafoetoproteln by dilut ions of 
asc i t ic  fluids.
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v )  C h a r a c t e r i z a t i o n  o f  c a n d i d a t e  a n t i b o d i e s
B o t h  m o n o c l o n a l s , AF5 /A2  and AF4 /B 11  were shown by r a d i a l  
i m m u n o d i f f u s i o n , u s i n g  a k i t  s u p p l i e d  by S e r o t e c  ( B i c e s t e r ,  UK) ,  t o  
f o r m  p r e c i p i t i n  a r c s  w i t h  a n t i s e r u m  t o  t h e  I g G l  i s o t y p e .  No r e a c t i o n  
was n o t e d  w i t h  a n t i s e r a  t o  i m m u n o g l o b u l i n s  G2a, G2b, G3, A o r  M.
v i )  D e t e r m i n a t i o n  o f  a v i d i t y
S c a t c h a r d  a n a l y s i s  o f  t h e  s e c o n d - c l o n e  p r o d u c t ,  A F5 / A 2 ,  u s i n g
an RIA s i m i l a r  t o  t h e  t e s t i n g  scheme showed t h a t ,  t h e  a s s o c i a t i o n
10
c o n s t a n t  was g r e a t e r  t h a n  10 L / m o l .  F i g u r e s  12 and 13 show d a t a  f o r  
t h e  m o n o c l o n a l  AF5 /A2  and f o r  t h e  sheep  p o l y c l o n a l  a n t i b o d i e s .
v i i )  F lo w  c h a r t s
The o v e r a l l  r e s u l t s  o f  i m m u n i s a t i o n  and a n t i b o d y  p r o d u c t i o n  a r e  
s u m m a r is e d  i n  F i g u r e s  14 and 15 .





































y = 0.65585 - 9.6489e-2x RA2 = 0.8200 . 7 -
0 .6 "
0 . 5 -
0 . 4 -




0 1 2 3 4 5 6 7 8
0 .8-1 y = 0.93257 -0.14192x RA2 = 0.749
0 . 7 -
0.6
0 . 5 -
0 . 4 -




0 2 31 4 5 6 7 8
AFP pmol/L
FIGURE 12 Two Scatchard plots for  the monoclonal antibody 
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FIGURE 13 Scatchard plots for the low avidi ty  and high avid ity  
groups of the sheep polyclonal antibody, showing avid i t ies  of 
2 .2x1 0 10 and 8.1 x 1 0 1 ° .
FUSION
T o t a l  c e l l s  a v a i l a b l e  H y b r i d  f o r m a t i o n :  2 3 5 , 0 0 0 , 0 0 0
TESTING
C o l o n i e s  ( a p p r o x . )  
P r o d u c e r s  (> 105K)
14400  
i n  28 80  w e l l s  
1136
TISSUE CULTURE
S t o r e d
C l o n e d




VALIDATION OF ASSAY 
---------------------------- IT S ------
- I o d i n a t i o n
S o l i d - p h a s e
ROUTINE USE
F i g u r e  15 F lo w  D ia g ra m  o f  M o n o c l o n a l  A n t i b o d y  P r o d u c t i o n
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v i i i )  O b s e r v a t i o n s
Two e p i s o d e s  o f  i n f e c t i o n  d u r i n g  t h e  t i s s u e  c u l t u r e  s t a g e s  d i d  
n o t  p r e v e n t  t h e  g e n e r a t i o n  o f  a l a r g e  number o f  h y b r i d  c e l l  l i n e s .  
From t h e s e ,  two were o b t a i n e d  w h i c h  e x p r e s s e d  a v i d  a n t i - A F P ,  g rew 
r a p i d l y  i n  t h e  i n c u b a t i o n  c o n d i t i o n s  and m a i n t a i n e d  a p p a r e n t l y  s t a b l e  
c o n s t i t u t i o n s  and a n t i b o d y  s e c r e t i o n  c h a r a c t e r i s t i c s .  I t  was c l e a r  
f r o m  t h e  b i n d i n g  c h a r a c t e r i s t i c s  t h a t  t h e y  w o u ld  be s u i t a b l e  even  f o r  
a r a d i o i m m u n o a s s a y  m e th od ,  and t h a t  t h e y  w o u l d  be good c a n d i d a t e s  f o r  
t h e i r  i n c l u s i o n  i n  a s e n s i t i v e  i m m u n o r a d i o m e t r i c a s s a y .
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3B DEVELOPMENT AND OPTIMIZATION OF AN IMMUNORADIOMETRIC ASSAY
i )  C a l i b r a t i o n  c u r v e
As shown i n  s e c t i o n  3A i v ) ,  t h e  m o n o c l o n a l  a n t i b o d i e s  have  t h e  
same s p e c i f i c i t y  b u t  e i t h e r  i s  c o m p a t i b l e  w i t h  t h e  sheep  
a n t i - h u m a n - A F P  p o l y c l o n a l  a n t i b o d y  s u p p l i e d  by SAPU. F i g u r e  16 shows 
t y p i c a l  d o s e - r e s p o n s e  c u r v e s  f o r  AF5 /A2  m o n o c l o n a l / S A P U  p o l y c l o n a l ,  
SAPU m o n o c l o n a l / S A P U  p o l y c l o n a l  and c o m m e r c i a l  d o u b l e - m o n o c l o n a l  
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FIGURE 16 Dose-response curves for three monoclonal antibody 
based AFP-IRMAs. ' .  ... ;
uln -  upper l i m i t  of "normal" males.
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i i )  D i f f e r e n c e s  be tw ee n  c a n d i d a t e  a n t i b o d i e s
The two  a n t i b o d i e s  chosen  showed l i t t l e  e v i d e n c e  o f  d i f f e r e n c e  
i n  b i n d i n g  p r o p e r t i e s  o r  i n  th e  g r o w t h  and s t a b i l i t y  o f  t h e  p a r e n t  
c e l l  l i n e s .  AF5/A2  was s e l e c t e d  b e c a u s e  i t  gave s l i g h t l y  h i g h e r
b i n d i n g  on i o d i n a t i o n .
i i i )  S p e c i f i c i t y
U s in g  t h e  p r e s e n t  c o m b i n a t i o n  o f  m o n o c l o n a l  and p o l y c l o n a l  
a n t i b o d i e s ,  t h e r e  has been no e v i d e n c e  o f  i n t e r f e r e n c e  f r o m  o t h e r  
m o l e c u l a r  s p e c i e s .  The l a c k  o f  c r o s s - r e a c t i o n  t o  p r o l a c t i n  and hCG 
was d e m o n s t r a t e d  a t  t h e  a n t i b o d y  p r o d u c t i o n  phase  ( s e c t i o n s  2A i )  4 
v ) ) •  Of  t h e  many h i g h - t i t r e  AFP s a m p l e s  t e s t e d  none has shown t h e  
n o n - l i n e a r i t y  on d i l u t i o n  w h ic h  w o u ld  s u g g e s t  t h a t  t h e  a n t i g e n  was 
n o t  AFP.
i v )  S o l i d  phase
L i t t l e  d i f f e r e n c e  i n  t h e  u p t a k e  o f  t h e  i m m u n o g l o b u l i n  f r a c t i o n s  
was n o t e d .  T y p i c a l  l o a d i n g  o f  t h e  s o l i d - p h a s e  w i t h  d i f f e r e n t
a n t i b o d i e s  w e r e :  AF4/B11 -  1.2mg/mL u s i n g  lOmg o f  IgG p e r  mL o f  
a d d e d ,  s e t t l e d  g e l ,  AF5/A2 -  1 .3m g/mL (21mg/mL a d d e d ) ,  p o l y c l o n a l  
1 .2 m g /m L  ( 6 . 8 m g /m L  a d d e d ) .  A modes t  e x c e s s  was used f o r  r o u t i n e  
p r e p a r a t i o n ,  240mg p e r  200mL s e t t l e d  g e l .
v )  D i f f e r e n c e s  be tween b a t c h e s  and s t a b i l i t y
P e r s o n a l  o b s e r v a t i o n s  on t h e  s m a l l  b a t c h e s  (3mL t o  200mL
s e t t l e d  g e l )  p r e p a r e d  d u r i n g  t h e  d e v e l o p m e n t  o f  t h e  t e c h n i q u e  showed
l i t t l e  v a r i a t i o n  i n  t h e  shape o f  s t a n d a r d  c u r v e  and p l a t e a u  l e n g t h .
Q u a l i t y  A s s e s s m e n t  p a r a m e t e r s  were  s e t  as ( u s i n g  s a l i n e  s e p a r a t i o n
125
and a s s u m i n g  f r e s h l y  - I o d i n a t e d  A F 5 / A 2 )  b i n d i n g  a t  Ok U/L<o .4% ,  a t  
6 1 k U / L  14SG and p l a t e a u  t o  2 5 , 0 0 0 k U / L .  The l a r g e r  r o u t i b e “~ b a t c h e s  
showed g r e a t e r  v a r i a t i o n ,  e s p e c i a l l y  i n  p l a t e a u  l e n g t h .  I t  was a l s o  
q u i c k l y  n o t i c e d  t h a t  t h e  s t a n d a r d  c u r v e  g r a d u a l l y  s h i f t e d  t o  t h e  
r i g h t  d u r i n g  t h e  3 - 4  months t h a t  each  b a t c h  was i n  u s e .  T h i s  p r o b l e m  
was o v er com e by w a sh in g  th e  s o l i d - p h a s e  b e f o r e  u s e ,  o r  p e r i o d i c a l l y .
v i )  I o d i n a t i o n
F i g u r e  17 shows a t y p i c a l  i o d i n a t i o n  p r o f i l e  f o r  m o n o c l o n a l  
a n t i b o d y  A F5 / A 2 .  The l a c t o p e r o x i d a s e  i o d i n a t i o n  p e r f o r m a n c e  was
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c o n s i s t e n t  u s i n g  t h e  p a r t i a l l y  p u r i f i e d  IgG a l i q u o t s .  Each
i o d i n a t i o n  i s  s u f f i c i e n t  f o r  a b o u t  1 0 , 0 0 0  t u b e s .  The l a b e l l e d  
p r o t e i n  s u p p l i e d  by SAPU u s i n g  a l a r g e  s c a l e ,  c h l o r a m i n e - T  i o d i n a t i o n  
t e c h n i q u e  gave i n d i s t i n g u i s h a b l e  r e s u l t s .
C a l c u l a t i o n  o f  i o d i n a t i o n  p a r a m e t e r s  f o r  t h e  i o d i n a t i o n  shown i n  t h e  
f i g u r e .
P = T o t a l  P r o t e i n  peak  1 , 3 0 9 , 7 0 0  c o u n t s
U = I m m u n o r e a c t i v e  P r o t e i n  pe ak  1 , 0 7 6 , 8 0 0  c o u n t s
I  = U n r e a c t e d  I o d i n e  pea k  1 1 2 , 2 0 0  c o u n t s
I n c o r p o r a t i o n  = P / ( P + I )  = 92%
A c t i v i t y  = 1 5 0 0 * U / ( P + I )  = 11 3 6 u C i
U s e a b le  P r o t e i n  = 5 7 . 6 * ( U / P )  = 4 7 . 4 u g
S p e c i f i c  A c t i v i t y  = 1 1 3 6 / 4 7 . 4  = 2 3 . 9 u C i / u g
C o n c e n t r a t i o n  = ( 4 7 . 4 / 1 0 ) u g / m L  = 4 7 4 0 n g / m l
T a b l e  18 and F i g u r e  19 d e m o n s t r a t e  t h e  i m m u n o r e a c t i v i t y  o f  t h e  
i n d i v i d u a l  f r a c t i o n s  c o l l e c t e d  f r o m  a s i m i l a r  i o d i n a t i o n  o f  
m o n o c l o n a l  a n t i b o d y  A F4 / B 1 1 .  L a b e l  p r e p a r a t i o n s  w i t h  s p e c i f i c  
a c t i v i t i e s  g r e a t e r  t h a n  2 5 u C i / u g  g e n e r a t e d  l o w - b i n d i n g  s t a n d a r d  
c u r v e s .
Counts
200000 n
1 6 0 0 0 0 -
120000 -
8 0 0 0 0  -
4 0 0 0 0  -
. eC
3 020 4 0 5 0 6 0 7 0 8 0
Fraction Number
FIGURE 17 A typical Iodination pro f i le  for monoclonal antibody 
A F 4 / B 1 1 .
Fract ion number 3 3 3 4 3 5 3 6 3 7 3 8
Counts ( x l 0 3 ) 9 7 1 7 5 2 1 5 2 1 0 1 65 9 9
% Bound
1OOOkU/L 4 8 . 2 4 6 . 2 4 5 . 2 4 4 . 7 3 7 . 6 3 2 . 5
3 3 3 4 0 . 5 3 9 . 4 3 6 . 6 3 6 . 5 3 0 . 2 2 6 . 6
1 1 1 2 6 . 9 2 5 . 4 2 3 . 7 2 3 . 4 1 9 .5 1 6 .5
3 4 9. 1 5 9. 1 7 8 . 4 0 8 . 4 4 7 . 0 4 6 . 1 0
1 1 5 . 3 9 5 . 2 8 5. 1 5 4 . 9 2 4 . 2 2 3 . 7 8
3 . 4 2 .7  1 2 . 7 2 2 . 6 3 2 . 6 0 2 . 2 5 2.1 2
1 . 1 1 .70 1 .7 0 1 .7 7 1 .8 1 1 .7 5 1 .6 0
. 3 4 1 .36 1 .4 5 1 . 4 4 1 . 5 4 1.36 1 . 3 4
0 1.12 1 .25 1 .3 2 1 . 3 4 1 .2 9 1 .2 8
Table 18’ Immunoreactivity of Individual column aliquots from a 
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v i i )  D i f f e r e n c e s  be t w e e n  b a t c h e s  and s t a b i l i t y
P e r s o n a l  o b s e r v a t i o n s  on t h e  b a t c h e s  p r e p a r e d  f o r  t h e  
d e v e l o p m e n t  o f  t h e  t e c h n i q u e  showed l i t t l e  v a r i a t i o n  i n  s p e c i f i c  
a c t i v i t y  u s i n g  t h e  s o l i d - p h a s e  l a c t o p e r o x i d a s e  m e t h o d ,  and dose 
r e s p o n s e  c u r v e s ,  f o r  f r e s h  l a b e l ,  were g e n e r a l l y  s u p e r i m p o s a b l e . The 
l a b e l  was s t a b l e  f o r  a t  l e a s t  7 weeks l o s i n g  a b o u t  20% o f  t h e  
o r i g i n a l  b i n d i n g ,  b u t  t h e  c o u n t i n g  t i m e  was by t h e n  t o o  g r e a t  f o r  
r o u t i n e  u s e .
The s c a l e d - u p  r o u t i n e  l a b e l  p r e p a r a t i o n ?  ( c h l o r a m i n e  T 
i o d i n a t i o n )  show g r e a t e r  v a r i a t i o n ,  e s p e c i a l l y  i n  t h e  l o s s  o f  b i n d i n g  
d u r i n g  t h e  4 - w e e k  w o r k i n g  l i f e  o f  t h e  l a b e l .  N o n e t h e l e s s ,  t h e  
e x t e n s i v e  q u a l i t y  c o n t r o l  d a ta  r a r e l y  show any e f f e c t  on t h e  r e p o r t e d  
v a l u e s .
F i g u r e  20 shows t h e  d o s e - r e s p o n s e  c u r v e s  o b t a i n e d  u s i n g  one 
t r a c e r  p r e p a r a t i o n  a t  10 and 40 d a y s .  F i g u r e  21 comp a re s  t h e  
d o s e - r e s p o n s e  c u r v e s  f o r  two m o n o c l o n a l  a n t i b o d i e s  u s i n g  t h e  same 
p r e p a r a t i o n  o f  s o l i d - p h a s e  r e a g e n t .
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v i i )  O p t i m i z a t i o n
The w o r k i n g  b u f f e r  was 0 .25M EPPS w i t h  2% sheep  se ru m ,  0.1% 
Tw een -2 0  and 0.1% Sodium a z i d e ,  u n l e s s  s t a t e d  o t h e r w i s e ,  p r e p a r e d  by 
d i s s o l v i n g  2 5 . 2 3 g  EPPS i n  750mL d i s t i l l e d  w a t e r ,  a d j u s t i n g  t h e  pH t o  
8 . 0  and a d d i n g  lmL Tween-20 b e f o r e  m a k i n g  up t o  1 l i t r e .  Sheep serum 
was added a t  t i m e  o f  p r e p a r a t i o n  o f  t h e  l a b e l  r e a g e n t .  D u r i n g  
o p t i m i z a t i o n  a l l  r e s u l t s  were o b t a i n e d  u s i n g  t h e  m i d d l e  v a l u e  o f  
t r i p l i c a t e s .
Sheep Serum C o n c e n t r a t i o n
The e f f e c t  on b i n d i n g  o f  a d d i t i o n  o f  i n c r e a s i n g  q u a n t i t i e s  o f  
sheep  serum i n  t h e  ab se nce  o f  Tween-20 i s  shown i n  T a b l e  2 2 .  Maximum 
b i n d i n g s  w ere  u n a f f e c t e d  by s t a n d a r d s  m a t r i x ;  minimum b i n d i n g s  were 
r e d u c e d  w i t h  i n c r e a s i n g  sheep serum c o n c e n t r a t i o n  and t h e  use o f  
se rum s t a n d a r d s .  A l t h o u g h  b i n d i n g  was l o s t  a t  h i g h  l e v e l s  o f  AFP i n  
t h e  d e n s i t y  s e d i m e n t a t i o n  s e p a r a t i o n  s y s t e m ,  t h i s  was more t h a n  
c o m p e n s a t e d  f o r  by t h e  r e d u c t i o n  a t  l o w  l e v e l s ,  w i t h  c o n c o m i t a n t  
i m p r o v e m e n t  i n  s e n s i t i v i t y .
Twee n- 20
The r e q u i r e m e n t  f o r  d e t e r g e n t  i n  t h e  a s s a y  was i n v e s t i g a t e d  f o r
b o t h  s e p a r a t i o n  m e t h o d s .  T a b le  23 shows a s l i g h t  i n c r e a s e  i n  maximum
b i n d i n g s  w i t h  i n c r e a s i n g  Tween c o n c e n t r a t i o n .  D i l u e n t  ( a s s a y  b u f f e r )  
s t a n d a r d s  gave h i g h e r  b i n d i n g .
Wash P r o t o c o l  -  S a l i n e / C e n t r i f u g a t i o n
Two e x t e n s i v e  w a sh in g  e x p e r i m e n t s  w ere  p e r f o r m e d  t o  d e t e r m i n e  
t h e  number  o f  washes  r e q u i r e d  u s i n g  0.9% S a l i n e  w i t h  0.2% T w een- 20 .  
T a b l e  24 and F i g u r e  25 d e m o n s t r a t e  t h a t  a l t h o u g h  t h e r e  was 
c o n s i d e r a b l e  a d v a n t a g e  f rom 4 ,  5 o r  6 w a s h e s ,  t h r e e  g i v e s  t h e  b e s t  
c o m p r o m is e  b e tw e e n  speed  and e f f i c i e n c y .  T h i s  s e p a r a t i o n  method  was 
c h o s e n  f o r  s m a l l  b a t c h e s  because  o f  t h e  g r e a t e r  s p e e d .  Time t a k e n  
f o r  t h e  s e p a r a t i o n  s t a g e  depends  on b a t c h  s i z e .
Wash P r o t o c o l  -  D e n s i t y  S e d i m e n t a t i o n
F i g u r e  26 shows t h e  r e s u l t s  o f  one e x t e n s i v e  e x p e r i m e n t  u s i n g
lmL wash (1% Tween-20  i n  w a t e r )  and 3mL 10% s u c r o s e  i n  w a t e r  (added  
t o  t h e  b o t t o m  o f  t h e  t u b e ) .  Two p a s s e s  showed good r e p r o d u c i b i l i t y
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and t h i s  s y s te m  was ch osen  f o r  l a r g e  r o u t i n e  a s s a y s ;  w i t h  i n c r e a s i n g  
b a t c h  s i z e  t h e  t i m e  d i s a d v a n t a g e  became l e s s ,  and l e s s  o p e r a t o r  
i n t e r v e n t i o n  i s  r e q u i r e d .  Time t a k e n  f o r  t h e  s e p a r a t i o n  s t a g e  i s  
i n d e p e n d e n t  o f  b a t c h  s i z e .
T ime and S e p a r a t i o n  Method
F o r  t h e  t w o - s t a g e  assay 20uL sample  and 200uL l a b e l  were  m i xed  
t h o r o u g h l y  and s u b j e c t e d  t o  v a r i o u s  i n c u b a t i o n  t i m e s  on an o r b i t a l  
s h a k e r .  Then 200uL  o f  s o l i d - p h a s e  was added and t h e  t u b e s  f u r t h e r  
i n c u b a t e d  f o r  1 h o u r  on th e  s h a k e r .  S e p a r a t i o n  was by e i t h e r ;  t h r e e  
p a s s e s  o f  0.9% s a l i n e  c o n t a i n i n g  0.2% Twe e n - 2 0 ,  b r i e f  c e n t r i f u g a t i o n  
and vacuum pump a s p i r a t i o n  o f  t h e  s u p e r n a t a n t ;  o r  tw o  p a s s e s  o f  lmL 
1% Twe en-20  i n  w a t e r  and 3mL 10% s u c r o s e ,  1% Tween-20 i n  w a t e r  ( t h e  
l a t t e r  added t o  t h e  b o t t o m  o f  each t u b e  u s i n g  a s u i t a b l e  p r o b e )  and 
vacuum pump a s p i r a t i o n  o f  t h e  s u p e r n a t a n t .
The s u p e r i o r i t y  o f  d e n s i t y  s e d i m e n t a t i o n  s e p a r a t i o n  i s  m a r k e d .  
S i x t y  m i n u t e ,  s e p a r a t e - a d d i t i o n  a ss ay  gave s a t i s f a c t o r y  b i n d i n g  f o r  
good  w o r k i n g  r a n g e ,  p r e c i s i o n  and s e n s i t i v i t y  as shown i n  T a b l e s  27 
and 28 .
Sample  Volume
The e f f e c t  o f  samp le  vo l um e  on t h e  d o s e - r e s p o n s e  c u r v e  was 
i n v e s t i g a t e d  by 1 and 2 hou r  i n c u b a t i o n  o f  m i x e d  r e a g e n t  w i t h  25uL o r  
50uL  o f  0 ,  100 and 5 0 0 0k U /L  AFP. The r e s u l t s  a r e  shown i n  T a b l e 29 .
M i x e d  R eagen t  A d d i t i o n
I n c u b a t i o n  o f  samp le  w i t h  l a b e l  f o r  60 m i n u t e s ,  f o l l o w e d  by a 
se c o n d  60 m i n u t e  i n c u b a t i o n  w i t h  s o l i d - p h a s e  (on  an o r b i t a l  s h a k e r )  
was compared  w i t h  a s i n g l e - s t a g e  60 m i n u t e  i n c u b a t i o n .  B o th  
s e p a r a t i o n  m et hods  were used and t h e  p o i n t s  i n v e s t i g a t e d  were 5000 ,  
100 and OkU/L AFP. T a b le  30 shows t h a t  t h e  r e a c t i o n  r a t e  a t  60 
m i n u t e s  i n c u b a t i o n  i n  th e  s i n g l e - s t a g e  a ssa y  was s t i l l  h i g h ,  w h i c h  
s u g g e s t e d  t h e  p r o b a b i l i t y  o f  d r i f t  i n  a l a r g e  a s s a y .  The p r e f e r r e d  
s o l u t i o n  w o u ld  be t o  have t i m e d  a d d i t i o n  o f  t h e  s o l i d - p h a s e / l a b e l  and 
wash r e a g e n t s .  T h i s  was i m p r a c t i c a b l e  w i t h  t h e  e q u i p m e n t  a v a i l a b l e  
and t h e  o t h e r  o p t i o n s  w ere ,  e i t h e r  t o  use t h e  t w o - s t a g e  a s s a y  o r  t o  
i n c r e a s e  t h e  i n c u b a t i o n  t i m e .  The a s s e s s m e n t  o f  a 2 . 5 h o u r  a s s a y  w i t h  
m i x e d  r e a g e n t  a d d i t i o n  showed t h a t  r e a g e n t  c o u l d  be added  o v e r  as
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l o n g  as 20 m i n u t e s  w i t h o u t  s i g n i f i c a n t  d r i f t  ( T a b l e  3 1 ) .  In
p r a c t i c e ,  o n l y  5 m i n u t e s  i s  n e c e s s a r y  f o r  a d d i t i o n  o f  m i x e d  r e a g e n t  
t o  400 t u b e s  w h ic h  i s  p e r f o r m e d  a f t e r  c o m p l e t i o n  o f  t h e  s a m p l i n g  and 
d i l u t i o n  o f  s p e c i m e n s .
The T a b l e  shows t h a t  b i n d i n g  a t  12 5 k U /L  AFP f o r  2 . 5  h o u r
i n c u b a t i o n  w i t h  m ix e d  r e a g e n t  a d d i t i o n  i s  e q u i v a l e n t  t o  t h e  90 m i n u t e
s e p a r a t e  a d d i t i o n  a s s a y .
S t a n d a r d s  M a t r i x
B u f f e r  s t a n d a r d s  gave v e r y  v a r i a b l e  r e c o v e r y  ( d a t a  n o t  s h o w n ) .  
A l l  c a n d i d a t e  s e r a ,  and serum d e r i v a t i v e s ,  t e s t e d  gave
r e c o v e r i e s  b e tw ee n  96 and 109% and t h e  r e s u l t s  a r e  s u m m a r iz e d  i n  
T a b l e  32 .  U s i n g  b o v i n e  serum s t a n d a r d s ,  r e c o v e r y  f r o m  f o u r  male
human s e r a  w i t h  2 5 ,  50 and 100 k U / L  o f  AFP s t a n d a r d  added  a v e r a g e d  
102%, 105% and 108%.
S e n s i t i v i t y  o f  t h e  o p t i m i z e d  a ssa y  t o  c o n c e n t r a t i o n  o f  s o l i d - p h a s e  
and t r a c e r
F i g u r e  33 shows t h e  e f f e c t  o f  a d d i n g  t h r e e  t i m e s ,  and one t h i r d
as much t r a c e r  and ( s e p a r a t e l y )  s o l i d - p h a s e .  C o m p le t e  s t a n d a r d
c u r v e s  were ass a ye d  and t o  i n v e s t i g a t e  c o n c e n t r a t i o n s  o v e r  5 0 0 k U / L ,  
d i l u t i o n s  o f  a c o r d  se rum ,  a p p r o x i m a t e l y  5 0 , 0 0 0 k U / L ,  were  a s s a y e d .  
The q u a l i t y  c o n t r o l  r e s u l t s  were n o t  a f f e c t e d  by c h a n g e s  i n
c o n c e n t r a t i o n  o f  e i t h e r  r e a g e n t .  N e i t h e r  i n c o r r e c t  s o l i d - p h a s e ,  n o r  
i n c o r r e c t  t r a c e r  c o n c e n t r a t i o n  has marked  e f f e c t  on t h e  b i n d i n g  o f  
t h e  a s c e n d i n g  c u r v e .  The d e s c e n d i n g  c u r v e  i s  g r e a t l y  a f f e c t e d  by 
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FIGURE 2 0  The e f f e c t  of t im e  on th e  b ind ing  o f  a la c to p e ro x ld a s e  
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FIGURE 21 Dose-response curves for  two optimized IRMAs using the 
same preparation of solid-phase reagent.
Concentration of sheep serum % (v /v ).
0 . 1 2 5  0 . 2 5  0 . 5  ■ 1. 0 2 . 0
Di luent  Standards
3 sal ine washes
OkU/L 2 . 0  1 .3  0 . 8 7  0 . 7 3  0 . 7 2
lO O kU /L  3 2 . 5  3 2 . 3  3 2 . 9  3 3 . 8  3 2 . 2
2 density sedimentation washes
OkU/L 0 . 4 7  0 . 3 7  0 .2 1  0 . 1 7  0 . 1 5
lO O kU /L  2 4 . 4  2 4 . 4  2 4 . 4  2 3 . 9  2 4 . 4
Serum Standards
3 sal ine washes
OkU/L 0 . 5 5  0 . 6 6  0 . 3 9  0 . 3 4  0 . 4 4
10OkU /L  2 9 . 5  2 8 . 0  3 0 . 4  3 0 . 7  2 9 . 0
2 density sedimentation washes
OkU/L 0 . 1 3  0 . 1 3  0 . 0 8 5  0 . 0 7 5  0 . 0 7 6
lOO kU /L  2 2 . 3  2 0 . 3  2 2 . 2  2 2 . 3  2 2 . 2
Table 22 Binding characterist ics of labelled monoclonal antibody in 
the presence of sheep serum, using two wash methods. No detergent  
added. Percentage of added t racer  bound at two concentrations of 
AFP.
Concentration of Tw een-20  % (v /v )
0.1 0 .2  0 . 4  0 .8  1.6
Diluent  Standards
3 sal ine washes
OkU/L 0 . 5 3  0 . 4 6  0 . 5 3  0 . 3 6  0 . 5 5
lOO kU/L  3 3 .8  3 3 . 2  3 4 . 4  3 5 . 7  3 6 . 4
2 density sedimentation washes
OkU/L 0 .11 0 . 1 2  0 . 1 0  0 .1 1  0. 1 3
lOO kU/L  2 5 . 9  2 4 . 8  2 5 . 8  2 6 . 8  2 8 . 0
Serum Standards
3 centr i fugation washes
OkU/L 0 . 3 7  0 . 3 4  0 . 3 7  0 . 2 5  0 . 3 4
lOO kU /L  3 0 .6  3 0 . 9  3 1 . 8  3 3 .1  3 3 . 4
2 density sedimentation washes
OkU/L 0 . 0 7 3  0 . 0 6 0  0 . 0 7 3  0 . 0 6 7  0 . 0 6 0
lO O kU /L  2 2 .3  2 0 . 3  2 2 . 2  2 2 . 3  2 2 . 2
Table 23 Binding characterist ics of labelled monoclonal antibody in 
the presence of detergent, using two wash methods. No serum 
added. Percentage of added t racer bound at two concentrations of 
AFP.
NUMBER OF WASHES
B i n d i n g  (%) 1 2 3 4 5 6 9 12
a t  lOOOkU/L 6 7 . 7 6 2 . 1 6 1 . 0 5 9 . 9 5 8 . 3 5 6 . 6 5 3 . 7 52 .  7
1 2 5kU /L 3 2 . 4 2 4 . 2 2 2 . 3 2 1 . 9 2 1 . 0 2 0 . 1 1 7 . 7 1 7 . 1
1 5 kU /L 1 1 . 5 5 . 1 4 . 3 4 . 0 3 . 8 3 . 7 2 . 8 2 . 7
l k U / L 1 2 . 0 2 . 0 1 . 0 0 . 8 5 0 . 8 4 0 .8 1 0 . 6 7 0 . 7 1
OkU/L 1 2 . 2 2 . 1 0 . 9 4 0 . 6 8 0 . 6 5 0 . 6 7 0 . 5 7 0 . 6 0
R a t i o  1 0 0 0 / 0 5 . 5 2 9 . 6 6 4 . 9 8 8 . 1 8 9 . 7 8 4 . 5 9 4 . 2 8 7 . 8
T a b l e  24 The e f f e c t  o f  number  o f  p a s s e s  on e f f i c i e n c y  o f  
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FIGURE 2 5  The e f f e c t  o f  num ber of passes  o f  c e n t r i f u g a t i o n  w a s h e s  








FIGURE 26 The effect  of number of passes of density sedimentation  
washes on the dose-response curve.
INCUBATION TIME ( m i n u t e s )
B i n d i n g  (%) 20 40 60 90 120
a t  5 0 0 0 k U / L 5 2 . 1 5 2 . 5 5 3 . 8 5 2 . 7 5 3 . 4
l OOkU/L 1 6 .6 2 1 . 3 2 5 . 0 2 8 . 2 3 1 . 3
OkU/L 0 .3 1 0 . 2 8 0 . 2 8 0 . 2 1 0 .  i :
R a t i o  5 0 0 0 / 0 168 188 192 251 281
T a b l e  27 T w o - s t a g e a s s a y : t h e  r a t e o f r e a c t i o n f o l l o w e d
c e n t r i f u g a t i o n  s e p a r a t i o n  ( t h r e e  p a s s e s ) . ( B a c k g r o u n d  S u b t r a c t e d
Time ( m i n u t e s )
B i n d i n g  (%) 20 40 60 90 120
5 0 0 0 k U / L 4 8 . 9 4 9 . 2 5 0 . 4 4 9 . 8 4 9 . 1
lOOkU /L 1 4 .6 1 8 . 6 2 1 . 9 2 4 . 8 2 6 . 6
OkU/L 0 . 0 9 0 0 . 0 8 1 0 . 0 5 7 0 . 0 3 8 o.o:
R a t i o  5 0 0 0 / 0 543 607 884 1310 1292
T a b l e  28 T w o - s t a g e  a s s a y :  t h e  r a t e  o f  r e a c t i o n  f o l l o w e d  by d e n s i t y  
s e d i m e n t a t i o n  ( t w o  p a s s e s )  s e p a r a t i o n .  ( B a c k g r o u n d  S u b t r a c t e d )
AFP Concentration  
60 minute Incubation 
25uL  
50uL
120 minute Incubation 
25uL  
50uL
0 100 5 0 0 0  kU/L
% B i n d i n g
0.41 1 6 .2  4 6 . 0
0 . 3 5  1 6 .2  4 7 . 0
0 . 3 6  2 3 . 5  5 2 . 7
0 . 3 5  2 2 . 8  5 2 . 3
Table 29 Choice of sample volume for two possible Incubation t imes.
AFP Concentration 0 100  5 0 0 0  kl l /L
C ent r i fuga t io n  % B i n d i n g
Single Stage 0 . 2 3  1 0 .7  5 3 . 2
Tw o-Stage  0 . 2 8  2 5 . 0  5 3 . 8
Densi ty Sedimentation
S ing le -S tag e  0 . 0 8 4  8 . 8  4 8 . 8
T w o - S t a g e  0 . 0 5 7  2 1 . 9  5 0 . 4
Table 30 Choice of single- or two-s tage reagent addition, 
minute incubation.
Percent Bound
shaking 20 mln 10 mln 0
5 0 0 k U / L 3 6 . 6 3 5 . 5 35
12 5 k U / L 2 6 .  1 2 4 . 4 2 3
4 kU /L 1.9 2 . 0 1
OkU/L 0 . 4 8 0 . 4 8 0
Table 31 The effect of reagent addition for the s ingle-stage assay 
taking up to 20 minutes before a 2.5hour Incubation.
AFP ( k U / L ) 25 50 100 Mean S.D
H o r s e  Serum (HS) 104 104 102 1 0 3 . 3 1 . 2
HS/EPPS B u f f e r 101 99 106 1 0 2 . 0 3 . 6
N ewb orn  C a l f  Serum (NCS) 102 101 96 9 9 . 7 3 . 2
NCS/EPPS B u f f e r 109 107 ■ 107 1 0 7 . 7 1 . 2
Human Serum 106 101 98 1 0 1 . 7 4 . 0
Mean 104 .4 1 0 2 . 6 1 0 1 .8
S.D . 3 . 2 3 . 0 4 . 8
T a b l e  32 R e c o v e r y  o f  exogenous  AFP a t  t h r e e  c o n c e n t r a t i o n s  
s e v e r a l  p o s s i b l e  " s t a n d a r d s  d i l u e n t "  m a t r i c e s
f r o m
Percent
Bound
60 -i 1/3 Solid-Phase 
Normal
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FIGURE 33 The consequences of varying the concentration of sol ld-  





i x )  C o m p a r i s o n  w i t h  r a d i o i m m u n o a s s a y
P r o t o c o l  f o r  t h e  IRMA was as g i v e n  i n  2B x i )  and x i i ) .
The r o u t i n e  R IA was u sed  as t h e  b a s i s  f o r  c o m p a r i s o n .  B u f f e r  
u sed  was 0 . 0 5 M  b a r b i t o n e  w i t h  1% b o v i n e  gamma g l o b u l i n ,  0 .1%  s o d i u m  
a z i d e  and 8 .4% p o l y e t h y l e n e  g l y c o l  6000  (P E G ) .  l n g  o f  l a b e l l e d  AFP 
was u se d  p e r  t u b e .  A l l  s a m p l e s  w e re  a s s a y e d  i n  d u p l i c a t e .  7 0 0 u L  o f  
b u f f e r / P E G / l a b e l  and 4Qul_ o f  s a m p l e  w e r e  t a k e n  up and lOOuL o f  
1 : 5 0 , 0 0 0  ( i n  b u f f e r )  g o a t - a n t i - h u m a n  AFP add e d  by M i c r o m e d i c  A P S - 2 .  
R e a c t i o n  t u b e s  w e re  v o r t e x - m i x e d  i m m e d i a t e l y  a f t e r  p r o c e s s i n g  and 
a l l o w e d  t o  s t a n d  a t  room t e m p e r a t u r e  ( 1 5 - 2 5 ° C )  f o r  1 6 - 6 4 h r .  A l l  
t u b e s  w e re  c e n t r i f u g e d  a t  2 0 00 rp m  f o r  3 0 m i n  a t  + 4c>C i n  a D am o n -6 0 0 0  
r e f r i g e r a t e d  c e n t r i f u g e .  The s u p e r n a t a n t  was a s p i r a t e d  m a n u a l l y  and 
t h e  boun d  f r a c t i o n  was c o u n t e d .  C a l c u l a t i o n  was by  4 - p a r a m e t e r  
l o g - l o g i t  m e t h o d .
The r e s u l t s  o f  l i n e a r  r e g r e s s i o n  a n a l y s i s  o f  22 91  s a m p l e s  
a s s a y e d ,  i n  p a r a l l e l  by b o t h  RIA and IRMA, a r e  s u m m a r i z e d  i n  F i g u r e  
3 4 .  D e m o n s t r a t e d  a r e ;  g r a d i e n t  o f  1 . 2 9  ( f o r  l o c a l  r e a s o n s ,  1 . 2 5  was 
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FIGURE 34  Regression analysis for the 2291 maternal  serum 
samples assayed by RIA and IRMA. The regression l ine (so l id )  Is 
plot ted, w i t h  the l ine of equivalence (dotted).  LEL- lo west  equivocal  
level.  ULN- upper l i m i t  of normal.
Page 49
x )  C o m p a r i s o n  w i t h  c o m m e r c i a l  i m m u n o r a d i o m e t r i c  a s s a y
Each  a s s a y  was r u n  as p e r  p r o t o c o l .  I n - h o u s e  s t a n d a r d s ,  w h i c h  
had been  p r e p a r e d  u s i n g  b o v i n e  s e r u m ,  w e re  c o m p a r e d  w i t h  k i t  
s t a n d a r d s  p r e p a r e d  f r o m  human s e ru m  i n  one a s s a y .  35 s a m p l e s  w e re  
a s s a y e d  g i v i n g  a c o r r e l a t i o n  c o e f f i c i e n t  o f  0 . 9 9 7 8 .  The e q u a t i o n  o f  
t h e  l i n e a r  r e g r e s s i o n  a n a l y s i s  was Y ( K i t  R e s u l t s )  = 1 . 2 8 ( I R M A
R e s u l t s )  -  7 . 3 k U / L .  A l t h o u g h  t h e  g r a d i e n t  i s  1 . 2 8 ,  S t u d e n t ' s  " t "  
s t a t i s t i c  o f  1 . 7 0  f o r  t h e  d i f f e r e n c e  b e t w e e n  m e t h o d s  d i d  n o t  a t t a i n  
s i g n i f i c a n c e  ( p > 0 . 0 5 ) .  T h i s  may be due t o  t h e -  s m a l l  numb er  o f  
s a m p l e s .  The d i f f e r e n c e  i s ,  h o w e v e r ,  o u t s i d e  t h e  u s u a l  v a r i a t i o n  
i n h e r e n t  i n  d a t a  r e d u c t i o n  and s u g g e s t s  s i g n i f i c a n t  d i f f e r e n c e s  
b e t w e e n  s t a n d a r d  p r e p a r a t i o n s .
To c o m p a r e  t h e  a s s a y  m e t h o d s ,  5 a s s a y s  w e re  r u n  i n  p a r a l l e l  
c o n t a i n i n g  a t o t a l  o f  217 s a m p l e s  ( d a t a  n o t  s h o w n ) .  The c o r r e l a t i o n  
c o e f f i c i e n t  was 0 . 9 9 5 3 ,  and t h e  e q u a t i o n  o f  t h e  r e g r e s s i o n  l i n e ,  
Y ( K i t  R e s u l t s )  = 1 . 0 7 ( IRMA R e s u l t s )  -  2 . 5 k U / L .  D e s p i t e  t h e  much
s m a l l e r  g r a d i e n t ,  t h e  l a r g e r  numb er  o f  p o i n t s  gave  a " t "  s t a t i s t i c  o f  
3 . 2 8  w h i c h  was h i g h l y  s i g n i f i c a n t  ( 0 . 0 0 5 > p > 0 . 0 0 0 5 ) .  T h i s  d e g r e e  o f  
b i a s  i s  p r o b a b l y  a c c o u n t e d  f o r  by t h e  d i f f e r e n c e  d e m o n s t r a t e d  b e t w e e n  
s t a n d a r d s .
F i g u r e  16 ( A f t e r  Page 4 1 )  shows d o s e - r e s p o n s e  c u r v e s  f o r  
A F 5 / A 2  m o n o c l o n a l / S A P U  sheep p o l y c l o n a l ,  SAPU m o n o c l o n a l / S A P U  sheep  
p o l y c l o n a l ,  and t h e  c o m m e r c i a l  a s s a y .
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3C ROUTINE USE AND EXPERIENCE
i )  S c o t t i s h  A n t i b o d y  P r o d u c t i o n  U n i t
On c o m p l e t i o n  o f  a s s e s s m e n t  o f  t h e  d e v e l o p e d  a s s a y ,  t h e
S c o t t i s h  A n t i b o d y  P r o d u c t i o n  U n i t  (SAPU) b a s e d  a t  Law H o s p i t a l ,
C a r l u k e ,  L a n a r k s h i r e ,  u n d e r t o o k  t o  m a i n t a i n  r o u t i n e  s u p p l i e s  o f
r e a g e n t s  t o  N a t i o n a l  H e a l t h  S e r v i c e  (NHS) l a b o r a t o r i e s .
The s o l i d - p h a s e  r e a g e n t  i s  p r e p a r e d  a t  C a r l u k e  f r o m  t h e
i m m u n o g l o b u l i n  f r a c t i o n  o f  SAPU s h e e p - a n t i - h u m a n  AFP p o l y c l o n a l
a n t i b o d y ,  i n  5 - l i t r e  b a t c h e s ,  u s i n g  t h e  c a r b o n y l d i i m a d a z o l e  m e t h o d
d e s c r i b e d  i n  s e c t i o n s  2B i ) ,  i v ) ,  v )  and  v i ) .  L a r g e  s c a l e
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p r e p a r a t i o n  o f  t h e  - I o d i n a t e d  m o n o c l o n a l  a n t i b o d y  i s  e f f e c t e d  by 
t h e  R a d i o i m m u n o a s s a y  L a b o r a t o r y  a t  t h e  D e p a r t m e n t  o f  O b s t e t r i c s  and 
G y n a e c o l o g y ,  N i n e w e l l s  H o s p i t a l  and M e d i c a l  S c h o o l ,  Du nd ee ,  u s i n g  t h e  
C h l o r a m i n e - T  t e c h n i q u e .
Q u a l i t y  a s s e s s m e n t  o f  r e a g e n t s  i s  p e r f o r m e d  a t  b o t h  s i t e s  and
a t  t h e  I n s t i t u t e  o f  B i o c h e m i s t r y  i n  G l a s g o w  R o y a l  I n f i r m a r y .
i i )  E x t e r n a l  Q u a l i t y  A s s e s s m e n t  Scheme ( EQAS)
The p e r c e n t a g e  d e v i a t i o n  f r o m  t h e  a l l - l a b o r a t o r y  t r i m m e d  mean 
(ALTM:  Cameron 1 9 7 8 :  Bacon  e t  a l . 1 9 8 3 )  f o r  e a c h  s a m p l e  i n  6
d i s t r i b u t i o n s  i s  t a b u l a t e d  i n  T a b l e  35 f o r  t h e  p e r i o d  d u r i n g  1985
w h i c h  i n c l u d e d  t h e  c h a n g e o v e r  f r o m  RIA t o  IRMA. P e r f o r m a n c e  f o r  eac h
s a m p l e  i s  shown and t h e  r e s u l t s  f o r  e a c h  m o n t h  i s  g i v e n .  To r e d u c e  
b i a s  f r o m  a s s e s s m e n t  i n  o n l y  one m o n t h ,  t h e  f i g u r e s  a r e  c o m b i n e d  t o  
g i v e  t w o - m o n t h l y  e s t i m a t e s .  The u s u a l  m e t h o d  o f  i n s p e c t i n g  a 
s i x - m o n t h  w in d o w  i s  n o t  s u i t a b l e  f o r  t h i s  p u r p o s e ,  b u t  i s  shown f o r  
t h e  24 mo n th  p e r i o d  o f  t h e  c h a n g e o v e r  i n  T a b l e  3 6 ;  t h e  d i s p l a y  i s  o f  
t h e  s i x - m o n t h  w in dow  w he re  p o s s i b l e  and t h e  IRMA a d v a n t a g e s  a r e  
c l e a r .
The v a r i a b l e  b i a s  o f  t h e  RIA was r e p l a c e d  by a s u b s t a n t i a l  
p o s i t i v e  b i a s  i n  t h e  IRMA. The v a r i a n c e ,  as shown by t h e  r a n k i n g  i n
T a b l e  35 and  t h e  F i g u r e  3 6 ,  was m a r k e d l y  i m p r o v e d .  I n  t h e  c o m p a r i s o n
o f  t h e  RIA and IRMA t e c h n i q u e s  t h e  g r a d i e n t  o f  1 . 2 9  was g r e a t e r  t h a n  
t h e  e x p e c t e d  v a l u e  o f  1 . 2 5  w h i c h  s u g g e s t e d  a p o s i t i v e  b i a s  o f  k% 
u s i n g  r o u t i n e  p r e g n a n c y  s a m p l e s .  The EQAS u s e d  p o o l e d  human s e r a  and  
t h i s  may a l s o  add a s y s t e m a t i c  b i a s  n o t  d e t e c t a b l e  i n  t h e  i n t e r n a l  
q u a l i t y  c o n t r o l  d a t a .  C o m p a r i s o n  o f  R IA and IRMA v a l u e s  f o r  50
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s t o r e d  EQAS s a m p l e s  had shown a p o s i t i v e  b i a s  t o  t h e  l a t t e r  o f  11.9% 
( S t e v e n s o n  e t  a l .  1 9 8 7 ) .  The IRMA shows a p o s i t i v e  b i a s  comp a re d  
w i t h  RIA f o r  a l l  v a l u e s ,  p r o b a b l y  b e c a u s e  o f  t h e  l a c k  o f  c o m p e t i t i o n  
b e t w e e n  t h e  d i f f e r e n t  s p e c i f i c i t i e s  and a v i d i t i e s  o f  a n t i b o d i e s  
p r e s e n t  i n  p o l y c l o n a l  a n t i s e r a .
T h e r e  was no e v i d e n c e  o f  d os e  d e p e n d e n t  r e c o v e r y  i n  e i t h e r
a s s a y .
A ss ay  M e th od
< ---------------------------------- r i a ---------------------------> < ------------------ IRMA->
B a t c h  Number 118 119 120 1 2 1 .  122 123
S am pl e  1 -  3 . 2 -  3 . 7 -  5 . 5 -  5 . 1  + 1 1 . 0 + 7 . 3
2 + 2 . 7 -  4 . 4 -  9 . 3 -  1 . 1  + 1 3 . 0 + 7 . 5
3 -  8 . 6 -  6 . 4 + 1 3 . 0 -  5 . 7  + 7 . 8 + 4 . 7
4 + 6 . 8 -  8 . 5 -  5 . 8 -  7 . 4  + 5 . 7 + 1 0 . 0
5 + 5 . 3 -  0 . 6 0 + 1 1 . 0 -  3 . 7  + 5 . 8 + 5 . 7
M o n t h l y  B i a s + 0 . 6 0 -  4 . 7 + 0 . 6 8 -  4 . 6  + 8 . 7 + 7 . 0
M o n t h l y  V a r i a n c e 6 . 4 3 . 0 1 0 . 4 2 . 4  3 . 2 2 . 0
Two Mon th  B i a s -  2 . 1 -  2 . 0 + 7 . 9
R a n k i n g 1 9 / 4 1 1 8 / 5 1 2 9 / 3 8
Two M on th  V a r i a n c e 5 . 5 7 . 7 2 . 6
R a n k i n g 3 4 / 8 4 6 1 / 8 4 1 / 8 4
T a b l e  35 R e s u l t s  o f a n a l y s i s o f  s i x  b a t c h e s  o f  t h e EQAS fo :
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FIGURE 3 6  EQAS r e s u l t s  f o r  th e  2 A m o n th  p e r io d  a ro u n d  t h e  
c h a n g e o v e r  f r o m  R IA  to  IRMA. S i x - m o n t h  w in d o w s  f o r  B I A S  and  











i i i )  I n t e r n a l  Q u a l i t y  C o n t r o l
To m o n i t o r  t h e  d a i l y  a s s a y  p e r f o r m a n c e ,  4 q u a l i t y  c o n t r o l  s e r a ,  
p r e p a r e d  f r o m  n o r m a l  human se ru m  p o o l s  w i t h  added  c o r d  se ru m  o r  
a m n i o t i c  f l u i d ,  a r e  r u n  a t  t h e  b e g i n n i n g  and a t  t h e  end  o f  e ach  
a s s a y .  A s i m i l a r  s a m p l e  i s  u s e d  f o r  d e t e r m i n a t i o n  and  e s t i m a t i o n  o f  
i n t e r n a l  a s s a y  d r i f t  and i s  a s s a y e d  e v e r y  f i f t e e n  s p e c i m e n s .  
C o m m e r c i a l l y  a v a i l a b l e  p o o l e d  s e r u m  t e s t e d  f o r  t h e  a b s e n c e  o f  HIV and 
HBsAg a r e  u s e d  (HD S u p p l i e s ,  A y l e s b u r y ,  U K) .  They  a r e  t a r g e t t e d  a t  
p o i n t s  o f  c l i n i c a l  s i g n i f i c a n c e  on t h e  d o s e  r e s p o n s e  c u r v e  ( F i g u r e  16 
f o l l o w i n g  page  4 1 ) ;  3 ,  2 5 ,  6 5 ,  110  and o v e r  300 k U / L  w h i c h  r e p r e s e n t ;  
n o r m a l  a d u l t  (3  k U / L ) ,  t y p i c a l  " D o w n ' s  r i s k "  p r e g n a n c y  a t  16 w eek s  
g e s t a t i o n  (2 5  k U / L ) ,  i n t e r v e n t i o n  l e v e l s  a t  16 and 20 wee ks  g e s t a t i o n  
( 6 5  and 110 k U / L ) ,  and " v e r y  h i g h "  w h i c h  i s  t y p i c a l  o f  a n e n c e p h a l u s  
( o v e r  300 k U / L ) .  A b o u t  f i f t e e n  o f  t h e  1 6 0 - t u b e  b a t c h e s ,  e a c h  
c o n t a i n i n g  up t o  57 serum  s a m p l e s ,  a r e  p r o c e s s e d  e ach  w eek .
D e t a i l s  o f  t h e  w o r k l o a d  a r e  r e c o r d e d  f o r  e a c h  m o n t h .  A 
c o m p l e t e  f r e q u e n c y  d i s t r i b u t i o n  f o r  e a c h  week o f  p r e g n a n c y  f r o m  16 t o  
20 c o m p l e t e d  weeks  i s  g e n e r a t e d  e v e r y  t h r e e  m o n t h s  and t h i s  i s  u s e d  
t o  v a l i d a t e  t h e  i n t e r v e n t i o n  l e v e l s  and m e d i a n s .
The m e d i a n s  a t  .16 and 17 w eeks  a r e  n o t e d  f o r  p e r i o d s  o f  1 w e e k ,  
1 m o n t h  and t h r e e  m o n t h s .  T y p i c a l  n u m b e r s  o f  s a m p l e s  a r e  ( a t  16 
w e e k s )  2 5 0 ,  1100 and 3 3 0 0 .  F o l l o w - u p  r a t e s  a r e  c o l l a t e d  s i m i l a r l y .
S e v e r a l  a s s a y  p a r a m e t e r s  a r e  r e c o r d e d ,  and i n  T a b l e  38 i t  i s  
c l e a r  t h a t  f o r  mon th  3 ,  t h e  b i n d i n g  o f  t h e  t o p  s t a n d a r d  was l o w e r  
t h a n  u s u a l .  T h i s  was a s s o c i a t e d  w i t h  a p a r t i c u l a r  b a t c h  o f  l a b e l  and 
c a u s e d  t h e  m on th  t o  show t h e  l o w e s t  m e d i a n  f i g u r e s ,  a l t h o u g h  t h e  
f o l l o w - u p  r a t e  and q u a l i t y  c o n t r o l  d a t a  a p p e a r  s a t i s f a c t o r y .
T a b l e  37 shows t h e  p r e s e n t  m o n t h l y  w o r k l o a d ,  and  T a b l e  38 a 
summary o f  t h e  l a t e s t  p r e s e n t a t i o n  o f  w o r k l o a d ,  i n t e r n a l  q u a l i t y  
c o n t r o l  and d i s t r i b u t i o n  o f  s a m p l e  r e s u l t s  s u b m i t t e d  t o  t h e  
E n d o c r i n o l o g y  S e c t i o n  o f  t h e  I n s t i t u t e  o f  B i o c h e m i s t r y  a t  G l a s g o w  
R o y a l  I n f i r m a r y  f o r  e x t e r n a l  a u d i t .
BATCHES P e r f o r m e d 61 D r i f t  3 L a c k  o f  F i t  
(No s a m p l e s  r e a s s a y e d )
SAMPLES F i r s t  S a m p l e s  
L e s s  t h a n  16 w eek s  188 8 .  8056
1 6 - 2 0  wee ks  1942 9 0 . 9  %
S a m p l e s  r e a s s a y e d  
Swapped Ra cks  
Bad D u p l i c a t e
14 0 .  556
$270  8 .6%
More t h a n 20 w ee ks 6 0 .  28%
T o t a l 2136
A m n i o t i c F l u i d s 177 D i s t r i b u t i o n  o f  r e s u l t s
R e p e a t  B l o o d  S a m p l e s 134 6 .27% " T r i s o m y R i s k "  174 8 .1%
O t h e r  B l o o d  S a m p l e s 803 9 0 t h - 9 5 t h  C e n t i l e  142 6 .0%
I n t e r n a l QC S a m p l e s 29 Over  9 5 t h  C e n t i l e  142 6 .0%
T o t a l 1116 M e d i a n  a t  16 wks 33 n= 998
GRAND TOTAL 3145 M e d i a n  a t  17 wks  37 n= 631
INTERNAL QUALITY CONTROL
C o n t r o l T a r g e t  Mean S.D . C. V. Number BD# Low H i g h Range
Q1 2 . 9  2 . 3 9 0 . 5 3 22 # 46 6 6 1 2 -  4
Q2 1 7 . 4  1 7 . 7 1 . 2 6 . 9 111 10 2 3 1 5 -  19
Q3 7 7 . 9  7 7 . 7 3 . 0 3 . 9 108 14 2 11 7 2 -  83
Q4 195 193 1 1 .1 5 . 8 108 16 2 4 1 8 5 - 2 2 5
P 108 108 5 . 0 4 . 6 61 0 0 1 0 7 - 1 1 7
# o n l y  i n t e g r a l  v a l u e s  c o l l a t e d ,  t h u s n o t  a c c u r a t e
S E N S I T I V I T Y  Min im um 0 . 4 3 k U / L Maximum 3 . 8 k U / L
$ Vacuum pump m a l a d j u s t e d
T a r g e t f o r  " T r i s o m y R i s k " i s  6 .7% . • BD = bad d u p l i c a t e
T a b l e  37 One m o n t h  o f i n t e r n a l  q u a l i t y  c o n t r o l ;  F e b r u a r y  1989 •
1 9 8 8 / 1 9 8 9 OCT NOV DEC J A N FEB M A R
WORKLOAD
Reported Batches 6 2 7 1 6 2 6 4 6 1 7 4
F irs t  Samples 2 1 63 2 6 6 8 2 2 4 6 2 3 9 6 2 1 36 2 5 7 3
Other Samples 1 0 3 0 9 6 3 9 4 5 9 7 4 1 0 0 9 12 12
Rejected Es t im at io ns 1 62 2 6  1 1 9 9 1 3 1 2 7 0 1 6 1
DISTRIBUTION and MEDIANS
9 0 - 9 5 t h  c e n t i l e  ( %) 5 . 3 5 . 3 4 . 5 5 . 8 5 . 7 4 . 4
>95th c en t i l e  (%>) 5 . 9 5 . 3 5 . 7 6 . 2 5 . 3 5 . 2
“Tr isomy Risk" (%) 7 . 3 7 . 2 7 . 7 5 . 9 8. 1 7 . 6
Median at  16 weeks 3 3 3 3 3 2 3 5 3 3 33
at 1 7 weeks 3 7 3 6 3 6 3 8 3 7 37
STANDARDS
Mean % Bound 3 2 . 0 3 3 . 5 3 1 .9 3 5 . 1 2 9 . 6 3 7 . 5
Minimum Zero ( % ) 0 . 1 1 8 0.1 7 9 0.1 2 9 0. 1 3 7 0. 1 4 7 0.1 28
QUALITY CONTROL
ee>us-xooIIco 2 1 @ 2 4 2 5 2 2 1 5
Q 2 n - 1 0 0  (CV9S) 5 . 8 6 . 2 6 . 6 6 . 4 6 . 9 7 . 2
Q 3 n= 1 00  (CV9S) 3 . 0 3 . 3 3 . 6 4 . 4 3 . 9 3 . 2
0 4  n = 1 0 0  (CV%) 4 . 4 4 . 9 4 . 2 4 . 2 5 . 8 5 . 3
Q5 n=50 (mean6) 2 . 6 2 . 4 4 . 3 3 . 5 4 . 6 3 . 8
- -  Assay separat ion problems, In s en s i t i ve  assays.  
@ Integer values col lected,  thus high CVs.
Table 38 Six months of Internal qual i ty  control:  October 1988 to 
March 1 989
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i v )  G e n e r a l  R o u t i n e  E x p e r i e n c e
The l a b e l l e d  p r o t e i n  s u p p l i e d  by SAPU p r e p a r e d  u s i n g  a 
c h l o r a m i n e - T  i o d i n a t i o n  t e c h n i q u e  g i v e s  good r e s u l t s .  I n  t h e  l o n g  
t e r m  t h i s  m e t h o d  seems t o  p r o d u c e  a more v a r i a b l e  and more f r a g i l e
r e a g e n t ,  as shown by m o n i t o r i n g  t h e  ch a n g e  i n  b i n d i n g  d u r i n g  t h e  A 
we eks  o f  i t s  c u r r e n c y ,  t h a n  t h e  l a c t o p e r o x i d a s e  t e c h n i q u e  w h i c h  was
u s e d  d u r i n g  t h e  v a l i d a t i o n  o f  t h e  m e t h o d .
I n  r o u t i n e  u s e ,  l e a k a g e  o f  a n t i b o d y  f r o m  t h e  5 - l i t r e  b a t c h e s  
o c c u r r e d  d u r i n g  t h e  3 - 4  month  s h e l f  l i f e  o f  t h e  r e a g e n t .  T h i s  c a u s e d  
a s l o w  b u t  s e v e r e  s h i f t  o f  t h e  dose  r e s p o n s e  c u r v e  t o  t h e  r i g h t  
( F i g u r e  3 9 )  and a s s o c i a t e d  l o s s  o f  s e n s i t i v i t y  and p r e c i s i o n .  
A c c o r d i n g l y ,  t h e  a s s a y  p r o t o c o l  was amended t o  i n c l u d e  r o u t i n e  
r e p l a c e m e n t  o f  t h e  s u p e r n a t a n t  b e f o r e  use  ( o r  p e r i o d i c a l l y ) .
I n t e r n a l  q u a l i t y  c o n t r o l  d a t a  f o r  t h e  IRMA showed c o e f f i c i e n t  
o f  v a r i a t i o n  o f  <2% o v e r  t h e  r a n g e  5 - 5 0 0 k U / L  co m p a r e d  w i t h  R IA d a t a  
o f  <5% o v e r  t h e  r a n g e  5 0 - 5 0 0 k U / L .  T h i s  i m p r o v e m e n t  i n  p r e c i s i o n  had 
c o n s i d e r a b l e  e f f e c t  on t h e  w e e k l y  f o l l o w  up f i g u r e s .  The e x t r e m e  
r a n g e  f o r  RIA u s i n g  3% n o m i n a l  f o l l o w - u p  was 0 . 6  t o  4 . 6%  and use  o f  
5% n o m i n a l  f o l l o w - u p  w o u l d  h ave  g i v e n  ev en  g r e a t e r  r a n g e .  The 
m a r k e d l y  i m p r o v e d  p r e c i s i o n  a l l o w e d  a r e d u c t i o n  i n  t h e  i n t e r v e n t i o n
l e v e l  f r o m  t h e  9 7 t h  t o  t h e  9 5 t h  c e n t i l e ,  and t h e  e x t r e m e  r a n g e  o f  
f o l l o w - u p  o v e r  26 weeks was 3 .4%  t o  6 . 6 % .  I m p r o v e d  p r e c i s i o n  has  
e n a b l e d  t h e  i n i t i a t i o n  o f  D o w n ' s  s y n d r o m e  s c r e e n i n g  u s i n g  l o w - M S - A F P  
t o  g i v e  a r i s k  f a c t o r  i n  m o t h e r s  aged  25 y e a r s  and o v e r .  P r a c t i c a l  
e f f e c t s  o f  t h e  p r e c i s i o n  a v a i l a b l e  a r e  shown i n  T a b l e  40 ( t a k e n  f r o m  
S t e v e n s o n  e t  a l . ( 1 9 8 7 ) )  and s u g g e s t  i t s  s u i t a b i l i t y  f o r  us e  i n
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FIGURE 39 Dose-response curves, before and a f t e r  washing (3  
replacements of supernatant ),  f o l lo w in g  s ix -months  storage of  
so l id -p h ase .
Serum Sample  
f r o m
T y p i c a l  AFP 95% c o n f i d e n c e  l i m i t  o f  r e s u l t  ( k U / L )  
r e s u l t  ( k U / L )  IRMA______ R I A - t u m o u r  R I A - m a t e r n a l
N o r m a l  s u b j e c t
T r e a t e d  t u m o u r  5 4 - 6  C r a n g e  < r a n g e
C h o r i o n i c  v i l l u s  s a m p l e  10 9 - 1 1  6 - 1 4  C ra nge
( 6 - 1 0  week p r e g n a n c y )
D o w n ' s  p r e g n a n c y  25 2 3 - 2 7  1 9 - 2 9  1 6 - 3 4
N o r m a l  p r e g n a n c y
( m e d i a n  1 6 - 1 7  w e e k s )  35 3 3 - 3 7  3 1 - 3 9  2 9 - 4 1
A b n o r m a l  p r e g n a n c y  
16 weeks  65 6 2 - 6 8  5 9 - 7 2  5 9 - 7 2
N o r m a l  ( b u t  e q u i v o c a l  l e v e l )  
p r e g n a n c y  20 w eeks  100 9 6 - 1 0 4  9 0 - 1 1 0  9 0 - 1 1 0
T a b l e  40 The e f f e c t  o f  i m p r o v e m e n t  o f  p r e c i s i o n  on t h e  c o n f i d e n c e  
l i m i t s  a c h i e v e d  by  t h r e e  AFP a s s a y  m e t h o d s  i n  v a r i o u s  c l i n i c a l  
s i t u a t i o n s .
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v )  A m n i o t i c  f l u i d  a s s a y
A l i m i t e d  a s s e s s m e n t  o f  t h e  s u i t a b i l i t y  o f  t h e  IRMA f o r  
d i a g n o s t i c  AFP a s s a y  was p e r f o r m e d  u s i n g  38 c o n s e c u t i v e  r o u t i n e ,  and 
12 s t o r e d  a b n o r m a l  a m n i o t i c  f l u i d s .  Each s a m p l e  was p r o c e s s e d  i n  t h e  
r o u t i n e ,  q u a n t i t a t i v e ,  " r o c k e t "  i m m u n o e l e c t r o p h o r e s i s  a s s a y  and t h e n  
d i l u t e d  1 : 1 0 0 0  i n  e a c h  o f  t h r e e  d i l u e n t s ;  EPPS IRMA a s s a y  b u f f e r ,  
b o v i n e  se ru m  and d i s t i l l e d  w a t e r .
R o c k e t  a s s a y  -  X m g / L ,  IRMA -  Y MU/L
B u f f e r  r =  . 9 9 7 7  G r a d i e n t  = . 4 1 2 6  I n t e r c e p t  = . + 2 . 0 9 8
Serum r =  . 9 9 7 4  . 3 8 6 7  + . 3 4 0
W a t e r  r =  . 9 9 8 5  . 4 0 6 0  + 2 . 5 2 5
T h i s  b a t c h  o f  se rum g i v e s  l o w e r  r e c o v e r y  t h a n  t h e  o t h e r  
d i l u e n t s  and b e f o r e  r o u t i n e  use was s t a r t e d  s e v e r a l  o t h e r  s e r a  w ere  
i n v e s t i g a t e d ;  p a r t i c u l a r  b a t c h e s  o f  p o o l e d  s h e e p  o r  human s e r a  w e re  
shown t o  g i v e  r e c o v e r y  o f  >95% ( d a t a  n o t  s h o w n )  and go od  p a r a l l e l i s m .
The r o c k e t  a s s a y  u n i t a g e  i s  u n s t a n d a r d i z e d  a g a i n s t  e x t e r n a l  
c a l i b r a n t s ,  t h u s  no comment  can be made c o n c e r n i n g  t h e  g r a d i e n t s ,  b u t  
i s  b a s e d  on i n t e r n a l  d a t a  c o l l e c t e d  o v e r  6 y e a r s  and  s e v e n  t h o u s a n d  
p r e g n a n c i e s .  C o r r e l a t i o n  c o e f f i c i e n t s  a r e  v e r y  g o o d .  P r e p a r a t i o n  o f  
1 : 1 0 0 0  d i l u t i o n s  i s  r e l i a b l e  u s i n g  t w o - s t a g e  d i l u t i o n ,  m a n u a l l y  o r  
u s i n g  t h e  H a m i l t o n  M i c r o l a b  M ( B o n a d u z ,  S w i t z e r l a n d ) .
R o u t i n e  I R M A - b a s e d  d i a g n o s t i c  a s s a y  w i l l  o n l y  r e q u i r e  t h e  use  
o f  e x t e r n a l  c a l i b r a n t  and i n t e r n a l  s t a n d a r d  f o r  a m p l e  q u a l i t y  c o n t r o l  
o f  t h e  d i l u t i o n  and a s s a y  p r o c e d u r e s .
v i )  O b s e r v a t i o n s
The two  m o n o c l o n a l  a n t i b o d i e s  g e n e r a t e d  i n  t h i s  s t u d y  (A F 5 / A 2  
and A F 4 / B 1 1 )  h a v e  shown t h e i r  s u p e r i o r i t y  o v e r  c o m m e r c i a l  and o t h e r  
a n t i b o d i e s  and a s a t i s f a c t o r y  and c o n v e n i e n t  a s s a y  g e n e r a t e d  f r o m  one 
o f  th e m .
The MS-AFP s c r e e n i n g  p rog ra mm e c u t - o f f  f o r  s t r u c t u r a l  
a b n o r m a l i t i e s  o f  t h e  f o e t u s  has  been  r a i s e d  f r o m  3% t o  5% o f  a l l  
p r e g n a n c i e s .  T a b l e  41 shows t h e  numb er  and t y p e  o f  l e s i o n s  d e t e c t e d  
by se ru m  s c r e e n i n g  i n  t h i s  a r e a  d u r i n g  t h e  y e a r s  1 9 8 4 - 5  t o  1 9 8 7 - 8 .  
D i f f e r e n t  t o t a l  n u m b e r s  o f  l e s i o n s  r e f l e c t  t h e  v a r y i n g  i n c i d e n c e  
r a t e .  The e f f e c t  o f  t h e  chan ge  t o  IRMA t e c h n o l o g y  i s  q u a n t i t a t e d  by 
n o t i n g  t h e  p r e g n a n c i e s  i n  w h i c h  t h e  o l d  i n t e r v e n t i o n  l i m i t  w o u l d  n o t  
h ave  d e t e c t e d  t h e  a b n o r m a l i t y .  O v e r a l l  d e t e c t i o n  r a t e  f o r  open  s p i n a
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b i f i d a  i n c r e a s e d  by 1 6 .5 % .  I n  a d d i t i o n ,  tw o  a n e n c e p h a l i c  f o e t u s e s  
w o u l d  have  been  m i s s e d  i f  t h e  RIA had s t i l l  been  us ed  f o r  s c r e e n i n g .
The w i d e  w o r k i n g  r a n g e  o f  t h e  a s s a y  a l l o w s  a s s e s s m e n t  o f  t u m o u r  
m a r k e r  f o l l o w - u p  and m a t e r n a l  se ru m  s a m p l e s  i n  t h e  same b a t c h .  I t  i s  
n e c e s s a r y  t o  d i l u t e  a l l  a m n i o t i c  f l u i d s  t o  1 : 1 0 0 0  and un kno w n t u m o u r  
m a r k e r  s a m p l e s  t o  1 : 1 0 0 0  i n  a c a r e f u l l y  s e l e c t e d  d i l u e n t .  The a s s a y  
i s  u s e d  f o r  f o r  m o n i t o r i n g  s m a l l  n u m b e r s  o f  t u m o u r  m a r k e r  p a t i e n t s ,  
l a r g e  n u m b e r s  o f  m a t e r n a l  s e r a  and a b o u t  1200  a m n i o t i c  f l u i d  s a m p l e s  
p e r  y e a r .  The m e t h o d  i s  a l s o  u s e d  f o r  r o u t i n e  t u m o u r  m a r k e r  s t u d i e s  
a t  G l a s g o w  R o y a l  M a t e r n i t y  H o s p i t a l .
LESION
A n e n c e p h a l u s
YEAR
RIA
1 9 8 4 - 5  
IRMA
1 9 8 5 - 6
1 9 8 6 - 7
1 9 8 7 - 8
18
26 ( 0 )  
24 ( 2 )  
17 ( 0 )
S p i n a
B i f i d a
24
33 ( 7 )  
35 ( 4 )  
31 ( 3 )
A n t e r i o r  A b d o m i n a l  Body S t a l k  O t h e r s
W a l l  D e f e c t
4 ( 0 )  
13 ( 2 )  
6 ( 0 )
A b n o r m a l i t y
0 ( 0 )
3 ( 0 )
4 ( 1 )
T a b l e  41 E f f e c t  o f  c h a n g i n g  i n t e r v e n t i o n  l i m i t s  f r o m  9 7 t h  t o  9 5 t h  
c e n t i l e .  The f i g u r e s  i n  b r a c k e t s  a r e  l e s i o n s  w h i c h  w o u l d  h a v e  been  
m i s s e d  u s i n g  t h e  R I A .
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CHAPTER 4 DISCUSSION
The p r i m a r y  o b j e c t i v e  o f  t h i s  p r o j e c t  was t o  d e v e l o p  a r o b u s t ,  
l o w - c o s t ,  s e n s i t i v e  and s p e c i f i c  IRMA f o r  AFP a s s a y  i n  b i o l o g i c a l  
f l u i d s ,  by u s i n g  h y b r i d o m a  t e c h n o l o g y  t o  g e n e r a t e  h i g h  a v i d i t y ,  
m o n o c l o n a l  a n t i b o d i e s .  The o b j e c t i v e  has  bee n  a c h i e v e d ,  and t h e  
d i s c u s s i o n  i s  d i v i d e d  i n t o  s i x  s e c t i o n s ;  A:  A n t i b o d y  g e n e r a t i o n
m e t h o d s ,  B:  AFP a s s a y  t e c h n i q u e s ,  C: L i m i t a t i o n s  o f  t h e  d e v e l o p e d
a s s a y ,  D: P o s s i b l e  i m p r o v e m e n t s ,  E:  C l i n i c a l  i m p a c t  on NTD s c r e e n i n g  
i n  t h e  West  o f  S c o t l a n d ,  F :  A u t o s o m a l  t r i s o m y  and G: C o n c l u d i n g
o b s e r v a t i o n s .
4A ANTIBODY GENERATION METHODS
The s t r a t e g y  ( s e e  F a z e k a s  de S t .  G r o t h  & S c h e i d e g g e r  1980  and 
James e t  a l . 1 9 8 4 )  e m p l o y e d  i n  t h e  p r o j e c t  was t o  i m m u n i s e  m i c e  u s i n g  
a m n i o t i c  f l u i d  c o n t a i n i n g  a h i g h  c o n c e n t r a t i o n  o f  AFP w i t h  s u b s e q u e n t  
c r e a t i o n  and s e l e c t i o n  o f  a n t i - A F P  s e c r e t i n g ,  h y b r i d o m a  c e l l  l i n e s .  
The v e r y  h i g h  s u c c e s s  r a t e  w i t h  t h i s  a p p r o a c h  may r e p r e s e n t  a 
c o m b i n a t i o n  o f  f a c t o r s .
E x p e r i e n c e  o f  g e n e r a t i o n  o f  p o l y c l o n a l  a n t i b o d i e s  a t  t h e  
S c o t t i s h  A n t i b o d y  P r o d u c t i o n  U n i t  s i n c e  t h e  i n c e p t i o n  o f  m a t e r n a l  
se ru m  s c r e e n i n g  p ro g ra mm e AFP a s s a y s  i n  1975  has  shown t h a t  t h e  
m o l e c u l e  i s  h i g h l y  i m m u n o g e n i c ,  and i t  i s  common t o  f i n d  
h i g h - a f f i n i t y  a n t i b o d i e s  i n  i m m u n i z e d  a n i m a l s  ( s h e e p  and g o a t s ,  
u n p u b l i s h e d  o b s e r v a t i o n s ) .  The r e a s o n s  f o r  t h i s  a r e  p o s s i b l y  
c o n n e c t e d  w i t h  i t s  p re su m ed  f u n c t i o n  as a t r a n s p o r t  p r o t e i n  f o r  w h i c h  
i t  w o u l d  r e q u i r e  a v a r i e t y  o f  i m m u n o g e n i c  b i n d i n g  s i t e s  w h i c h  w o u l d  
a c t  as e p i t o p e s .  AFP a l s o  c o n t a i n s  a b o u t  4% c a r b o h y d r a t e  ( R u o s l a h t i  
and H i r a i  1 9 7 8 ) .
The f u s i o n  t e c h n i q u e  was b a s e d  on s e v e r a l  p u b l i s h e d  m e t h o d s ,  
b u t  p o s s i b l y  i m p o r t a n t  l o c a l  m o d i f i c a t i o n s  i n c l u d e d  t h e  use  o f  a 1 : 1  
r a t i o  o f  mye lo ma  t o  s p l e e n  c e l l s  and t h e  u b i q u i t o u s  use  o f  3000  
c e l l s / w e l l  ( 9 6 - w e l l  p l a t e )  m a c r o p h a g e  f e e d e r  c e l l s .  I t  p r o v e d  v e r y  
s u c c e s s f u l  i n  g e n e r a t i n g  v e r y  l a r g e  n u m b e r s  o f  h y b r i d  c e l l  l i n e s  
( s e v e r a l  p e r  w e l l )  and l a r g e  n um be rs  o f  a n t i b o d y - s e c r e t i n g ,  h y b r i d  
c e l l  l i n e s .  R o b u s t n e s s  o f  t h e  c e l l  l i n e s  was e n s u r e d  by a l l o w i n g
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them t o  g ro w  i n  c o m p e t i t i o n  w i t h  n o n - s e c r e t i n g  l i n e s  and t h e  l i n e s  
c h o s e n  f o r  e x t e n s i v e  i n v e s t i g a t i o n  p r o v e d  s t a b l e  t h r o u g h  a l l  
p r o c e d u r e s .
To e n s u r e  t h a t  o n l y  s u i t a b l e  a n t i b o d i e s  w e r e  i n v e s t i g a t e d ,  t h e  
i n i t i a l  s c r e e n i n g  p r o c e d u r e  was b i p h a s i c .  The f i r s t  s t a g e  d e t e c t e d  
t h e  p r e s e n c e  o f  a n t i - A F P  s e c r e t i n g  c e l l  l i n e s ,  b u t  c o u l d  n o t  
d i s t i n g u i s h  b e t w e e n  r o b u s t  c o l o n i e s  s e c r e t i n g  l a r g e  a m o u n t s  o f  
l o w - a f f i n i t y  a n t i b o d y  and s l o w e r  g r o w i n g  c o l o n i e s  s e c r e t i n g  s m a l l  
a m o u n t s  o f  h i g h - a f f i n i t y  a n t i b o d y .  The s e c o n d  s t a g e ,  d i s p l a c e m e n t  
t e s t i n g ,  e n a b l e d  a r a p i d  a s s e s s m e n t  o f  t h e  p o t e n t i a l  a f f i n i t y  o f  t h e  
a n t i b o d i e s .  T h i s  r i g o r o u s  s e l e c t i o n  a l s o  r e d u c e d  t h e  n e e d  t o  c l o n e  
l a r g e  num b e r s  o f  c e l l  l i n e s .
A t  e ach  s t a g e  and p e r i o d i c a l l y ,  e s p e c i a l l y  a f t e r  e a c h  c l o n i n g  
p r o c e d u r e  and b e f o r e  f r e e z i n g  down,  t h e  c e l l  l i n e s  w e r e  t e s t e d  f o r  
d i s p l a c e m e n t  t o  c o n f i r m  t h e  m a i n t e n a n c e  o f  t h e  d e s i r e d  
c h a r a c t e r i s t i c s .
The s y s t e m  f o r  a n t i - A F P  a n t i b o d y  g e n e r a t i o n  was p a r t  o f  a 
s m a l l ,  h i g h l y  m o t i v a t e d  team w o r k i n g  i n  p a r a l l e l  on a numb er  o f  
a n t i g e n s ;  t h i s  c o n f e r r e d  e f f i c i e n c y ,  s p e e d  and  f l e x i b i l i t y  on t h e  
s y s t e m .
4B AFP ASSAY TECHNIQUES
F o l l o w i n g  t h e  p a p e r  w r i t t e n  by B r o c k  & S u t c l i f f e  ( 1 9 7 2 )  
and t h e  i n - h o u s e  d e v e l o p m e n t  o f  a s u i t a b l e  R IA ( V i n c e  e t  a l . 1 9 7 5 ) ,  
t h e r e  has  been  a m a t e r n a l  se rum s c r e e n i n g  p ro g r a m m e  f o r  AFP i n  t h e  
West  o f  S c o t l a n d  s i n c e  1 9 7 5 .  E x p e r i e n c e  and c o s t - b e n e f i t  a n a l y s i s  
( F e r g u s o n - S m i t h  e t  a l . 1 9 7 8 ,  C h a m b e r l a i n  1 9 7 8 )  l e d  t o  w i d e s p r e a d  
a v a i l a b i l i t y  o f  t h e  t e s t ;  23 l a b o r a t o r i e s  w e re  p a r t i c i p a t i n g  i n  t h e  
U n i t e d  K in gdom  E x t e r n a l  Q u a l i t y  A s s e s s m e n t  Scheme i n  1976  ( S e t h  
e t  a l . 1 9 8 8 ) ,  and t h a t  f i g u r e  i s  now 1 0 3 .  T h i s  i n c l u d e s  s e v e r a l
l a b o r a t o r i e s  whose  s o l e  use  f o r  AFP a s s a y  i s  as a t u m o u r  m a r k e r .  
A l t h o u g h  t h e  p r i n c i p l e  o f  IRMA had been  e x p o u n d e d  i n  1968  by M i l e s  
and H a l e s ,  i n t r o d u c t i o n  o f  r e l i a b l e  m e t h o d s  had  t o  a w a i t  t h e  
d e v e l o p m e n t  o f  h i g h - a f f i n i t y  m o n o c l o n a l  a n t i b o d i e s  a v a i l a b l e  i n  l a r g e  
q u a n t i t y .  RIA a c c o u n t e d  f o r  a l l  o f  t h e  23 a s s a y s  i n  1 9 7 6 .  I n  e a r l y  
1 9 8 8 ,  78 l a b o r a t o r i e s  s t i l l  used  RIA (3 0  u s i n g  one o f  t h r e e  t y p e s  o f
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c o m m e r c i a l  k i t s )  and o n l y  13 u sed  IRMA (1 0  u s i n g  one o f  t h r e e  
c o m m e r c i a l  k i t s  t h e  o t h e r  t h r e e  use  t h e  d e s c r i b e d  i n - h o u s e  m e t h o d ) .  
F o r  t h e  r e s t ,  11 use one o f  6 n o n - i s o t o p i c  c o m m e r c i a l  k i t s  and one 
l a b o r a t o r y  u s e s  an i n - h o u s e  n o n - i s o t o p i c  m e t h o d .
The p o t e n t i a l l y  d e s i r a b l e  c h a r a c t e r i s t i c s  ( H u n t e r  1 9 8 2 )  o f  a 
m o n o c l o n a l  a n t i b o d y  ba s e d  IRMA a r e  shown g r a p h i c a l l y  i n  F i g u r e  42 and 
h a v e  been  r e a l i s e d  w i t h  t h e  d e v e l o p m e n t  o f  a p r e c i s e  and  
c o m p r e h e n s i v e  a s s a y .  I t  i s  r o b u s t ,  c o n v e n i e n t  t o  use  and u n d e m a n d i n g  
o f  r o u t i n e  s k i l l s .  The r e a g e n t s  a r e  a c c e s s i b l e  and s t r a i g h t f o r w a r d  
i n  p r e p a r a t i o n  and have  been made a v a i l a b l e  t o  a l l  NHS l a b o r a t o r i e s  
( w i t h o u t  c h a r g e  i n  S c o t l a n d ) .  The h i g h  a v i d i t y  a n t i b o d y  p r o v i d e s  t h e  
s e n s i t i v i t y  n e c e s s a r y  t o  i n v e s t i g a t e  t h e  s i g n i f i c a n c e  o f  s m a l l  
c h a n g e s  i n  c o n c e n t r a t i o n  a t  l o w  l e v e l s  and t o  g i v e  a more r e s p o n s i v e  
f o l l o w  up f o r  t u m o u r  m a r k e r  s t u d i e s .  The f o l l o w - u p  r a t e s  and m o n t h l y  
m e d i a n  f i g u r e s  a r e  s t a b l e  and a p p r o p r i a t e .
L i p a e m i a  and h a e m o l y s i s  hav e  n o t  been  shown t o  a f f e c t  t h e  
a p p a r e n t  AFP l e v e l  and t h e  new a s s a y  i s  much l e s s  s e n s i t i v e  t o  m a t r i x  
e f f e c t s ,  a l l o w i n g  t h e  use o f  p l a s m a  and  s e ru m  s a m p l e s  i n  t h e  a s s a y .  
W i t h  d i l u t i o n  i n  a s u i t a b l e  m a t r i x ,  t h e  m e t h o d  i s  u s e f u l  f o r  a m n i o t i c  
f l u i d  AFP e s t i m a t i o n .
The m o n o c l o n a l  a n t i b o d y  A F 5 / A 2  h a s  been  p u r c h a s e d  by a 
c o m m e r c i a l  company  t o  f o r m  one h a l f  o f  a d o u b l e  m o n o c l o n a l ,  
n o n - i s o t o p i c  i m m u n o a s s a y .
The b i a s  shown i n  t h e  EQAS scheme ha s  been  i n v e s t i g a t e d :  EQAS 
r e c o v e r y  s a m p l e s  a r e  a l w a y s  p o s i t i v e l y  b i a s e d .  The m a g n i t u d e  o f  t h e  
b i a s  has  v a r i e d  f r o m  5% t o  12% d e s p i t e  t h e  i n - h o u s e  use  o f  B S 7 2 / 2 2 7  
s t a n d a r d s .  I n t e r n a l  q u a l i t y  c o n t r o l s  a r e  p r e p a r e d  f r o m  human p o o l e d  
s e r a  w i t h  added  h i g h - t i t r e  AFP f o r  w h i c h  a c c u r a t e  r e c o v e r y  d a t a  i s  
n o t  c o l l a t e d .
A l i m i t e d  a s s e s s m e n t  ( s e c t i o n  3B i x ) )  c o m p a r i n g  t h e  n e w l y  
d e v e l o p e d  a s s a y  w i t h  a c o m m e r c i a l  d o u b l e - m o n o c l o n a l ,  i s o t o p i c  IRMA 
sho w ed  t h e  i n - h o u s e  m et hod  t o  h a v e  b e t t e r  s e n s i t i v i t y  ( F i g u r e  16 
A f t e r  Page 4 1 ) ,  b u t  i n  o t h e r  r e s p e c t s  was n o t  d i s t i n g u i s h a b l e .
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4C L IM IT A T I O N S  OF THE DEVELOPED ASSAY
The f o l l o w i n g  a d v a n t a g e s  o f  IRMA w e re  c o n s i d e r e d  g e r m a n e ;  
s m a l l e r  s a m p l e  v o l u m e ,  g r e a t e r  w o r k i n g  r a n g e ,  g r e a t e r  s e n s i t i v i t y ,  
g r e a t e r  p r e c i s i o n ,  r o b u s t n e s s  and s h o r t e r  i n c u b a t i o n  t i m e .  I t  was 
a l s o  i m p o r t a n t  t h a t  t h e  f i n a l  p r o t o c o l  was s t r a i g h t f o r w a r d  and 
r e q u i r e d  o n l y  c h e a p ,  a c c e s s i b l e  r e a g e n t s  and no i n v e s t m e n t  i n  
e x p e n s i v e ,  s p e c i a l i z e d  e q u i p m e n t .  The s o l e  d i s a d v a n t a g e  t o  be 
e x p e c t e d  was t h e  p r e s e n c e  o f  t h e  " h i g h - d o s e  h o o k "  e f f e c t .  T h i s  i s  an 
i n e v i t a b l e  c o n s e q u e n c e  o f  t h e  t w o - s i t e  t e c h n i q u e ;  w i t h  n o r m a l  o r  h i g h  
l e v e l s  o f  AFP i n  t h e  s a m p l e ,  t h e  l a b e l  p r e c i p i t a t e d  i s  p r o p o r t i o n a l  
t o  t h e  c o n c e n t r a t i o n  o f  AFP. H o w e v e r ,  w i t h  a g r o s s  e x c e s s  o f  a n a l y t e  
i n  t h e  s a m p l e  b o t h  r e a g e n t  a n t i b o d i e s  a r e  s e p a r a t e l y  bou n d  t o  t h e  
a n t i g e n  and t h e  l a b e l  p r e c i p i t a t e d  i s  t h e n  i n v e r s e l y  p r o p o r t i o n a l  t o  
i n c r e a s i n g  AFP c o n c e n t r a t i o n .  The l e n g t h  o f  t h e  p l a t e a u  c a n  be 
q u a n t i t a t e d  e a s i l y  and  p r o b l e m s  m i n i m i z e d  by r i g o r o u s  q u a l i t y
a s s e s s m e n t  o f  new b a t c h e s  o f  t h e  s o l i d - p h a s e  r e a g e n t .
The h i g h - d o s e  hook  e f f e c t  ( s h o w n  i n  F i g u r e  4 2 ) ,  w h i c h  c a u s e s  
d e c r e a s i n g  b i n d i n g s  o v e r  a b o u t  2 5 , 0 0 0 k U / L  w i t h  t h e s e  r e a g e n t s ,  i s  n o t  
a p r o b l e m  i n  m a t e r n a l  se rum s c r e e n i n g  p r o g r a m m e s .  I n  2 5 0 , 0 0 0  
m a t e r n a l  s e r a  i n  t h e  West  o f  S c o t l a n d  none  has  e x c e e d e d  1 6 , 0 0 0 k U / L .  
To use  t h i s  a s s a y  m et h o d  i n  t u m o u r  m a r k e r  s t u d i e s ,  i n  w h i c h  l e v e l s  o f  
2 5 0 , 0 0 0 k U / L  a r e  n o t  uncommon,  i t  i s  rec om me nded  t h a t  a l l  unknow n 
s a m p l e s  be a s s a y e d  t w i c e ;  n e a t  and a t  a d i l u t i o n  o f  1 i n  1000
( S t e v e n s o n  e t  a l . 1 9 8 7 ) .
The need  t o  use  seru m s t a n d a r d s  n e c e s s i t a t e s  c a r e f u l  a s s e s s m e n t  
o f  c a n d i d a t e  m a t r i c e s .  I t  i s  a l s o  p o s s i b l e  t h a t  b i o l o g i c a l  f l u i d s  
o t h e r  t h a n  serum  m i g h t  r e q u i r e  d i f f e r e n t  d i l u e n t s  t o  m a i n t a i n  
a c c e p t a b l e  r e c o v e r y  and p a r a l l e l i s m .  Thus  a m n i o t i c  f l u i d  IRMA a s s a y ,  
w h i c h  r e q u i r e s  1 i n  1000  p r e d i l u t i o n  o f  a l l  s a m p l e s ,  n e e d s  s e p a r a t e
a s s e s s m e n t  o f  d i l u e n t  b e f o r e  i n t r o d u c t i o n  i n t o  r o u t i n e  u s e .  S i m i l a r
r e c o v e r y  and p a r a l l e l i s m  e x p e r i m e n t s  s h o u l d  be p e r f o r m e d  when t h e  
b a t c h  o f  d i l u e n t  i s  c h a n g e d  o r ,  f o r  e . g .  t u m o u r  m a r k e r  s a m p l e s ,  w h e r e  
t h e  AFP i s  f r o m  a d i f f e r e n t  s o u r c e  and may p o s s e s s  d i f f e r e n t  
e p i t o p e s .
The m i x e d  r e a g e n t  a d d i t i o n  a s s a y  c o m p r o m i s e s  t h e  u l t i m a t e  
s e n s i t i v i t y  and r e q u i r e s  l o n g e r  i n c u b a t i o n  t i m e ,  b u t  r e d u c e s  o p e r a t o r  
i n t e r v e n t i o n s  and o p e r a t o r  t i m e  c o n s i d e r a b l y .  The use  o f  a
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r a d i o a c t i v e  l a b e l  as t r a c e r  on t h e  m o n o c l o n a l  
s h e l f  l i f e  o f  t h i s  r e a g e n t  t o  60 d a y s ,  
s o l i d - p h a s e  r e a g e n t  i s  a t  l e a s t  12 m o n t h s ,  b u t  
wash t h e  r e a g e n t  b e f o r e  use  t o  p r e v e n t  a p p a r e n t
a n t i b o d y  l i m i t s  t h e  
The s h e l f  l i f e  o f  t h e  
i t  i s  n e c e s s a r y  t o  
















FIGURE 4 2  T h e  s y m m e t r i c a l  s ta n d a r d  c u r v e  t y p i c a l  o f  IRMA 
t e c h n iq u e s ,  s h o w in g  c o m p a ra b le  d a t a  f o r  an RIA.
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4D POSSIBLE IMPROVEMENTS
I n  t h e  s h o r t - t e r m  a m a g n e t i c  s o l i d - p h a s e , u s i n g  D y n o s p h e r e s  (TM 
D y n a l  L t d ,  L i v e r p o o l  UK) w i t h  an a f f i n i t y - p u r i f i e d  p o l y c l o n a l  
a n t i b o d y ,  i s  b e i n g  e v a l u a t e d  b e c a u s e  o f  t h e  p o t e n t i a l  r e d u c t i o n  i n  
i n c u b a t i o n  and s e p a r a t i o n  t i m e s  and i n c r e a s e  i n  p r e c i s i o n  a s s o c i a t e d  
w i t h  t h i s  t y p e  o f  r e a g e n t .
The r e l i a b i l i t y  o f  t h e  IRMA a s s a y  d u r i n g  r o u t i n e  use  ( d e s p i t e  
t h e  use  o f  a p a r t i a l l y  p u r i f i e d ,  p o l y c l o n a l  a n t i s e r u m  l i n k e d  t o  t h e  
s o l i d  p h a s e )  i s  r e a s s u r i n g ,  b u t  t h e  a s s a y  c o u l d  be c o n s i d e r a b l y  
i m p r o v e d  by u s i n g  a n o t h e r  m o n o c l o n a l  a n t i b o d y  t o  f o r m  a 
m o n o c l o n a l - m o n o c l o n a l  s a n d w i c h .  A l t h o u g h  t h i s  w o u l d  n o t  be l i k e l y  t o  
h a v e  s u c h  a d r a m a t i c  e f f e c t  on AFP a s s a y  as t h e  c h a n g e  f r o m  RIA t o  
IRMA i t  w o u l d  be e x p e c t e d  t o  ha ve  some o r  a l l  o f  t h e  f o l l o w i n g  
e f f e c t s ;  s h o r t e r  i n c u b a t i o n  t i m e ,  s m a l l e r  s a m p l e  v o l u m e ,  i m p r o v e d  
w o r k i n g  r a n g e ,  more e c o n o m i c a l  use  o f  t h e  s o l i d  p h a s e  a n d / o r  l a b e l  
and  r e d u c e d  o p e r a t o r  d e p e n d e n c e .  Owing t o  t h e  g r e a t  s p e c i f i c i t y  o f  
t h e  ' m o n o c l o n a l  a n t i b o d y ,  i t  w o u l d  r e q u i r e  e x t e n s i v e  c o m p a r i s o n  w i t h  
t h e  e x i s t i n g  t e c h n i q u e  t o  e n s u r e  no l o s s  o f  p r a c t i c a l  s e n s i t i v i t y ,  
w h i c h  i s  t h e  d e t e c t i o n  o f  a b n o r m a l  p r e g n a n c i e s .
The p a t t e r n  o f  b i n d i n g  o f  AFP t o  p l a n t  a g g l u t i n i n s  ( l e c t i n s ) ,  
w h i c h  r e c o g n i z e  c a r b o h y d r a t e  s i d e - c h a i n s ,  shows t h a t  AFP p o s s e s s e s  
some d e g r e e  o f  h e t e r o g e n e i t y ,  p r e s u m a b l y  d e p e n d i n g  on t h e  s o u r c e  o f  
AFP and t h e  numb er  and n a t u r e  o f  t h e  b a r r i e r s  t h r o u g h  w h i c h  i t  
p a s s e s .  The e x t r e m e  s p e c i f i c i t y  o f  a n t i b o d i e s  s h o u l d  be a b l e  t o  make 
use  o f  t h i s  h e t e r o g e n e i t y  t o  p r o d u c e  d i s e a s e -  o r  a b n o r m a l i t y - s p e c i f i c  
a s s a y s  and t h u s  i m p r o v e  d i f f e r e n t i a l  d i a g n o s i s .
The h e t e r o g e n e i t y  i s  a p o t e n t i a l  p r o b l e m  i n  IRMA w h e r e  o n l y  one 
( o r  t w o )  h i g h l y  s p e c i f i c  m o n o c l o n a l  a n t i b o d y ( i e s ) i s  ( a r e )  u s e d ;  i t  
may be t h a t ,  f o r  m a t e r n a l  se ru m  s c r e e n i n g ,  a m i x t u r e  o f  2 t o  5 
l a b e l l e d  m o n o c l o n a l  a n t i b o d i e s  and  2 t o  5 s o l i d - p h a s e  a n t i b o d i e s  
w o u l d  g i v e  b e t t e r  p a r a l l e l i s m ,  even  l e s s  d e p e n d e n c e  on m a t r i x  and 
b e t t e r  d i f f e r e n t i a l  d i a g n o s i s .
The d e v e l o p m e n t  o f  a h i g h l y  s e n s i t i v e  i m m u n o a s s a y  f o r  AFP u s i n g  
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c o n v e n t i o n a l  - I  t e c h n o l o g y ,  d e s p i t e  t h e  d e v e l o p m e n t  o f
t i m e - r e s o l v e d  f l u o r e s c e n c e  ( S u o n p a a  e t  a l . 1 9 8 5 )  and s e v e r a l  o t h e r  
l a b e l l i n g  t e c h n i q u e s ,  was d i c t a t e d  by  t h e  i n - h o u s e  a v a i l a b i l i t y  o f  
e q u i p m e n t .  The m o n o c l o n a l  a n t i b o d y  i s  s u i t a b l e  f o r  t h e  more  mo der n
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a s s a y  m e t h o d s ,  a l t h o u g h  t h e s e  h a v e  n o t  y e t  d e m o n s t r a t e d  m a r k e d  
s u p e r i o r i t y  o v e r  t h e  IRMA t e c h n i q u e  now i n  r o u t i n e  u s e ,  as has  been  
d e m o n s t r a t e d  by i t s  c o m m e r c i a l  a c c e p t a b i l i t y .
A l t h o u g h  t h e  d e t e c t i o n  and q u a n t i t a t i o n  o f  r a d i o a c t i v i t y  i s  
s t r a i g h t f o r w a r d ,  t h e  t h e o r e t i c a l  s e n s i t i v i t y  i s  s e v e r e l y  l i m i t e d  when 
c o m p a r e d  w i t h  s y s t e m s  i n  w h i c h  t h e  s i g n a l  can  be a m p l i f i e d  by t h e  
l a b e l ,  e . g .  p a r t i c l e - c o u n t i n g  ( C o l e t - C a s s a r t  e t  a l . 1 9 8 1 ) ,
c h e m i l u m i n e s c e n c e  (Weeks e t  a l . 1983  and John e t  a l . 1 9 8 6 ) ,  en zym es  
( E L I S A ;  M c D o n a ld  & K e l l y  1 9 78 ,  B r o c k  e t  a l . 1 9 82 ,  Chan e t  a l . 1 9 8 6 )
and  f l u o r e s c e n c e  (S u o n p a a  e t  a l . 1985 and Chan e t  a l . 1 9 8 7 ) .
A l t h o u g h  t h e s e  r e a g e n t s  a r e  l e s s  h a z a r d o u s  t h a n  r a d i o a c t i v i t y ,  t h i s  
may n o t  a p p l y  t o  t h e i r  p r e p a r a t i o n  and a g r e a t e r  d e p e n d e n c e  on 
h i g h l y - d e v e l o p e d  c o m m e r c i a l  k i t s  may e n s u e .  The t e c h n i q u e s  r e q u i r e
s o p h i s t i c a t e d  t e c h n o l o g y  i n  t h e  p r e p a r a t i o n  o f  t h e  l a b e l s  and i n  t h e  
d e t e c t i o n  s y s t e m s .  The a v a i l a b i l i t y  o f  h i g h - a v i d i t y , m o n o c l o n a l  
a n t i b o d i e s  has  s t i m u l a t e d  i n v e s t m e n t  i n  t h e s e  m e t h o d s ,  w h i c h  a r e  
p o t e n t i a l l y  s u p e r i o r  i n  ease  o f  s t a r t i n g  up MS-AFP and D o w n ' s  
Syn d ro m e  s c r e e n i n g  p r o g r a m m e s .
4E C LI N IC AL  IMPACT ON NTD SCREENING IN THE WEST OF SCOTLAND
The i m p a c t  o f  MS-AFP s c r e e n i n g  on open  n e u r a l  t u b e  d e f e c t s  i n  
E n g l a n d  and Wa les  i s  d e s c r i b e d  by C u c k l e  & Wald ( 1 9 8 7 )  and  t h e  s t a t u s  
i n  S c o t l a n d  i s  g i v e n  by F e r g u s o n - S m i t h  ( 1 9 8 3 ) .  T a b l e  43 shows  t h e  
a m n i o c e n t e s i s  r a t e  ( p e r  t h o u s a n d  p a t i e n t s  s c r e e n e d )  i n  t h e  West o f  
S c o t l a n d  d u r i n g  t h e  y e a r s  1 9 7 6 - 1 9 8 6  and t h e  r e s u l t s  o f  c a r e f u l  and 
c o m p l e t e  a s c e r t a i n m e n t  o f  t h e  t o t a l  i n c i d e n c e  o f  n e u r a l  t u b e  d e f e c t s .  
D u r i n g  t h i s  p e r i o d  t h e  p r e v a l e n c e  o f  NTD f l u c t u a t e d  b e t w e e n  2 . 4  and 
5 . 4  p e r  t h o u s a n d ,  w h i l e  b i r t h  i n c i d e n c e  was r e d u c e d  by t e r m i n a t i o n  o f  
61% o f  t o t a l  NTDs. The e f f e c t  o f  IRMA on t h e  numb er  o f  a m n i o c e n t e s e s  
i s  m a r k e d ,  b u t  has  r e d u c e d  ( f o r  NTD i n d i c a t i o n )  s i n c e  19 86  as a 
r e s u l t  o f  i m p r o v e d  u l t r a s o u n d  t e c h n i q u e s  and e q u i p m e n t .
As shown i n  T a b l e  4 2 ,  t h e  e f f e c t  o f  t h e  i n t r o d u c t i o n  o f  t h e  
IRMA and t h e  c o n s e q u e n t  r e d u c t i o n  o f  t h e  i n t e r v e n t i o n  l e v e l  f r o m  t h e  
9 7 t h  t o  t h e  9 5 t h  c e n t i l e ,  o v e r a l l  d e t e c t i o n  r a t e  f o r  op en  s p i n a  
b i f i d a  i n c r e a s e d  by 16 .5 % .  I n  a d d i t i o n ,  tw o  a n e n c e p h a l i c  f o e t u s e s  
w o u l d  have  been m i s s e d  i f  t h e  RIA had s t i l l  been u s e d  f o r  s c r e e n i n g .
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The r e l a t i o n s h i p  b e t w e e n  m a t e r n a l  w e i g h t  and s e ru m  AFP and i t s  
e f f e c t  on s c r e e n i n g  f o r  n e u r a l  t u b e  d e f e c t s  was n o t e d  by Haddow 
e t  a l . ( 1 9 8 1 )  and q u a n t i f i e d  by Wald e t  a l . ( 1 9 8 1 ) .  I t  was s u g g e s t e d  
as a way o f  r e d u c i n g  s c r e e n i n g  p ro gr am m e f a l s e  p o s i t i v e s  and f a l s e  
n e g a t i v e s ,  b u t  was n o t  i n t r o d u c e d  i n t o  t h e  West  o f  S c o t l a n d  MS-AFP 
s y s t e m  u n t i l  t h e  o n s e t  o f  r i s k  e s t i m a t i o n  f o r  D o w n ' s  Sy nd ro me  
s c r e e n i n g  i n  J u l y  1 9 8 7 .  The p r e c i s i o n  o f  t h e  IRMA a t  r e l a t i v e l y  l o w  
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4F AUTOSOMAL TRISOMY 
i )  B a c k g r o u n d
The f i r s t  r e p o r t e d  a s s o c i a t i o n  o f  l o w  MS-AFP w i t h  a u t o s o m a l
t r i s o m y  by M e r k a t z  e t  a l . i n  1984  was t h e  r e s u l t  o f  a s s i d u o u s
q u e s t i o n i n g  o f  t h e  m e d i c a l  s t a f f  by a p a t i e n t .  T h i s  l e d  t o  a 
r e t r o s p e c t i v e  s t u d y  o f  278  p r e g n a n c i e s  and c o n s i d e r a b l e  i n t e r e s t  i n  
t h e  p o s s i b l e  p r e n a t a l  d i a g n o s i s  o f  a n e u p l o i d i e s . C u c k l e  e t  a l .
( 1 9 8 4 )  f o u n d  a s i g n i f i c a n t  r e d u c t i o n  i n  AFP l e v e l  a t  1 4 - 2 0  weeks  
g e s t a t i o n  ( 0 . 7 2  m u l t i p l e s  o f  t h e  m e d i a n  (MoMs) c o m p a r e d  t o  0 . 9 8  i n  
u n a f f e c t e d  p r e g n a n c i e s )  and s u g g e s t e d  t h a t  a s c r e e n i n g  t e s t  f o r  
d i a g n o s t i c  a m n i o c e n t e s i s  and k a r y o t y p i n g  w i t h  t h e  c u t - o f f  a t  0 . 5  MoMs 
w o u l d  i d e n t i f y  21% o f  D o w n ' s  S yndr om e  (DS) f o e t u s e s  f o r  a 5%
a m n i o c e n t e s i s  r a t e  i f  g e s t a t i o n a l  age c o n f i r m e d  w i t h  u l t r a s o u n d  (W a ld  
e t  a l . 1 9 8 2 ) .  They  p r e d i c t e d  t h a t  r o u t i n e  a m n i o c e n t e s i s  o f  a l l  
m o t h e r s  o v e r  38 y e a r s  c o m b i n e d  w i t h  age d e p e n d e n t  MoM c u t o f f  w o u l d  
d e t e c t  40% o f  D o w n ' s  S yndro me  f o e t u s e s  f o r  a 6 .8%  a m n i o c e n t e s i s  r a t e .
A r e t r o s p e c t i v e  s t u d y  by  S e l l e r  ( 1 9 8 4 )  f o u n d  o n l y  one DS f o r
500  a m n i o c e n t e s e s  b u t  a c a r e f u l l y  c o n t r o l l e d  s t u d y  by M u r d a y  and 
S l a c k  ( 1 9 8 5 )  gave  e n c o u r a g i n g  r e s u l t s .  P a l o m a k i  ( 1 9 8 6 ) ,  u s i n g  o n l y  
one se rum  r e s u l t  (Haddow e t  a l . 1 9 8 6 ) ,  gave  r e s u l t s  o f  a l a r g e  s t u d y
( 5 1 , 0 0 0  s c r e e n i n g  t e s t s )  i n  w h i c h  21% o f  e s t i m a t e d  DS c a s e s  w e re
d e t e c t e d  w h i l e  s u b j e c t i n g  o n l y  2 .1% t o  a m n i o c e n t e s i s .
Comment i n  t h e  L a n c e t  ( E d i t o r i a l  1 9 8 5 )  s t r e s s e d  t h e  i m p o r t a n c e  
o f  t h e  r e d u c e d  r i s k  w her e  t h e  AFP l e v e l  was r e l a t i v e l y  h i g h  ( > 2 . 5  
MoM).  C u c k l e  e t  a l . ( 1 9 8 5 )  f o u n d  a mean MoM i n  a m n i o t i c  f l u i d  f r o m
48 a f f e c t e d  p r e g n a n c i e s  o f  0 . 6 4  c o m p a r e d  t o  1 . 0 2  i n  4005  n o r m a l
p r e g n a n c i e s .  H e r s h e y  e t  a l . ( 1 9 8 6 )  and P a l o m a k i  and Haddow ( 1 9 8 7 )
g a v e  i n d i v i d u a l  odds  c a l c u l a t i o n s  f o r  t h e  s c r e e n i n g  p r o g r a m m e .
S c r e e n i n g  i n  t h e  f i r s t  t r i m e s t e r ,  u s i n g  a s e n s i t i v e  IRMA, has  
been  s u g g e s t e d  by B r a m b a t i  e t  a l . ( 1 9 8 6 )  and B a r k a i  e t  a l . ( 1 9 8 7 )  and 
an e x t e n s i v e  p i l o t  s t u d y  i s  i n  p r o g r e s s  i n  t h e  West  o f  S c o t l a n d .
i i )  S c r e e n i n g
U s i n g  t h e  c o m p r e h e n s i v e  r i s k  e s t i m a t e s  p u b l i s h e d  f o r  D o w n ' s  
S y n d ro m e  by C u c k l e  e t  a l . ( 1 9 8 7 ) ,  t h e  IRMA has  been  u s e d ,  s i n c e  J u l y
1 9 8 7 ,  f o r  a n t e n a t a l  s c r e e n i n g  f o r  f o e t a l  a u t o s o m a l  t r i s o m y  i n  women
o v e r  t h e  age o f  25 y e a r s  i n  t h e  West  o f  S c o t l a n d .  T h i s  r e q u i r e s  t h a t
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t h e  a s s a y  be a c c u r a t e  and p r e c i s e  f r o m  8 ( 0 . 2 5  Mom a t  16 w e e k s )  t o  
100 ( u p p e r  l i m i t  o f  n o r m a l  a t  20 w e e k s )  k U / L .  The a l g o r i t h m  us e s  
u l t r a s o n i c  c o n f i r m a t i o n  o f  g e s t a t i o n ,  w he re  a v a i l a b l e ,  w i t h  m a t e r n a l  
age  and a m a t e r n a l  w e i g h t  c o r r e c t i o n  ( a s  Wald e t  a l . 1 9 8 1 )  t o
c a l c u l a t e  t h e  MoM. The a c t i o n  l i m i t  was s e t  a t  a c o m b i n e d
m i d - t r i m e s t e r  r i s k  o f  D o w n 's  S yn d ro m e  o f  1 : 2 5 0 ,  i n  t h e  l i g h t  o f  t h e
l o c a l  i n c i d e n c e  o f  p r e g n a n c i e s  i n  p a t i e n t s  aged  o v e r  35 y e a r s .  The
e x p e c t e d  p r o p o r t i o n  o f  t h e  p o p u l a t i o n  t o  be i d e n t i f i e d  was 5 .4%  b u t  
o n l y  3 .6% w e re  d e t e c t e d  as a r e s u l t  o f  d i s p a r i t y  b e t w e e n  l o c a l  d a t a  
and p u b l i s h e d  d a t a .  R e s u l t s  f r o m  t h e  f i r s t  y e a r  o f  s c r e e n i n g  a r e  
d e t a i l e d  i n  T a b l e  4 4 .  S u b s e q u e n t l y ,  l o c a l  d a t a  f o r  AFP
c o n c e n t r a t i o n s  i n  a u t o s o m a l  t r i s o m y  p r e g n a n c i e s  ( c h r o m o s o m e s  1 3 ,  18 
and  2 1 )  u s i n g  s c r e e n e d - p o p u l a t i o n  a g e - d i s t r i b u t i o n s  ( C r o s s l e y  e t  a l . 
1 9 8 8 )  were  us ed  f r o m  J u l y  1 9 8 8 .  The c u t - o f f  r i s k  f a c t o r  o f  1 : 2 8 0  was 
e q u i v a l e n t  t o  t h e  m i d - t r i m e s t e r  p o p u l a t i o n  a g e - r e l a t e d  r i s k  o f  a 35 
y e a r  o l d  woman. The p r e d i c t e d  f o l l o w - u p  r a t e  was 6 . 6 % ;  u s i n g  age 
a l o n e ,  and m a t e r n a l  age 35 y e a r s  as c u t - o f f  6 .7% o f  p r e g n a n c i e s  w o u l d  
be f o l l o w e d - u p .  A c t u a l  f o l l o w - u p  i s  c l o s e  t o  t h a t  p r e d i c t e d .
The d e c i s i o n  t o  o f f e r  f u r t h e r  i n v e s t i g a t i o n  ( a m n i o c e n t e s i s )  t o  
t h e  p a t i e n t s  was t a k e n  by t h e  o b s t e t r i c i a n .  P r i o r  t o  t h e  s t a r t  o f  
D o w n ' s  Syndro me s c r e e n i n g  by AFP a s s a y ,  30% o f  m o t h e r s  o v e r  35 y e a r s  
had  a m n i o c e n t e s i s  and none b e l o w  3 5 .  Now o v e r  60% o f  m o t h e r s  aged  
o v e r  35 y e a r s ,  and some 30% o f  m o t h e r s  u n d e r  35 a l l  o f  whom a r e  g i v e n  
a r i s k  f a c t o r  o f  > 1 : 2 8 0  a r e  i n v e s t i g a t e d .  A g e - r e l a t e d  d i a g n o s t i c  
a s s a y  was a s s o c i a t e d  w i t h  a m n i o c e n t e s i s  r a t e  o f  3%, b u t  6 .7%  o f  
m o t h e r s  w e r e  e l i g i b l e .  A F P - r e l a t e d  D o w n ' s  s c r e e n i n g  w o u l d  be 
a s s o c i a t e d  w i t h  6 .6% a m n i o c e n t e s i s  r a t e  i f  a l l  m o t h e r s  i d e n t i f i e d  
w e r e  t o  h av e  a m n i o c e n t e s i s .
P a t i e n t s  s c r e e n e d  d u r i n g  p e r i o d  298 0 0  + 360 #
C om bin ed  r i s k  e s t i m a t e  > 1 : 2 5 0  956  + 200 #
P e r c e n t a g e  c o m b i n e d  r i s k  > 1 : 2 5 0  3 .8%
M a t e r n a l  age l e s s  t h a n  35 y e a r s  334
A m n i o c e n t e s i s  p e r f o r m e d  93 (28%)
3
A u t o s o m a l  T r i s o m y  (21  ) 3
O t h e r  A b n o r m a l i t i e s  (47XXY)  1
A v e r a g e  r i s k  f o r  A u t o s o m a l  T r i s o m y  1 : 1 1 0
M a t e r n a l  age o v e r  35 y e a r s  547
A m n i o c e n t e s i s  p e r f o r m e d  277
C h o r i o n i c  V i l l i  s a m p l e d  50
T o t a l  i n t e r v e n t i o n s  327 (60%)
3
A u t o s o m a l  T r i s o m y  (21  ) 4
O t h e r  A b n o r m a l i t i e s  (4 5 X / 4 6 X Y  m o s a i c )  1
A v e r a g e  r i s k  f o r  A u t o s o m a l  T r i s o m y  1 : 1 4 0
TOTAL AUTOSOMAL TRISOMY_____________________________ ( 1 1 / 1 1 5 6 )  1 : 1 0 5
C a l c u l a t e d  A v e r a g e  R i s k  f o r  age >35 y e a r s ___________________ 1 : 1 2 5
665 p a t i e n t s  w e r e  aged  o v e r  35 y e a r s  b u t  a s s i g n e d  a l o w - r i s k  o f
D o w n ' s  S y n d r o m e .  220 o f  t h e s e  had  a m n i o c e n t e s i s  o r  CVS ( 3 3 % ) .  Two 
3
a b n o r m a l i t i e s  (2 1  ) w e re  f o u n d  i n  t h e  w h o l e  g r o u p ;  r a t i o  1 : 3 3 3
# 360  p a t i e n t s  d i d  n o t  have  serum  AFP a s s a y  b e f o r e  a m n i o c e o t e s i s , o f
whom 200 w o u l d  h a v e  been  i d e n t i f i e d  as " a t  r i s k " .  T h i s  s u b - g r o u p  o f
3 3
200 c o n t a i n e d  4 o f  t h e  5 a b n o r m a l i t i e s  (2  x 13 3 x 21 ) i n  t h e  w h o l e
g r o u p .
T a b l e  44 West  o f  S c o t l a n d  m a t e r n a l  se ru m AFP S c r e e n i n g  Pro gramme 
r e s u l t s  o f  D o w n ' s  Sy nd ro me  S c r e e n i n g  f o r  c o m b i n e d  AFP, m a t e r n a l  age 
and w e i g h t  r i s k s  f o r  J u l y  1987 t o  Ju ne  1 9 8 8 .
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4G CONCLUDING OBSERVATIONS
N e u r a l  t u b e  d e f e c t  s c r e e n i n g  u s i n g  AFP a s s a y  has  be en  f u l l y  
p r o v e n  and t h e  v a l u e  o f  AFP e s t i m a t i o n  has  be en  g r e a t l y  e n h a n c e d  by 
t h e  a d v e n t  o f  D o w n ' s  Syn d ro m e  s c r e e n i n g .  Q u a n t i t a t i o n  o f  o t h e r  
a n a l y t e s ,  e s p e c i a l l y  hCG (Wa ld  e t  a l . 1 9 8 8 a )  and u n c o n j u g a t e d
o e s t r i o l  ( W a l d  e t  a l . 1 9 8 8 b ) ,  i n  c o n j u n c t i o n  w i t h  AFP i s  e v i d e n t l y  o f  
v a l u e  i n  t h i s  a r e a  and t h e  g e n e r a t i o n  o f  a d o u b l e - l a b e l  IRMA, o r  
m i x e d  AFP-IRMA and  hC G -R IA  ( b e c a u s e  o f  t h e  h i g h ,  c o n c e n t r a t i o n  o f  
hC G) ,  m e t h o d  f o r  s i m u l t a n e o u s  and c o s t - e f f e c t i v e  AFP and HCG 
a s s e s s m e n t  i s  b e i n g  a c t i v e l y  i n v e s t i g a t e d .  M i c r o h e t e r o g e n e i t y  o f  AFP 
s u g g e s t s  t h a t  t h e r e  a r e  f u r t h e r  o p p o r t u n i t i e s  f o r  s p e c i f i c  d i a g n o s i s .
An i m p r o v e d  m e t h o d  f o r  AFP d e t e r m i n a t i o n  has been  t h o r o u g h l y  
e v a l u a t e d  and  i n t r o d u c e d  i n t o  t h e  West  o f  S c o t l a n d  m a t e r n a l  se rum  
a l p h a - l - f o e t o p r o t e i n  s c r e e n i n g  p ro g r a m m e .  T h i s  IRMA t e c h n i q u e  i s  
p r e c i s e ,  r o b u s t  and has  a w i d e  w o r k i n g  r a n g e .  I t  has  a l l o w e d  t h e  
m a t e r n a l  se ru m  s c r e e n i n g  p ro g ra mm e i n t e r v e n t i o n  p o i n t  t o  be l o w e r e d  
t o  t h e  9 5 t h  c e n t i l e  ( 2 . 0  MoM) and has  e n a b l e d  t h e  d e v e l o p m e n t  o f  
D o w n ' s  S yn d ro m e  s c r e e n i n g .  T h e r e  i s  no l o n g e r  a ne ed  t o  m a i n t a i n  
s e p a r a t e  a s s a y  p r o t o c o l s  f o r  t u m o u r  m a r k e r  and s c r e e n i n g  a s s a y s .
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